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Abstract 
 
Peter N. Coneski:  Design and Synthesis of Nitric Oxide Releasing Polymers for Biomedical 
Applications 
 
(Under the direction of Professor Mark Schoenfisch.) 
 
 
Poor biocompatibility is an ongoing problem for almost all types of implanted 
medical devices.  The adhesion of cells and proteins at implant surfaces often results in 
serious complications such as infection, scar tissue formation, and thrombosis.  The 
mediation of these effects by the endogenously produced free radical nitric oxide (NO) 
support its use a biocompatibility agent for many types of implantable materials.  My 
dissertation research has focused on the development of materials capable of controllably 
releasing NO to facilitate implant compatibility. 
   To examine the influence of N-diazeniumdiolate structure on NO release 
characteristics and their physical retention within polymeric matrices, various dialkyl 
diamines were synthesized and covalently modified to store NO.  Diazeniumdiolation 
reactions of the synthesized diamines however resulted in the competitive formation of both 
N-diazeniumdiolates and potentially carcinogenic N-nitrosamines.  Amine spacing and total 
alkyl content of these polymer additives were investigated as a means to control the 
efficiency of the diazeniumdiolation reaction.  The ability of these amine compounds to form 
stabilizing hydrogen bonds to a nitrosamine intermediate species controlled the overall 
efficiency of diazeniumdiolation, with compounds more capable of forming intermolecular 
 ii
hydrogen bonds resulting in greater nitrosamine content.  Monoamine compounds were 
shown to predominantly form diazeniumdiolated products due to their inability to form 
stabilizing intermolecular hydrogen bonds. 
 As the characteristics of biomedical implants are closely selected based on their 
intended application, supplementing material properties is not a universal task.  To extend the 
therapeutic benefits of NO release to degradable materials, a group of absorbable NO-
releasing polyesters was synthesized.  Highly crosslinked polyesters were formed by the 
thermal polycondensation and curing of polyols with diacid compounds, followed by a thiol 
functionalization step.  Thiol-modified polymers could then be modified to store and 
controllably release NO via S-nitrosothiol functionalities.  The ability of these materials to 
store and release NO was dependent on the selection of starting materials, curing 
temperatures, and the material’s glass transition temperature.  Reduced bacterial adhesion 
was observed for all NO-releasing polyesters over controls, with materials capable of 
releasing higher amounts of NO providing greater antibacterial character.  Synthesizing these 
polymers from metabolic intermediates and non-toxic compounds resulted in products with 
minimal toxicity to healthy mammalian cells. 
 Further diversification of NO-releasing materials was provided by the synthesis and 
characterization of S-nitrosothiol-modified polyurethanes.  The modification of both hard and 
soft segment domains of polyurethanes was shown to result in the formation of NO-releasing 
polyurethane species.  The extent and characteristics of NO release were shown to be highly 
dependent on NO donor position along the polymer backbone, with more substantial NO 
release resulting from soft segment modified materials.  Increased phase miscibilities were 
 iii
shown to occur as a result of specific hard segment modifications, which in turn influenced 
the extent of NO release. 
 Finally, the fabrication of electrospun polymer microfibers with NO release 
capabilities is reported.  The physical dispersion of various NO donating materials such as 
nanoparticles and low molecular weight compounds was investigated as a means to 
controllably deliver NO to physiological environments.  The release of NO from these 
scaffolds was shown to be diffusion mediated both in terms of solution uptake into the fibers 
and diffusion of NO out of the fiber.  Hydrophobic microfibers exhibited prolonged NO 
release durations compared to hydrophilic materials as they inhibited solution uptake into 
fibers regulating the rate of diazeniumdiolate decomposition.  As a result, microfiber 
diameter also influenced the rate of NO release from fibers due to greater diffusion pathways 
required to trigger NO release via diazeniumdiolate protonation. 
 
 iv
 
 
 
 
 
Acknowledgements 
 
In my opinion, one of the most difficult aspects of preparing this dissertation has been 
attempting to write an acknowledgements section without sounding too sappy.  I’ve started 
countless times only to read what I had just written and then delete everything.  Then I just 
gave up.  I have obviously learned a great deal since being in graduate school as evidenced 
by the following chapters, but I have also come to a rather unexpected conclusion that 
writing an acknowledgements section to a dissertation will inevitably sound a little bit sappy.  
Resistance is futile.  So to begin with an accurate but overused statement, I couldn’t have 
gotten to where I am today without the help of numerous people.  I wouldn’t have even 
gotten to graduate school without support of my parents, who gave me un-ending support and 
motivation, and allowed me to take risks and pursue everything that I wanted to.  I also have 
to thank two high school teachers in particular, Linda Kranick and Chris Shanks, whose 
classes made me realize that a career in the sciences was right for me.  At Clarkson 
University, I had the opportunity to work with and around a group of great professors, 
particularly Devon Shipp and Jim Peploski, that further fueled my passion for Chemistry and 
helped me decide to continue my academic pursuits. 
 Since arriving at UNC the influence of numerous people has guided me through 
graduate school.  First, I need to thank Mark for allowing me to join his lab and pursue a lot 
of research areas that were new and foreign to him; some that worked well, and a lot more 
that didn’t.  I would also like to thank the members of the Schoenfisch lab, past and present, 
as a whole for all of their help.  Kevin Dobmeier and Evan Hetrick for their scientific advice, 
 v
experiment ideas, and introducing me to the deliciousness that was Hector’s (RIP); Susan 
Deupree for the opportunity to collaborate on the NO synergy project; and Laurel (Averett) 
Miner for editing and re-editing manuscripts for me.  I also need to thank Dan (Tony) Riccio, 
BJ Privett, and Alexis (Wells) Carpenter, for being great labmates to work with for the past 4 
(or so) years, and listening to me complain about failed experiments and all of the pitfalls and 
obstructions related to writing manuscripts and dissertation chapters.  Without the three of 
you I probably would have been institutionalized a long time ago.  Although I haven’t had 
the opportunity to work collaboratively with them, I would also like to thank Scott Nichols, 
Wesley Storm, Danielle Herrod and Ahyeon Koh for fostering a creative and productive 
work environment.   Finally, I would like to thank Kavitha Rao, a postdoc who performed 
cytotoxicity experiments for the polyester materials, and Jessica Nash, an undergraduate 
student who helped me to develop the electrospinning project to what it has become. 
 In addition to coworkers, in the Schoenfisch lab, I have also met a group a great 
people while at UNC that helped me through all of the tough times that research threw my 
way.  My fiancée, Julie, has been a great inspiration to me and provided me with all of the 
support that I could have asked for.  You’ve kept me moving forward the past 4 years and 
through all of my stubbornness  taught me that I could be productive without being in lab all 
of the time.  Travis Falconer, Stephanie Urbin, Matt Crowe, and Abby O’Connor, have all 
been great friends and were instrumental in making sure that I took the time to appreciate the 
simple things and reminded me never to take life too seriously.      
 
 
 
 
 
 
 vi
 
 
 
 
 
TABLE of CONTENTS 
List of Tables            xi 
List of Figures           xii 
List of Schemes           xv 
List of Abbreviations and Symbols        xvi 
Chapter 1. Introduction: Improving implant biocompatibility via nitric 
oxide releasing polymers 111 
 
1.1 Overview of Polymeric Biomaterials      111 
1.2 Issues Relating to the Biocompatibility of Medical Devices   1  2 
1.2.1 Infection         1  2 
1.2.2 Thrombosis            4 
1.2.3 Foreign Body Response      1     5 
1.3 Strategies for Improving Polymer Biocompatibility               1  5 
1.3.1 Antibacterial materials        1 6 
1.3.2 Antithrombotic materials             1              6 
1.3.3 Materials eliciting a reduced foreign body response           8 
1.3.4 Nitric oxide’s role in implant biocompatibility                    9 
1.4 Materials containing N-diazeniumdiolate NO donors   110 
1.4.1 Overview of N-diazeniumdiolates        10 
1.4.2 N-diazeniumdiolates as polymer additives      13 
1.4.3 Covalently modified N-diazeniumdiolated polymers     19 
1.5 Materials containing S-nitrosothiol NO donors      26 
1.5.1 Overview of S-nitrosothiols                    26 
1.5.2 S-nitrosothiols as polymer additives                  28 
1.5.3 Covalently modified S-nitrosothiol-containing materials                          31 
 vii
1.6 Future directions of NO-releasing materials   1                        34 
1.7 Summary of dissertation research      137 
1.8 References         140 
 
Chapter 2.   Competitive formation of N-diazeniumdiolates and N-
nitrosamines via anaerobic reactions of polyamines with nitric 
oxide  151 
 
2.1 Introduction         151 
2.2 Experimental         155 
2.2.1 General         155 
2.2.2  Synthesis of N,N’ –Dialkyl Diamines       55 
2.2.3  Nitric oxide addition reactions        68 
2.2.4  Nitric oxide release analysis      168 
2.3  Results and Discussion          69 
2.3.1  Nitric oxide releasing dialkyl diamines    1            69 
2.4  Conclusions         178 
2.5  References         179 
 
Chapter 3.  Degradable nitric oxide-releasing biomaterials via post-
polymerization functionalization of crosslinked polyesters 183 
 
3.1  Introduction         183 
3.2  Experimental           86 
3.2.1  Materials           86 
3.2.2  Characterization          86 
3.2.3  Polyester synthesis                    87 
3.2.4  Polyester functionalization                                         88 
3.2.5  In vitro degradation                                                                           88 
3.2.6  NO release analysis         89 
3.2.7  Bacterial viability                                89 
3.2.8  In vitro toxicity of polyesters        90 
3.3  Results and Discussion          93 
3.3.1  Polyester synthesis and characterization                             93 
3.3.2  In vitro degradation   95 
 viii
3.3.3  Polyester functionalization and nitrosation                 96 
3.3.4  NO release analysis                                                   105 
3.3.5  Bacterial adhesion 106 
3.3.6  In vitro toxicity of polyesters                 107 
3.4  Conclusions         116 
3.5  References         117 
 
Chapter 4.   Synthesis of nitric oxide-releasing polyurethanes with S-
nitrosothiol-containing hard and soft segments 120 
 
4.1 Introduction         120 
4.2 Experimental         122 
4.2.1 Materials         122 
4.2.2 Characterization        122 
4.2.3 General procedure for the S-tritylation of mercaptoacids  123 
4.2.4 General procedure for the coupling of S-trityl mercaptoacids and 
diethanolamine                                                                                         124 
4.2.5 Polyurethane synthesis       125 
4.2.6 Deprotection of protected thiol polyurethane 126 
4.2.7 Polymerization of epichlorohydrin                126 
4.2.8 Polymerization of polyepichlorohydrin-containing polyurethane (PU-
PECH)                                                                 126 
4.2.9 Thiolation of polyepichlorohydrin-containing polyurethane  127 
4.2.10 Casting and nitrosation of thiol-containing polyurethane films  127 
4.2.11 Nitric oxide release characterization                127 
4.3 Results and Discussion        128 
4.3.1 Synthesis and characterization of hard segment-modified polyurethanes
                                                                                                  128 
4.3.2 Synthesis and characterization of soft segment-modified polyurethane 136 
4.3.3 Nitrosation and NO release characterization                                          138 
4.4 Conclusions         147 
4.5 References         148 
   
 ix
Chapter 5.    Nitric Oxide-Releasing Electrospun Polymer Microfibers 151 
   
5.1 Introduction         151 
5.2 Experimental         153 
5.2.1 Materials         153 
5.2.2  Characterization          153 
5.2.3  Synthesis of PROLI/NO                  154 
5.2.4  Fiber formation        154 
5.2.5  Nitric oxide release analysis    1                      155 
5.3  Results and Discussion        155 
5.3.1  Fiber formation    1    1 1   1 1                      155 
5.3.2  Dopant effects on fiber formation  1               158 
5.3.3  Nitric oxide release   1               169 
5.4  Conclusions         174 
5.5  References         175 
 
 
Chapter 6.   Summary and future research directions     178 
 
6.1  Summary and Future Research Directions                           178 
6.2 Conclusions         184 
6.3 References         185 
 
Appendix A.  Supplemental materials for Chapter 2     187 
 
Appendix B.  Supplemental materials for Chapter 3     236 
 
Appendix C.  Supplemental materials for Chapter 4     249 
 
 x
List of Tables 
 
Table 1.1   Concentration dependence of NO activity  112 
 
Table 2.1  NO release characteristics for monoamine and polyamine 
compounds exposed to 4 atm NO for 72 h 175 
 
Table 3.1   Composition of synthesized polyesters.  192 
 
Table 3.2   Melt and curing temperatures for polyesters.     99 
 
Table 3.3   Thermal analysis of polyesters PE1–PE6.  100 
 
Table 3.4  Thermal analysis for functionalized and nitrosated polyesters.  104 
 
Table 3.5  Nitric oxide release characteristics for nitrosated polyesters.  110 
 
Table 3.6  Reduction of P. Aeruginosa adhesion to representative NO-releasing 
polyester substrates.  113 
 
Table 3.7  Statistical analysis of cell viability of L929 mouse fibroblasts 
exposed to polyester degradation products.  115 
 
Table 4.1  Modified chain extender and soft segment polyurethane properties.  141 
    
Table 4.2  Nitric oxide-release properties of nitrosated polyurethanes.  135 
 
Table 5.1  Flow rate dependence on electrospun fiber diameter.  160 
 
Table 5.2  Influence of needle gauge on electrospun fiber diameters.  162 
 
Table 5.3  Influence of dopant type and concentration on fiber diameter  166 
 
Table 5.4  Influence of dopant type on conductivity of electrospinning solutions  171 
 
Table 5.5  Nitric oxide-release characteristics of PROLI/NO-doped electrospun 
polymer microfibers  173 
 
 
 xi
List of Figures 
 
Figure 1.1   Bacterial adhesion at a material surface. Non-specific adhesion 
occurs during Phase 1, with the first appearances of molecular 
bridging occurring after 2-3 h.  Exopolysaccharide secretion 
from the bacterial membranes result in the formation of what is 
known as a bacterial biofilm..  113 
 
Figure 1.2   Typical foreign body response to implanted materials.  After 
implantation, the substrate is non-specifically coated with a layer 
of proteins.  Recruitment of macrophages and other phagocytes 
leads to the formation of foreign body giant cells.  If foreign 
body giant cells are unable to phagocytose the foreign material, 
the material may be sequestered via a dense collagen capsule 
(scar tissue) in a process known as fibrosis.  117 
 
Figure 1.3   Structure of A) DEA/NO sodium salt and B) DETA/NO 
zwitterion   116 
 
Figure 1.4   Structures of A) isobutyltrimethoxysilane (BTMOS), B) N-[3-
(trimethoxysilyl)propyl]diethylenetriamine (DET3), and C) N-(6-
aminohexyl)aminopropyltrimethoxysilane (AHAP3).  24 
 
Figure 1.5  Structures of A) S-nitrosoglutathione (GSNO) and B) S-nitroso-
N-acetylcysteine (SNAC)  1 32 
 
Figure 2.1  Common diazeniumdiolate NO donors and their corresponding 
half lives at pH 7.4 and 37 °C.14,15   163  
 
Figure 2.2 O2-protected diazeniumdiolates: A) sulfonated,16 B) benzyl-
substituted,17 and C) glycosylated.20   164 
 
Figure 2.3  Amine compounds investigated: (1) proline, (2) pyrrolidine, (3) 
piperidine, (4) diethylenetriamine, (17) N,N’-dibutyl 
ethylenediamine (DBED), (18) N,N’-diheptyl ethylenediamine 
(DHED), (19) N,N’-dilauryl ethylenediamine (DLED), (20) 
N,N’-dipalmityl ethylenediamine (DPED), (21) N,N’-dibutyl-1,4-
butylenediamine (DBBD), (22) N,N’-diheptyl-1,4-
butylenediamine (DHBD), (23) N,N’-dilauryl-1,4-
butylenediamine (DLBD), (24) N,N’-dipalmityl-1,4-
butylenediamine (DPBD), (25) N,N’-dibutyl-1,10-
decylenediamine (DBDD), (26) N,N’-diheptyl-1,10-
decylenediamine (DHDD), (27) N,N’-dilauryl-1,10-
decylenediamine (DLDD), (28) N,N’-dipalmityl-1,10-
decylenediamine (DPDD).  167
 
 xii
Figure 2.4  Real-time and total (inset) NO release of NO-treated 17 analyzed 
in the presence of 1.0 M NaOH, light (─ ), and PBS, pH 7.4 (─ ).  174 
 
Figure 2.5  UV/Vis spectra for NO treated 2 (--), 5 (─), and 6 (─) in MeOH.  
[Inset: Expanded view of N-nitrosamine absorbance region.].   176 
 
Figure 2.6   Real-time NO release of NO-treated 1 analyzed in 1.0 M NaOH 
with direct light (─), and PBS pH 7.4 (─).  [Inset: enlarged view 
of NO flux in  1.0 M NaOH with direct light.]  177 
 
Figure 3.1  13C NMR spectra of A) glutaric acid, B) glycerol, and C) PE1 
prepolymer in methyl sulfoxide – d6.   198 
 
Figure 3.2 Degradation rates of PE1 – PE6 as mass lost (%) vs. time (■ – 
PE1, ● – PE2, ▲ – PE3,  ▼ - PE4, ♦ - PE5, ◄ – PE6)..   101 
 
Figure 3.3   Kinetic fits of polyester degradation for PE1, PE2, PE3, PE5, and 
PE6..   102 
 
Figure 3.4 Functionalization efficiency of PE1 as % degradation (•) and NO 
release (□).   103 
 
Figure 3.5 Temperature dependence of NO release for NPE1A.   108 
 
Figure 3.6  Nitric oxide release comparison of NPE1A with light trigger (—, 
200 W broad spectrum) and thermal trigger (---, 37 °C, shielded 
from light).   109 
 
Figure 3.7 Total NO release triggered by direct light irradiation for NPE1A 
as a function of cysteamine concentration in functionalization 
solutions (— 2 mM cysteamine, --- 1 mM cysteamine).  111 
 
Figure 3.8  Representative bright field optical micrographs of P. aeruginosa 
surface coverage on polyester substrates. A) PE3, B) FPE3A, C) 
NPE3A, D) PE4, E) FPE4A, F) NPE4A, G) PE6, H) FPE6A, and 
I) NPE6A.  Dark spots are bacteria.        112 
 
Figure 3.9  Viability of L929 mouse fibroblasts exposed to polyester 
leachables and degradation products for 24 h.   114 
 
Figure 4.1  Contact angles of polyurethane samples (  – PPU1, ● – PPU2,           
-PPU3,     –PPU4,     – PU-PECH, □ – TPU1,○ – TPU2,     – 
TPU4, ◊ – PU-POMT).   142 
 
Figure 4.2 1H NMR spectra of epichlorohydrin (---) and PECH (—).                143 
 
 xiii
Figure 4.3 UV/Vis spectra of TPU1 (—) and NTPU1 (---).                144 
 
Figure 4.4 Instantaneous NO flux for NTPU1 (—) in PBS at pH 7.4 and 37 °C compared 
to antithrombotic threshold values (---).                146 
 
Figure 5.1 Fiber diameter as a function of applied voltage and needle gauge for A) 12 
wt% and B) 16 wt% Tecoflex                   159 
 
Figure 5.2 SEM images of Tecoflex polyurethane fibers electrospun from 8 wt% solutions 
with flow rates of A) 15 µL min-1,  B) 50 µL min-1, and C) 100 µL min-1   161 
 
Figure 5.3 SEM images of Tecoflex fibers electrospun from A) 8, B) 12, and C) 16 wt% 
solutions at 15 kV with flow rates of 15 µL min-1 using a 22 gauge needle  163 
 
Figure 5.4 SEM images of Tecoflex fibers electrospun from  8 wt% polymer solutions at 
15 kV, using a 22 gauge needle , at flow rates of 15 µL min-1 containing A) no 
additives, B) 0.4 wt% proline, and C) 0.4 wt% PROLI/NO          168 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 xiv
List of Schemes 
 
Scheme 1.1 NOS mediated reduction of L-arginine to L-citrulline generating 
one molecule of NO.  111 
 
Scheme 1.2  N-diazeniumdiolates are typically formed via exposure of 
secondary amines to high pressures of NO gas in basic 
conditions.  Diazeniumdiolate decomposition occurs via pH 
dependent hydrolysis.  115 
 
Scheme 1.3  S-nitrosothiol A) synthesis and B) decomposition pathways  130 
 
Scheme 2.1   Proton-initiated decomposition of diazeniumdiolates    62 
 
Scheme 2.2  Mechanisms of diazeniumdiolate formation A) Sequential NO 
addition, B) dimer addition    65 
 
Scheme 2.3  Synthesis of N,N’ dialkyl diamines (where x =2, 5, 10, 14 and y 
= 1, 2, 5).     66 
 
Scheme 3.1  Representative synthesis of NO-releasing polyesters derived 
from glutaric acid and glycerol.    91 
 
Scheme 4.1  Protected mercaptoacid (1a-4a) and chain extender (1b-4b) 
synthesis   129 
 
Scheme 4.2  Representative polymerization, deprotection, and nitrosation of 
TPU polymers.  130 
 
Scheme 4.3  Epichlorohydrin polymerization.   131 
 
Scheme 4.4  Polymerization, substitution, and nitrosation of PU-PECH.  132 
 xv
List of Abbreviations and Symbols 
 
~    approximately 
°    degree(s) 
>    greater than 
<    less than 
≤    less than or equal 
µL    microliter(s) 
µm    micrometer(s) 
µM    micromolar 
µmol   micromole(s) 
µS   microsiemen(s) 
-    negative 
%    percent 
+    positive 
±    statistical margin of error 
2°    secondary 
α    alpha   
AA    adipic acid 
AcOH    acetic acid 
ACRL-PEG-NHS  polyethylene glycol N-hydroxysuccinimide 
monoacrylate 
ADP    adenosine diphosphate 
AHAP3    N-(6-aminohexyl)aminopropyltrimethoxysilane 
Akt    serine/threonine protein kinase 
APTMS    (3-aminopropyl)trimethoxysilane 
Ar    argon 
atm    atmosphere(s)  
Au    gold  
BH3    boron trifluoride 
BTMOS    isobutyltrimethoxysilane 
C    Celsius 
 xvi
Ca2+    calcium ion 
CDCl3    deuterated chloroform 
CFU    colony forming unit 
CHCl3    chloroform 
CH2Cl2    methylene chloride 
cm    centimeter(s) 
Cu    copper 
Cu+    copper ion 
Cu2+    copper ion 
Cys    cysteine 
d    day(s) 
DBHB/NO    diazeniumdiolate-modified dibutyl hexanediamine 
DCC    dicyclohexylcarbodiimide 
DEA/NO    diazeniumdiolate-modified diethylamine 
DETA    diethylenetriamine 
DETA/NO    diazeniumdiolate-modified diethylenetriamine 
DET3    N-[3-(trimethoxysilyl)propyl]diethylenetriamine 
DMF    N,N’ dimethylformamide 
DMHD/NO    diazeniumdiolate-modified dimethyl hexanediamine 
DSC    differential scanning calorimetry 
DSP    digital signal processing 
DTPA    diethylenetriamine-pentaacetic acid 
DTT    dithiothreitol 
ε    molar extinction coefficient 
ECH    epichlorohydrin 
ECM    extracellular matrix 
EDC    N-(3-dimethylaminopropyl)-N-ethycarbodiimide  
e.g.    for example 
EG    ethylene glycol 
eq.    equivalent 
ERK    extracellular signal-regulated kinases 
 xvii
Et3N    triethylamine 
Et2O    diethyl ether 
Fig.    figure 
FBGC   foreign body giant cell 
g   gram(s) 
GA   glutaric acid 
GPC   gel permeation chromatography 
GSNO   S-nitrosoglutathione 
h   hour(s) 
H+   proton 
H2O   water 
HCl   hydrochloric acid 
HIF-1α   hypoxia-inducible factor 1α 
HMDI   methylene bis(4-cyclohexyl isocyanate) 
ID   inner diameter 
i.e.   in essence 
K2CO3   potassium carbonate 
KTpClPB   potassium tetrakis (4-chlorophenylborate) 
kV   kilovolt(s) 
LMW   low molecular weight 
LPEI   linear polyethyleneimine 
m   meter 
M   molar 
MEM   minimum essential media 
MeOH   methanol 
MDI   4,4’-methylene(p-phenyl isocyanate) 
mg   milligram(s) 
mL   milliliter 
Mg2+   magnesium ion 
MHz   megahertz 
min   minute(s) 
 xviii
mM   micromolar 
MMA   methyl methacrylate 
mmol   millimoles 
mN   micronewton 
Mn   number average molecular weight 
Mw   weight average molecular weight 
mol   mole(s) 
MPTMS   3-mercaptopropyltrimethoxysilane 
MTMOS   methyltrimethoxysilane 
N   nitrogen 
N2   molecular nitrogen 
N2O2   dinitrogen dioxide 
N2O3   dinitrogen trioxide 
N2O4   dinitrogen tetroxide 
NAP   N-acetyl-penicillamine 
NADP+   nicotinamide adenine dinucleotide phosphate 
NADPH  reduced nicotinamde adenine dinucleotide 
phosphate 
NaNO2  sodium nitrite 
NaOH   sodium hydroxide 
NaOMe   sodium methoxide 
NaSH   sodium hydrosulfide 
NHS   N-hydroxysuccinimide 
nm   nanometer 
NMR   nuclear magnetic resonance 
NO   nitric oxide 
NO*   nitrosonium ion 
[NO]m   maximum nitric oxide flux 
NOS   nitric oxide synthase(s) 
O2   molecular oxygen 
p   para- 
 xix
P. aeruginosa   Pseudomonas aeruginosa 
PBS   phosphate buffered saline 
PCL   polycaprolactone 
Pd   palladium 
PDI   polydispersity index 
PDMS   polydimethylsiloxane 
PE   polyester 
PECH   polyepichlorohydrin 
PEG   polyethylene glycol 
PEI   polyethyleneimine 
pH   -log proton concentration 
PLA   polylactic acid 
PLGA   poly(lactide-co-glycolide) 
pmol   picomole(s) 
PMMA   polymethyl methacrylate 
PPB   parts per billion 
PPM   parts per million 
PROLI/NO  disodium 1-[2-(carboxylato)pyrrolidin-1-yl]diazen-
1-ium-1,2-diolate 
PRP   platelet-rich plasma 
psig   pounds-force per square inch gauge 
PTFE   polytetrafluorethylene 
PTMO   poly(tetramethylene oxide) 
PU   polyurethane 
PVA   polyvinyl alcohol 
PVC   polyvinyl chloride 
PVMMA   poly(vinyl ether-co-maleic anhydride) 
PVP   polyvinyl pyrrolidone 
QA   quaternary ammonium 
RSNO   S-nitrosothiol 
s   second(s) 
 xx
S   sulfur 
SEM   scanning electron microscopy 
SMC   smooth muscle cell 
SNAC   S-nitroso-N-acetylcysteine 
t1/2   half life of nitric oxide release 
tert   tertiary 
TFA   trifluoroacetic acid 
Tg   glass transition temperature 
TGA   thermogravimetric analysis 
THF   tetrahydrofuran 
TIPS   triisopropylsilane 
TM   thrombomodulin 
t[NO]   total nitric oxide released 
TSB   tryptic soy broth 
UV   ultraviolet 
v/v   ratio of volumes 
vis   visible 
vs.   versus 
W   watt(s) 
w/w   ratio of masses 
wt   weight 
Zn2+   zinc ion 
 xxi
  
Chapter 1: 
Introduction: Improving Implant Biocompatibility via Nitric Oxide Releasing 
Polymers 
1.1   Overview of Polymeric Biomaterials  
The use of polymeric materials in medicine dates back nearly as long as the field of 
polymer science itself.  In 1920, Hermann Staudinger proposed a controversial idea that rubber, 
proteins, and other polymeric materials are composed of long chains of covalently bound repeat 
units.1  During the following years in which this principle was gaining acceptance among the 
scientific community, Wallace Carothers was able to support Staudinger’s hypothesis by 
developing a variety of polymers with well-defined structures.2-4  These events came to signify 
the birth of a period that became known in chemistry as the Polymer Age.  Not long after these 
groundbreaking events, the use of synthetic polymers such as nylon, poly(vinyl chloride), 
poly(methyl methacrylate), and polyesters were being used as sutures and other surgical 
materials.5   
 As the principles of polymer science have become more understood in the past 60–70 
years, the use and applications of polymers in medicine has similarly gained momentum.  
Polyurethanes, silicone rubber, and synthetic biodegradable polymers, such as poly(α-esters) and 
polyanhydrides, have emerged as popular biomaterials due to their non-toxic nature and diverse 
mechanical properties.5-7  The initial applications of polymers in the medical field have also 
extended from primarily sutures and permanent prosthetic devices to now include rapidly 
developing techniques such as drug delivery, gene therapy, and tissue engineering.8, 9   
 Despite great strides in the development of new polymeric materials for medical 
applications, the clinical implementation of these materials remains hindered by physiological 
responses in vivo.  Problems associated with implantable medical devices include device-
associated infection caused by the adhesion and proliferation of opportunistic bacteria at the 
implant site,10 thrombus formation caused by the accumulation of blood proteins and platelets at 
the device surface,11 and tissue sequestration of the implant via the formation of a dense collagen 
capsule.12  New directions aimed at designing better polymers circumventing these detrimental 
conditions are being investigated. 
1.2  Issues Relating to the Biocompatibility of Medical Devices  
1.2.1 Infection 
Medical device-associated infections are an immense post-surgical concern for all 
implants due to the lack of therapeutic options for treating advanced bacterial biofilms, and 
implant-associated infections.10, 13  Device associated infections arise from a complex cascade of 
events that begin to occur soon after a material has been surgically implanted (Fig 1.1).13, 14    
Within 1-2 h after implantation, small organic compounds and macromolecules (i.e., proteins), 
adsorb to the materials surface.15  During this time, bacteria are able to non-specifically associate 
with the material through both long and short range forces, including but not limited to 
electrostatic interactions and hydrogen bonding.15  After an additional 2-3 h, specific chemical 
interactions begin to occur between the implant and bacteria resulting in the formation of 
stronger molecular bridges composed of polysaccharides and adhesion proteins from the 
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Figure 1.1  Bacterial adhesion at a material surface.  Non-specific adhesion occurs during Phase 
1, with the first appearances of molecular bridging occurring after 2-3 h.  Exopolysaccharide 
secretion from the bacterial membranes result in the formation of what is known as a bacterial 
biofilm. 
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bacterial membrane.14, 15  After molecular bridging, some strains of bacteria secrete an 
exopolysaccharide matrix that serves as a mechanism for retaining nutrients as well as protection 
against the host immune response.16  This complex bacteria/exopolysaccharide matrix, which is 
often referred to as a bacterial biofilm, has been shown to be ~1000 times more resistant to 
antibiotics than cellular suspensions.16  Thus, the most promising methods for avoiding device-
associated infections and their subsequent problems involve preventing the initial stages of 
bacterial adhesion and colonization at implant surface.     
 1.2.2 Thrombosis  
The formation of blood clots to repair damaged blood vessels is an essential aspect of the 
body’s numerous self-protective mechanisms.17  However, in the instance of implanted blood-
contacting medical devices (e.g. intravascular catheters), thrombus formation may be detrimental 
to patient health.11, 18, 19  Upon implantation of intravascular devices, circulating blood proteins 
begin to accumulate at the material surface due to nonspecific interactions.17  The adsorption of 
fibrinogen at the material surface activates platelets, which also begin adhering to the device 
surface.17, 20  The onset of fibrinogen polymerization to form the fiber-like protein chain fibrin, 
results in a 3-dimensional scaffold which may trap surrounding platelets and red blood cells 
forming a thrombus.17, 20  While this is an efficient repair mechanism for damaged blood vessels, 
a clot formed at a material interface may dislodge from the device and has the potential to cause 
vessel occlusion, heart attack or stroke.20  Additionally, blood-contacting medical devices may 
also damage the lining of blood vessels and can result in the narrowing of blood vessels due to 
neointimal hyperplasia.21   
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1.2.3 Foreign body response  
As with any type of foreign material, the implantation of medical devices results in a 
complex cascade of tissue responses that attempt to rid the body of foreign materials.12, 22  Upon 
implantation of a medical device, a wound in the vacularized connective tissue of the body is 
formed resulting in the non-specific adsorption of plasma proteins on the surface of the 
material.12  Soon thereafter, the inflammatory response begins with the migration of neutrophils 
and monocytes to the surface of the material in an attempt to rid the wound of foreign material.12  
In most cases, phagocytosis of the implant material is unsuccessful due to the size differences of 
the material and the phagocytes.  This unsuccessful phagocytosis results in the recruitment of 
other types of inflammatory cells (e.g., macrophages) to initiate degradation of the implant.  
Macrophages, also unable to rid the body of the foreign material, eventually fuse and form 
multinucleated foreign body giant cells (FBGC) that ultimately trigger the deposition of a dense 
collagen layer around the implant effectively isolating it from the rest of the body (Fig. 1.2).12  
Although beneficial in certain instances of wound healing, this scar tissue formation interferes 
with medical device operation and may even lead to heightened pain and discomfort for patients 
with certain types of prosthetic devices (e.g., hips).   
 1.3  Strategies for Improving Polymer Biocompatibility 
 The problems associated with the biocompatibility of polymers are well known and have 
received considerable attention from the scientific and medical research communities.  In this 
section some methods that have been promising for reducing the effects associated with fouling 
of implant surfaces are overviewed.   
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1.3.1  Antibacterial Materials 
The design of antibacterial coatings and materials for implantable devices is an important 
research area due to the consequences to patient health if a medical device were to become 
infected.  Many strategies for improving the antibacterial properties of polymers involve the 
active release of antibacterial agents from the material surface.13  The physical incorporation of 
silver,23, 24 antibiotics (e.g., ciprofloxacin, gentamicin),25, 26 and antibodies27 within polymeric 
matrices have all been investigated and the resultant antibacterial activity was related to dopant 
diffusion through the polymer and/or dopant release triggered by bulk erosion of the polymer.  
Other studies have linked the antibacterial character of surfaces to passive characteristics such as 
hydrophobicity28 and surface free energy.29  In general, in vitro bacterial adhesion is minimized 
for materials possessing surface free energies of approximately 25 mN m-1, while higher and 
lower surface energy values exhibit increased bacterial adhesion.29  The hydrophobic effect, 
which in the context of infection is the nonspecific adhesion of nonpolar microorganisms to 
nonpolar surfaces, has been implicated as one of the dominant forces for microbial adhesion.28  
As such, hydrophobic surfaces have been shown to possess heightened anti-adhesion character 
over hydrophilic materials due to the surface chemistry of bacterial cell membranes.  Surface 
grafting of quaternary ammoniums (QA) and other antimicrobial functionalities at the material 
interface has also shown promise in mediating bacterial adhesion to medical devices.30 
1.3.2  Antithrombotic Materials 
Methods to mitigate the accumulation of blood proteins and subsequent clotting and 
stenosis (narrowing of blood vessels) at the surface of blood-contacting medical devices are 
similar to techniques used for preventing the adhesion of microbes at the device surface (e.g., 
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Figure 1.2  Typical foreign body response to implanted materials.  After implantation, the 
substrate is non-specifically coated with a layer of proteins.  Recruitment of macrophages and 
other phagocytes leads to the formation of foreign body giant cells.  If foreign body giants cells 
are unable to phagocytose the foreign material, the material may be sequestered via a dense 
collagen capsule in a process known as fibrosis.  
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active and passive strategies).11, 31  Anticoagulants (e.g., heparin and curcumin) have been 
utilized as both surface grafted agents and controlled release agents for improving the ability of a 
material to resist protein and platelet adhesion.32, 33  Low surface energy materials (e.g., silicone 
rubber and polytetrafluoroethylene) generally inhibit the adhesion of blood proteins and platelets, 
resulting in decreased thrombosis, and better overall implant compatibility.34  
 1.3.3  Materials Eliciting a Reduced Foreign Body Response 
Much prior work to minimize the foreign body response to implanted materials has 
focused on the use of natural, hydrophilic materials (e.g., alginate,35 chitosan,36, 37 and collagen38, 
39) to mask the implant from tissue responses.  The promise for these materials lies in their 
similarity to endogenous macromolecular structures (e.g., endothelial cells).  Despite these 
similarities, the fact that these materials are not easily processable, posess high degrees of 
variability, and frequently elicit an immune response limit their potential applications.22  The 
well-controlled polymerizations of synthetic polymers such as poly(lactic acid) (PLA), 
poly(ethylene glycol) (PEG), and poly(vinyl alcohol) (PVA) provide less material variability 
while still taking advantage of the benefits of material hydrophilicity.22  Other methods 
investigated as a means to limit fibrosis surrounding medical implants utilize the active release of 
have employed anti-inflammatory drugs, such as glucocorticoids, secreted from a polymer 
matrix coated on the device surface.  These drugs inhibit the formation of inflammatory 
mediators and decrease the release of inflammatory cells and fibroblasts at the site of 
implantation, minimizing the extent of fibrosis.40  Materials with well-defined pore structure and 
size have also been shown to reduce the formation of fibrotic capsules around medical 
implants.41  Pore dimensions improve biocompatibility and tissue integration by reducing FBGC 
formation and subsequent immune responses caused by the giant cells.41     
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Improving implant performance by mediating physiological responses to a material is a 
complex aim.  The numerous complications associated with implant fouling require insight into 
methods for preventing multiple types of biological interactions stemming from infection, 
thrombosis and the foreign body response.  Unfortunately, strategies aimed at preventing these 
problems rarely target multiple mechanisms of fouling simultaneously.  While combination 
therapies are a valid option to mediate these problems, the behavior of such multi-component 
systems may be difficult to control.  It is evident that new strategies aimed at addressing all 
implant fouling mechanisms are warranted in the design of more biocompatible materials.   
1.3.4 Nitric Oxide’s Role in Implant Biocompatibility 
 Nitric oxide (NO) is an endogenously produced, diatomic free radical, formed by the 5-
electron oxidation of L-arginine to L-citrulline initiated by a group of enzymes known 
collectively as nitric oxide synthases (NOS, Scheme 1.1).  In the 1980s, NO was discovered to be 
the vascular endothelium derived relaxation factor, a molecule essential for controlling the 
relaxation and contraction of smooth muscle cells lining the vasculature.42-44  Since that time, 
research into the physiological effects of NO has increased substantially, and it has been 
discovered that NO mediates bacterial adhesion and viability,45 platelet activation,20 and the 
foreign body response.46  Furthermore, NO has also been shown to play an active role in 
angiogenesis,47 cancer biology,48 and bone remodeling.49, 50  As such, therapeutic materials that 
are capable of controllably releasing NO have been designed as a means to facilitate implant 
biocompatibility.  Due to the high reactivity of NO and its concentration dependent effects 
(Table 1.1), efficient methods of delivery has proven to be essential for limiting the effects of 
NO treatment to specific physiological loci.51-64  Functionalities capable of reversibly binding 
NO, termed “NO donors,” are currently one of the most promising ways of NO delivery in vivo.  
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In the remainder of this chapter, research aimed at the development of NO-releasing materials 
for improving the integration of medical materials in the body is highlighted.  Key material 
properties and significant results will be discussed.   
1.4  Materials Containing N-Diazeniumdiolate NO Donors 
1.4.1  Overview of N-Diazeniumdiolates 
First prepared in the 1960s by Drago and coworkers, N-diazen-1-ium-1,2-diolates, or N-
diazeniumdiolates are a class of ionic NO donor formed by the addition of two molecules of NO 
to primary or secondary amines, typically under high pressures (Scheme 1.2).     Although 
numerous attempts to isolate these compounds in their protonated forms have failed, they are 
generally isolable as salts.   Intramolecular stabilization of polyamines resulting in zwitterionic 
NO adducts have also been prepared.   The most common method of N-diazeniumdiolate 
characterization of is through the use of UV spectroscopy.  Characteristic absorbance bands for 
N-diazeniumdiolates are observed at approximately 250 nm under basic conditions (ε ~ 7.2 – 9.4 
mM cm ).    
65-67
68
69
-1 -1 68
The NO-release pathway of N-diazeniumdiolates is through a hydrolytic degradation 
mechanism initiated by protonation at the amine nitrogen.70  The NO release rates are 
predominantly first order and have been shown to be structurally dependent on the amine 
precursor.  Polyamines, many of which are capable of forming stabilizing hydrogen bonds upon 
diazeniumdiolation, tend to produce NO donor species with substantially longer half lives than 
their monoamine counterparts.69, 70  For example, the diazeniumdiolate adduct of diethylamine 
(DEA/NO) has a half life of approximately 2 min under physiological conditions of pH 7.4 and
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Scheme 1.1  NOS mediated reduction of L-arginine to L-citrulline generating one molecule of 
NO. 
 
 
 
 
11 
 
  
 
 
Table 1.1  Concentration dependence of NO activity. 
Nitric Oxide 
Concentration 
Signal Transduction 
Mechanism 
Physiological 
Results 
References 
< 1 - 30 nM Phosphorylation of 
extracellular signal-
regulated kinases (ERK) 
Mediation of 
proliferative and 
protective effects 
51-53 
30 - 60 nM Phosphorylation of Akt 
(protein kinases B) 
Apoptosis 
protection 
51,54-58 
100 nM Stabilization of hypoxia-
inducible factor 1α (HIF-
1α) 
Tissue injury 
protection 
51,59,60 
400 nM Phosphorylation and 
acetylation of p53 
Cytostatic to 
apoptotic 
responses, cell 
cycle arrest 
51,61 
> 1 uM Protein nitrosation 
(poly(ADP-ribose) 
polymerase, caspases) 
Apoptosis, full 
cell cycle arrest 
51,62-64  
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37 °C, while the diazeniumdiolate form of diethylenetriamine (DETA/NO), which is stabilized 
by hydrogen bonding, has a half life of 20 h (Fig. 1.3).71  Their ability to store two molecules of 
NO per donor, stability at room temperature, and well-studied NO release characteristics make 
N-diazeniumdiolates one of the most widely investigated NO donor classes.72 
1.4.2  N-Diazeniumdiolates as Polymer Additives 
 Although the rapid release of NO from low molecular weight (LMW) N-
diazeniumdiolates in physiological milieu limit the applications of these molecules as systemic 
therapeutics, new polymer-based formulations incorporating diazeniumdiolates rapidly appeared 
to address concerns surrounding poor implant biocompatibility.  The first and most 
straightforward diazeniumdiolate formulations designed to address undesirable surface-induced 
thrombosis employed LMW NO donors as polymer additives.  The susceptibility of N-
diazeniumdiolates to hydrolytic degradation allowed NO release from these materials to be 
controlled based on water uptake into and NO diffusion out of the polymeric matrix,73 in addition 
to the structure of the diazeniumdiolate.68  The noncovalent distribution of DETA/NO in a 
poly(caprolactone) (PCL) matrix afforded release of 93% of the total NO available from 
DETA/NO alone during a week of immersion in physiological conditions.74  Similar studies 
incorporating the LMW diazeniumdiolated form of proline (PROLI/NO) in a polyurethane 
matrix exhibited a high concentration burst of released NO followed by sustained levels of 
approximately 0.2–0.7 pmol NO min-1mg-1 over a period of 7 weeks.75  However, incorporation 
of the NO donors within a polymer melt resulted in thermal decomposition of the 
diazeniumdiolate, and decreasing total NO release.    
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 Meyerhoff and coworkers prepared plasticized poly(vinyl chloride) (PVC) and 
polyurethane (PU) films containing the diazeniumdiolate adduct of N,N’-dimethyl-1,6-
hexanediamine (DMHD/NO).76  The formulations were prepared by a straightforward polymer 
dissolution method to minimize thermal decomposition of NO donors experienced with a melt 
preparation.  Although these preparations were shown to increase thromboresistivity over control 
materials,77, 78 leaching of a toxic degradation byproduct, N,N’-dimethyl-N-nitroso-1,6-
hexanediamine, proved to be problematic.  Other related strategies included the formation of a 
PVC film containing an ion pair complex with diazeniumdiolated heparin.76  Under hysiological 
conditions, this coating released approximately 0.51 µmol NO mg-1 of doped polysaccharide 
over the course of 96 h.  However, reduced platelet adhesion and activation was not observed 
compared to controls despite its ability to release sufficient quantities of NO. 
The recombination of reactive nitrogen species formed from NO oxidation and amine 
compounds to form nitrosamines is a serious concern for therapeutic materials due to the well-
documented carcinogenicity of almost all nitrosamines.  As such, the retention of 
diazeniumdiolate-based dopants within their polymeric matrix is an extremely important aspect 
to the design of a successful therapeutic material.  To address this concern, NO donor 
functionalization of fumed silica particles used as reinforcing fillers for polymers has been 
reported.79  Specifically, surface silanol groups were exploited to couple various aminosilanes to 
the particle exterior.  Upon diazeniumdiolation, the filler particles were dispersed in a 
polyurethane layer and found to release NO continuously for approximately 4 h under 
physiological conditions, a period longer than the particles suspended in buffer alone.  Scanning 
electron microscopy (SEM) investigations of the surfaces after an extracorporeal circulation 
experiment in a rabbit model showed improved thromboresistivity of NO-releasing 
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Scheme 1.2  N-diazeniumdiolates are typically formed via exposure of secondary amines to high 
pressures of NO gas in basic conditions.  Diazeniumdiolate decomposition occurs via pH 
dependent hydrolysis. 
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Figure 1.3  Structure of A)DEA/NO sodium salt and B) DETA/NO zwitterion. 
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materials and no evidence of particulate leaching from the polymer.   
 Despite leaching from its polymeric scaffold, DMHD/NO-doped PU proved useful at 
reducing thrombus formation at the blood/material interface.  To mimic these results while 
preventing amine leaching, lipophilic modifications were made to DMHD in an attempt to 
enhance its retention within the polymer coating.80  While addition of methyl groups on the 
exterior did not prevent leaching of the amine species into the soak solutions, it was 
hypothesized that longer alkyl chain modifications promoted NO donor precursor retention in the 
polymeric matrix, evidenced only by the material’s inability to release its theoretical NO 
payload.  The authors hypothesized that as the NO was released from the diazeniumdiolate 
dopants within the polymer, the resulting secondary amine degradation products formed a basic 
environment in the polymer matrix, inhibiting further diazeniumdiolate degradation.  
Incorporation of potassium tetrakis(4-chlorophenylborate) (KTpClPB) into the matrix supported 
this hypothesis by providing a medium for hydroxide ion diffusion out of the polymer with 
concomitant greater NO release.  Follow-up studies utilizing similar systems confirmed that 
platelet density was indeed reduced by as much as 78% for compositions containing 4% (w/w) of 
the diazeniumdiolate adduct of N,N’-dibutyl-1,6,-hexanediamine (DBHD/NO)81 and that platelet 
and monocyte activation was also diminished.82  Vascular grafts coated with these materials were 
also shown to be thrombus-free compared to control grafts without the NO-releasing polymer 
when implanted in vivo.83      
 The Schoenfisch group has reported on the preparation of NO-releasing sol-gel particle 
doped polyurethane materials for use as biocompatible biosensor coatings.84  Large, polydisperse 
sol-gel particles (10-200 µm) were prepared by grinding aminosilane-modified xerogels with a 
mortar and pestle.  Subsequent exposure to high pressures of NO converted the amines to 
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diazeniumdiolates.  Incorporation of these NO-releasing particles within a polyurethane matrix 
provided a material capable of releasing NO for over 3 d, with minimal particle leaching (3.0 ± 
0.2%) in the presence of a polyurethane topcoat.  Furthermore, NO fluxes shown to reduce 
Pseudomonas aeruginosa adhesion to model substrates were maintained for over 40 h.85 
 To facilitate thromboresistivity of blood-contacting devices, a combined therapy utilizing 
NO release and immobilized heparin was designed by Zhou and Meyerhoff.86  A trilayer 
membrane was prepared consisting of a dense polymer layer, followed by a plasticized PVC or 
PU layer with a lipophilic diazeniumdiolate additive, and finally an aminated polymer layer.  The 
aminated polymer was used to covalently immobilize the anti-coagulant heparin to supplement 
the anti-platelet activity of the liberated NO.  The trilayer formulations provided tunable NO 
release from 0.5–60 x 10-10 mol NO cm-2 min-1 for periods lasting from 24 h to 1 week 
depending on the composition.  Synthetic procedures used to couple heparin to the surface of the 
aminated polymer were determined to not substantially influence the NO release from the 
substrate; however, experiments investigating the anti-platelet and anti-coagulation properties of 
the resulting material were not examined.   
 The Meyerhoff group further diversified their material coatings via incorporation of both 
heparin and surface-bound active thrombomodulin (TM) on NO-releasing materials.87  Bilayer 
formulations consisted of a DBHD/NO doped silicone rubber-polyurethane copolymer with a 
topcoat of a similar copolymer.  The surface of the material was aminated or carboxylated to 
provide binding sites for the covalent decoration with immobilized heparin and thrombomodulin 
(TM).  Similar to other NO-releasing polymer formulations, the thickness of the topcoat 
influenced the rates of NO release from the lower layer.  In vitro analysis of blood compatibility 
revealed a decreased incidence of platelet adhesion for NO-releasing substrates.  The inclusion of 
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the anti-coagulant TM at the polymer surface did not affect platelet adhesion.  However, high 
activity of TM was observed for materials containing sufficient spacers leaving the active site of 
TM more accessible to its substrates.  
  As mediation of NO release from within polymeric matrices is related to both water 
uptake and NO diffusion rates through these materials, the utilization of new polymers as 
scaffolds for incorporating N-diazenumdiolates has the potential to profoundly impact NO 
release characteristics.  For example, ethylcellulose substrates were investigated as a potential 
medium for the incorporation of DETA/NO.88  The duration of NO release from this DETA/NO-
doped polymer was prolonged from 7 to 30 d under physiological conditions.  Unfortunately, 
diethylenetriamine and/or diethylenetriamine-derived nitrosamines were found to leach from the 
material.    
1.4.3  Covalently Modified N-Diazeniumdiolated Polymers 
The utilization of N-diazeniumdiolates as polymer additives has proven to be an effective 
method for both decreasing platelet and bacterial adhesion to model surfaces; however, leaching 
of potentially carcinogenic N-nitrosamine byproducts remains a serious concern for the 
implementation of these materials in a clinical setting.  Diazeniumdiolate formation of covalently 
immobilized amines with polymers may provide the desirable slow and localized release of NO 
provided by NO donor-doped polymeric matrices without concern of potentially carcinogenic 
degradation byproducts leaching from the material.   
The first report of covalently immobilized diazeniumdiolates on polymeric matrices 
explored grafting diazeniumdiolated dipropylenetriamine to a dextran backbone using cyanogen 
bromide as the coupling agent.74  However, the potentially biodegradable imidocarbonate linkage 
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was reported to possibly release carcinogenic nitrosamine byproducts.  This toxicity concern, 
coupled with the preparation of this polymer formulation as microspheres, did not adequately 
address the need of an implant coating.  Nonetheless, it was the first report of the covalent 
immobilization of diazeniumdiolates on polymeric scaffolds.  In the same manuscript, Smith et 
al. also reported on the preparation of an insoluble polymeric material with potential medical 
coating applications.  Poly(ethyleneimine) (PEI) crosslinked with 1,4-butanediol diglycidyl ether 
was prepared to generate an insoluble polymeric material with high amine density.  Upon 
diazeniumdiolate formation and coating on poly(tetrafluroethylene) (PTFE) vascular grafts, the 
materials were found to release NO at a constant rate for approximately 5 weeks.  The 
diazeniumdiolated PEI-based material also reduced the amount of accumulated blood platelets 
adhered to an implant surface when inserted between segments of an artery-vein shunt in a 
baboon model.     
Saavedra et al. prepared PVC capable of controllably releasing NO by refluxing O2-
methoxymethylated piperazine diazeniumdiolates with a solution of PVC in THF.89  According 
to elemental analysis and NMR studies, the resultant material had approximately 1-2% of the 
chloride in the polymer replaced by the diazeniumdiolate piperazine analogs.  Later studies 
indicated that blending the diazeniumdiolated PVC with plasticizers and ionophores resulted in 
the formation of thromboresistant coatings that were employed as blood-contacting sensor 
membranes.76 
The high amine density of linear poly(ethyleneimine) (LPEI) makes it an attractive 
candidate for diazeniumdiolate modification to store large amounts of NO on a polymeric 
scaffold.  However, the water soluble nature of this polymer preparation, both before and after 
diazeniumdiolation prevent its use as a coating material for medical implants alone.  To remedy 
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this, Mowery et al. blended diazeniumdiolated LPEI with PVC and PU to generate NO-releasing 
coatings.76  The blends were shown to release up to 1 µmol NO for up to 96 h, effectively 
reducing the amount of platelet adhesion and activation when incubated in a solution of platelet-
rich plasma (PRP) for 2h.  Unfortunately, increased chain entanglement of LPEI within the PVC 
and PU did not prevent complete leaching of the NO donor from the matrix as approximately 4% 
of the total additive leached within 25 h of soaking.  In addition to the toxicity of nitrosamine 
byproducts, the well-known DNA intercalation capabilities of free PEI limits the potential 
applications of this material.90  
 Bohl and West synthesized two examples of NO-releasing hydrogels containing 
diazeniumdiolate moieties.91  A polyethylene glycol (PEG)-poly-L-lysine hydrogel was formed 
by reacting polyethylene glycol N-hydroxysuccinimide monoacrylate (ACRL-PEG-NHS) with 
poly-L-lysine in sodium bicarbonate buffer.  Diazeniumdiolate formation on the free amines of 
the lysine residues followed by photocrosslinking with PEG-diacrylate formed an NO-releasing 
hydrogel that was shown to reduce smooth muscle cell proliferation by 80%.  Hydrogels 
containing diethylenetriamine (DETA) as an amine source were prepared in a similar manner by 
reaction with ACRL-PEG-NHS and photocrosslinking.  These NO-releasing gels showed similar 
reductions in smooth muscle cell proliferation. 
Due to the established roles of silicone rubber in medical applications,5 the Schoenfisch 
group has formulated a method for incorporating NO donors within a crosslinked silica xerogel 
matrix.92  The hydrolysis and co-condensation of aminosilanes and isobutyltrimethoxysilane 
(BTMOS) in various mole percentages formed highly crosslinked amine-containing networks 
(Fig. 1.4).  Upon diazeniumdiolation of the secondary amines, these materials released variable 
quantities of NO depending on the aminosilane structure and concentration  Films composed of 
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20% (v:v) N-[3-(trimethoxysilyl)propyl]diethylenetriamine (DET3) were shown to release NO 
controllably for longer than 6 d.  By alteration of the aminosilane composition and amount to 
40% (v:v) N-(6-aminohexyl)aminopropyltrimethoxysilane (AHAP3) (balance BTMOS), the NO 
release from these films was extended to 20 d under physiological conditions.93  The adhesion of 
P. aeruginosa to these substrates was shown to be reduced in a flux dependent manner with 
AHAP3-modified xerogels having the most substantial reduction.85, 94, 95  Further studies utilizing 
these materials showed that microarrays could be prepared and still significantly reduce platelet 
adhesion to substrates, even though the entire surface was not modified.96 In vivo studies 
revealed that such substrates are capable of decreasing the thickness of collagen capsule 
formation associated with the foreign body response.97  
In a similar manner, NO-releasing silicone rubbers were prepared via crosslinking of 
hydroxyl-terminated polydimethylsiloxane (PDMS) with diamino- and triamino-
alkyltrimethoxysilane crosslinkers and subsequent diazeniumdiolate formation.98, 99  The 
resulting polymers were characterized by NO release durations of over 20 d under physiological 
conditions.  The extended NO-release durations were attributed to the slow water uptake of the 
silicone-based material.  Unfortunately, it was found that 2–5% of the crosslinker and PDMS 
were found to leach from the material even after crosslinking making toxicity of the starting 
materials a concern.       
The extensive applications of plastic components in biomedical procedures requires the 
development of diverse biocompatible materials.  For example, the Meyerhoff group has 
prepared polymethacrylate-based NO donating materials.100, 101   The synthesis of boc-protected 
amine-containing methacrylate monomers followed by radical copolymerization with methyl 
methacrylate (MMA) was shown to result in the formation of protected amine- containing 
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methacrylate copolymers.  Upon deprotection, solutions of these polymers could be exposed to 
high pressures of NO in the presence of sodium methoxide (NaOMe) base to generate N-
diazeniumdiolate NO donors.  The formation of diazeniumdiolates resulted in materials with 
apparent half lives of NO release ranging from 30–60 min and total NO release values 
approaching 1.99 µmol NO mg-1 polymer.  Similarly to previous studies, polymer blends of 
diazeniumdiolated polymethacrylate with silicone rubber and PVC demonstrated significant 
inhibition of NO release.  However, addition of lipophilic anionic salts (KTpClPB) or 
poly(lactide-co-glycolide) (PLGA) into the films accelerated decomposition of the NO donors 
due to reduced amine buffering capacity.  
The enhanced blood compatibility of polyurethanes makes them particularly interesting 
in the scope of NO-releasing materials.  West and coworkers have synthesized polyurethanes 
containing diazeniumdiolated domains as novel NO-releasing biomaterials.102  Isocyanate-
terminated prepolymers were first formed by the reaction of 4,4’-methylene di(p-phenyl 
isocyante) (MDI) with poly(tetramethylene oxide) (PTMO).  Chain extension of the prepolymers 
using a combination of lysine rich diazeniumdiolated peptide fragments and 1,4-butanediol 
yielded the NO-releasing polyurethane.  Total NO release levels approached 0.14 µmol and the 
inhibition of smooth muscle cell proliferation by over 90% compared to controls was reported. 
Additionally, platelet adhesion to such materials were reduced by over 75% compared to non 
NO-releasing control materials.  Despite the total NO release of these materials, the authors 
utilized primary amine diazeniumdiolates, which are known to be far less stable than their 
secondary amine counterparts.68 This instability coupled with the presence of unprotected pre-
diazeniumdiolated chain extenders in the heated polymerization reaction will likely cause
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Figure 1.4 Structures of A) isobutyltrimethoxysilane (BTMOS), B) N-[3-
(trimethoxysilyl)propyl]diethylenetriamine (DET3), and C) N-(6-
aminohexyl)aminopropyltrimethoxysilane (AHAP3). 
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extensive diazeniumdiolate degradation and limit the long-term application of these materials.  
Furthermore, the authors failed to adequately quantify the NO release from these materials.
 Reynolds et al. also prepared diazeniumdiolated polyurethanes through the covalent 
incorporation of NO donors along the polymer backbone.103  Boc-protected amine chain 
extenders were first prepared and used to couple isocyante-terminated prepolymers composed of 
methylene bis(4-cyclohexyl isocyanate) (HMDI) and terathane PTMO.  After polymerization 
and boc-deprotection, the polyurethanes were exposed to 75 psig of NO for 5 d to form 
diazeniumdiolates.  The resultant polymers were capable of releasing NO for approximately 6 d 
under physiological conditions.  Another route chosen by Reynolds et al. to generate NO-
releasing polyurethanes utilized the post-polymerization modification of a commercially 
available polyurethane, Pellethane.  Lithium tert-butoxide was used to couple 1,4-dibromobutane 
to the polymer backbone at the carbamate nitrogen atoms.  The resulting brominated pellethane 
was reacted with DETA to generate a polyurethane containing secondary amines suitable for 
diazeniumdiolation.  The diazeniumdiolated Pellethane derivative was also capable of releasing 
NO for 6 d.  Subsequent investigations detailed the use of methoxymethyl- and sugar-protected 
diazeniumdiolates polymerization into the backbone resulting in greater control over resultant 
NO fluxes from the surface.104 Unfortunately, after diazeniumdiolate decomposition, the 
resulting amine-functionalized polyurethanes may become protonated resulting in a charged 
surface.  The presence of charged surfaces may enhance protein adhesion in vivo resulting in the 
accumulation of platelets and thrombus formation, negating any impact from the surface-derived 
NO release.104     
 Effective mimicry of native tissues is the ultimate goal for biomaterials used in any type 
of application.  A recent approach for the preparation of a native endothelial extracellular matrix 
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(ECM) mimicking self-assembled nanofibrous matrix was detailed by Kushwaha et al.105  This 
nanofibrous matrix was prepared by the self assembly of various peptide amphiphiles that 
included domains capable of storing NO, endothelial cell adhesive ligands, and enzyme-
mediated degradable sites.  The NO release from these materials enhanced endothelial cell 
proliferation while concomitantly decreasing smooth muscle cell proliferation and platelet 
adherence, illustrating its promise as a coating for in vivo cardiovascular materials.  However, 
the formation of unstable primary amine diazeniumdiolates and lack of direct NO detection 
methods bring into question whether or not this material is actually capable of releasing 
sufficient quantities of NO or whether the thromboresistivity was the result of passive qualities.   
 One of the first synthetic biodegradable materials capable of releasing NO was prepared 
by Zhao et al.106  The crosslinked polyester was formed by condensation of citric acid with 1,8-
octanediol, and N,N’-bis(2-hydroxyethyl)ethylenediamine and subsequent thermal curing.  The 
amine containing polyester could then be diazeniumdiolated upon exposure to NO gas.  
Although the NO release from these materials was investigated indirectly, it was estimated that 
approximately 0.2 µmol NO was liberated from a graft containing 6.3% (w/w) polymer by 
quantifying residual nitrite, an NO byproduct, in solution. 
1.5  Materials Containing S-Nitrosothiol NO Donors 
1.5.1  Overview of S-Nitrosothiols  
Another common class of NO donor is S-nitrosothiols (RSNOs).  The rising popularity of 
RSNOs in therapeutic materials is due in part to their roles as the endogenous carriers of NO 
within the body.72 Due to NO’s short physiological half life, transport of this ubiquitous 
signaling molecule through the body requires a mechanism to prevent unwanted reaction with 
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any of the numerous radical scavengers in the body.  Although NO alone cannot react with thiols 
to generate RSNOs, even trace amounts of oxygen can react with NO to promote formation of 
the reactive species N2O3, a strong nitrosating agent, that can generate RSNOs typically on 
protein-bound thiols.107 
Synthetically, RSNOs may be prepared by exposing thiols to solutions of nitrous acid, 
organic nitrites, N2O4, or any other source of the nitrosonium ion (NO+, Scheme 1.3).107  A 
characteristic green or red color, dependent on the substitution at the carbon atom adjacent to the 
thiol, is often used to confirm the completion of the nitrosation reaction.  Likewise, characteristic 
absorbance bands at 330–350 nm (ε ~ 103 M-1cm-1) and 550–600 nm (ε ~ 20 M-1 cm-1) may be 
used to monitor the decomposition rates of these species.107  Decomposition of RSNOs occurs 
via 3 predominant pathways (Scheme 1.3).  Homolytic cleavage of the S–N bond occurs both 
thermally and photochemically to generate NO and the thiyl radical.108  The highly reactive thiyl 
radical then typically dimerizes with a like species resulting in the formation of a disulfide and 
another molecule of NO.109  Decomposition of RSNOs may also be catalyzed be free Cu+ ions.  
The reaction of Cu+ in solution with RSNOs results in the release of NO and formation of the 
Cu2+ ion along with a thiolate anion.110, 111  Subsequent thiolate reduction of the Cu2+ species 
regenerates the active Cu+ ion.  This mechanism has been shown to be specific to Cu2+ as other 
metal species such as Zn2+, Ca2+ , and Mg2+  have no catalytic activity.  The third decomposition 
pathway of RSNOs relies on their reaction with nucleophiles.  In this mechanism, RSNOs are 
able to react directly with a nucleophilic species whereby NO+ is transferred to the nucleophile.  
Interestingly, the appearance of free NO+ never occurs indicating a direct transfer of the reactive 
species.107  Although, numerous nucleophilic compounds capable of initiating this NO+ transfer 
exist, (e.g., ascorbate112 and the hydroperoxide anion113), the thiolate anion is the most 
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physiologically predominant.114  This specific case of nitrosonium exchange is termed 
transnitrosation.      
1.5.2  S-Nitrosothiols as Polymer Additives 
Analagous to diazeniumdiolate NO donors, physical incorporation of S-nitrosothiols into 
polymeric materials is a promising technique for the formation of NO-releasing biomaterials.  
However, prolonged NO release duration of nitrosothiols doped into polymeric materials is one 
of the only commonalities with diazeniumdiolate-doped materials.  The numerous decomposition 
pathways of nitrosothiols (Cu+, thermal, photolysis, and nucleophile) minimize the dependence 
of the material’s water uptake on NO release kinetics unlike that of diazeniumdiolates.107  
Additionally, the lack of pH dependent NO release avoids NO release reduction upon amine-
induced deprotonation of water.  However, Cu+ and nucleophile induced RSNO decomposition 
remains diffusion mediated.  The toxicity concerns associated with RSNO degradation products 
are reduced compared to diazeniumdiolates due to the endogenous nature of RSNOs.  Many of 
the most common S-nitrosothiols, such as S-nitrosoglutathione (GSNO) and other cysteine (Cys)-
containing peptides,  are endogenous to the tissue and plasma of mammals where they act as the 
physiological storage and transport mechanisms of NO.115, 116 
De Oliveira and coworkers incorporated the low molecular weight RSNOs GSNO and S-
nitroso-N-acetylcysteine (SNAC, Fig. 1.5) into numerous polymeric materials including 
hydrogels, solid films of poly(vinyl alcohol) (PVA), poly(vinyl pyrrolidone) (PVP), and blends 
therof.117-120  The incorporation of these NO donors into triblock copolymer hydrogels composed 
of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) was 
shown to slow the rate of NO release from the donor and thus prolong the NO release lifetime of 
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the material.117  When applied topically to the skin, these materials were observed to increase 
blood flow using laser Doppler flowmetry indicating vasodilation of the underlying blood 
vessels.118  Doping GSNO into solid films of PVA, PVP, and PVA/PVP blends also slowed S-
nitrosothiol decomposition kinetics over free GSNO.119, 120   
Meyerhoff and coworkers prepared S-nitrosothiol-derivatized polymer filler particles.121, 
122  Fumed silica with surface silanol groups was reacted with (3-aminopropyl)trimethoxysilane 
(APTMS) to generate amine-terminated fumed silica particles.  The amines were then used to 
either ring open N-acetyl-DL-penicillamine thiolactone or couple S-trityl-N-acetyl-L-cysteine to 
generate thiol- or protected-thiol- modified fumed silica particles respectively.  After 
deprotection of the N-acetyl-L-cysteine derivative, the thiol-modified particles were nitrosated 
using t-butylnitrite to generate nitrosothiol-modified particles.  Upon incorporation into silicone 
rubber these materials were shown to thermally release NO.  
Using sol-gel chemistry, Riccio et al. synthesized S-nitrosothiol-modified colloidal silica 
with high NO storage capabilities.123  Samples capable of storing up to 4.60 µmol NO mg-1 were 
dispersed in both polyurethane and silicone rubber films.  The resultant NO release 
characteristics were documented thermally, with a light trigger, and in presence of Cu+.  Silicone 
rubber materials were shown to release at higher initial NO release fluxes both thermally and in 
the presence of high intensity light than the polyurethane counterparts.  This trend was attributed 
to the rapid diffusion of NO through hydrophobic materials.73  The polyurethane counterparts 
exhibited more sustained NO release with certain preparations still releasing measurable 
quantities of NO after 4 d.  Nitric oxide release kinetics of these films were also examined in the 
presence of the Cu+ initiation mechanism.  The polyurethane films exhibited greater initial NO
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release fluxes than the silicone rubber compositions due to the greater Cu solution penetration 
into the polyurethane matrix over the silicone rubber film,liberating stored NO more rapidly.  
The slower NO release kinetics provided by the silicone rubber film enhanced the duration of 
NO release over the polyurethane in the presence of the Cu catalyst.       
1.5.3  Covalently Modified S-Nitrosothol-Containing Materials 
The first reports of an RSNO-derivatized surface investigated the self-assembly of 
dithiothreitol (DTT) on gold surfaces.  Nitrosation was accomplished via transnitrosation using a 
flowing solution of S-nitrosodithiothreitol.124  The coating suffered only a minimal 5% mass lost 
during 4 h of continuous flow conditions,  attributed to the exceptional stability of gold-thiol 
surfaces125 and the hydrogen bonding provided by lateral hydroxyl groups of the DTT.  The 
monolayer was shown to release NO in the presence of a light trigger; however, the thermal 
stability of the monolayer severely limits potential biomedical applications.      
The formation of the first polymeric surface with covalently linked S-nitrosothiol 
functionalities detailed the synthesis and characterization of hydrogels with immobilized S-
nitrosocysteine.91  L-Cysteine was reacted with ACRL-PEG-NHS to form thiol-containing PEG 
species that were subsequently nitrosated in the presence of nitrous acid and photopolymerized 
to yield an NO-releasing hydrogel.  The NO release from these materials was very rapid with 
most NO liberated within the first 4 h.  Nevertheless this rapid release was sufficient to inhibit 
smooth muscle cell (SMC) growth and reduce platelet adhesion compared to control hydrogels. 
Polynitrosated polyesters formed via the polycondensation of diols with 
mercaptosuccinic acid and subsequent nitrosation have been reported by De Oliveira and 
coworkers.126, 127  The nitrosated polyesters were shown to release NO controllably for over 20 h
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Figure 1.5 Structures of A) S-nitrosoglutathione (GSNO) and B) S-nitroso-N-acetylcysteine 
(SNAC) 
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 under physiological conditions, and more rapidly in the presence of direct light.  Topical 
application of these polynitrosated polyesters, a viscous liquid, resulted in local vasodilation 
confirmed by hyperaemia.  Polymer blends of the polynitrosated polyesters with poly(methyl 
methacrylate) (PMMA) were also formed and shown to significantly decrease platelet adhesion 
compared to controls.127 
The synthesis and characterization of S-nitrosothiol-modified xerogels was reported by 
the Schoenfisch group.128  The hydrolysis and co-condensation of 3-
mercaptopropyltrimethoxysilane (MPTMS) and methyltrimethyoxysilane (MTMOS) generated 
thiol-containing xerogels.  These materials were nitrosated in a solution of nitrous acid to yield 
RSNO-modified surfaces with a characteristic pink color.  The xerogels were shown to release 
up to 1.31 µmol NO mg-1 for periods extending beyond 14 d at physiological conditions.  The 
potential as implant coating materials was shown by their ability to resist bacterial and platelet 
adhesion, while exhibiting minimal cytotoxicity to L929 mouse fibroblasts.  Further studies by 
this group also demonstrated that an N-acetyl-penicillamine (NAP) derived silane could be co-
condensed with MTMOS resulting in a xerogel matrix incorporating a tertiary carbon atom 
adjacent to the thiol functionality.129 Tertiary RSNOs have been previously been shown to 
exhibit enhanced stability (i.e., longer NO release duration) and a characteristic green color.107, 
116  
Li and Lee reported on the preparation of a RSNO-conjugated interpolymer complex 
designed to aid in diabetic wound healing.130  Poly(vinyl methyl ether-co-maleic anhydride) 
PVMMA grafted with GSNO was shown to form interpolymer complexes with PVP.  These 
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complexes, self assembled and stabilized by hydrogen bonding interactions between the 
PVMMA and PVP, were shown to controllably release NO for over 10 d.  Wound healing 
studies on diabetic rat models demonstrated that the controlled release provided by the 
complexes aided in wound healing compared to controls.   
            1.6 Future Directions of NO-Releasing Materials 
The development of biocompatible materials has remained an elusive goal for the 
scientific community due to the numerous fouling mechanisms inherent to an implant surface.  
As such, the amount of research funding devoted to developing such materials has initiated a 
biomaterial revolution.  The design of new materials has encompassed all facets of polymer 
science ranging from absorbable to persistent polymers with applications ranging from coatings 
for electrochemical sensors to prosthetic implants.  Unfortunately, many biomaterial design 
approaches only look to solve one of the numerous fouling mechanisms.  The inherent 
advantages of NO-releasing materials lie in their ability to combat numerous issues ranging from 
infection and thrombosis to the foreign body response and neointimal hyperplasia.  Even with the 
numerous advances made to NO-releasing materials in the past 15 to 20 years, the development 
of materials resistant to fouling remains a long-term goal.  While numerous NO-releasing 
materials have shown great promise, the development of materials with application specific 
properties combined is a critical step toward the development of NO-releasing biomaterials.  
The physical incorporation of NO-releasing dopants into polymeric materials is a 
promising avenue for the development of better biomaterials.80  Diffusion-mediated NO release 
of diazeniumdiolated additives embedded within these materials provides a method for 
significantly prolonging the therapeutic effects of NO.76  Furthermore, tunable NO release may 
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be achieved by controlling the dopant type and amount dispersed within the polymeric matrix.  
Unfortunately, many of the dopants to date actually leach from their polymeric scaffold, 
liberating potentially carcinogenic nitrosamine byproducts into the body.76  As a result, the 
development of diazeniumdiolated additives with increased polymeric retention is an important 
factor for the fabrication of NO-releasing material coatings.  Increasing the hydrophobicity of 
low molecular weight additives may provide enhanced polymeric retention of the additives 
thereby avoiding leaching of potentially carcinogenic diazeniumdiolate degradation byproducts.  
Although previous reports have investigated this correlation, the elusiveness of a non-leaching 
NO-releasing polymer additive warrants the synthesis of diazeniumdiolate precursors with even 
greater alkyl content.  The synthesis and characterization of lipophilic diamine diazeniumdiolates 
as potential polymer additives was one goal of my dissertation research. 
The first reports of using degradable polymers as sutures occurred over 50 years ago.8, 9  
Since that time, advancements in polymer science have led to the development of unique 
polymeric materials with well-defined degradation rates capable of use for a variety of new 
medical applications including gene therapy, drug delivery, and tissue engineering.7  However, 
problems associated with persistent implants, such as infection and the foreign body response 
also plague degradable implant materials.10, 12  Although bulk degradation of the polymeric 
materials enables controlled release of antibacterial agents and other drugs to facilitate material 
integration into the body, the realization of a fouling-resistant material is yet to be achieved.9  As 
such, introducing the physiological benefits of NO release to a material that can be absorbed by 
its host is an interesting avenue of research.  The proven benefits shown by persistent NO-
releasing implants may be extended to materials with new applications where material 
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degradation is also essential.  The development and characterization of NO-releasing degradable 
materials was a second focus of my dissertation research.   
    Blood compatibility is an important aspect for the development of intravascular 
implants such as catheters, stents, and sensors.11  Polyurethanes represent one of the most 
popular blood-contacting materials as their low surface energy segments significantly reduce 
blood protein and platelet adhesion.  The inherent anti-platelet characteristics of polyurethanes 
have been shown to be enhanced by the addition of NO release in the form of polymer additives 
and diazeniumdiolate modification.102-104  However, leaching of polymer additives and protein 
adhesion caused by surface charge accumulation of diazeniumdiolate-modified materials pose 
compatibility risks for implants.103  Additionally, these materials suffer from low NO storage 
capacities (up to 0.02 µmol mg-1).102-104  S-nitrosothiol modification of polyurethanes is a 
promising avenue for the development of blood compatible materials.  Nitric oxide release from 
these surfaces should enhance blood compatibility of the material, and the absence of surface 
charge accumulation may prevent the adhesion of blood proteins at the polymer interface.  
Furthermore, the incorporation of NO donors at different places (hard vs. soft segment) along the 
polymer backbone, which has yet to be investigated, may increase total NO storage and influence 
the kinetics of NO release.  The design and synthesis of S-nitrosothiol-modified polyurethanes 
and NO-release dependence on NO donor position along the polymer backbone was another 
aspect of my research. 
An important design aspect for therapeutic materials is matching morphological and 
chemical characteristics of the material with its intended application. For example, tissue 
engineering is most effective using high surface area scaffolds to maximize cell seeding and 
promote differentiation.  Unfortunately, current NO-releasing materials lack morphological 
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diversity required for numerous therapeutic applications.  In order to extender the therapeutic 
benefits of NO to high surface areas materials coupling the electrospinning technique, used to 
make well defined monodisperse, micro and nanofibers, with NO release represents a promising 
avenue for the development of biomaterials.  Diversity of electrospun materials may easily be 
attained by varying fiber composition, size, and NO donor type giving rise to numerous 
therapeutic platforms.  Investigating the NO release dependence on size, composition, and 
morphology of electrospun polymer microfibers doped with various NO donors is the final 
aspect of my dissertation research.        
1.7 Summary of Dissertation Research 
The goal of my dissertation research was to design and synthesize novel polymeric 
materials capable of controllably releasing NO.  The effects of increasing the hydrophobicity of 
diazeniumdiolated polymer additives on NO storage capacity and byproduct formation were 
investigated as a means to develop a non-leaching polymer additive for coating applications.  
Degradable polyesters modified with functionalities capable of storing and controllably releasing 
NO were designed to extend the therapeutic benefits of NO release to absorbable materials.  
Specifically, polyesters with a range of degradation rates and glass transition temperatures were 
synthesized from metabolic intermediates and FDA approved compounds by controlling 
polymerization stoichiometry and curing conditions.  The addition of NO release functionalities 
to these scaffolds resulted in materials with varied NO storage capacity and release kinetics 
dependent on material properties such as composition and glass transition temperatures.   
To better control total NO storage and release within polyurethanes the influence of NO 
donor position (hard segment vs. soft segment) within polyurethanes was investigated by 
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preparing S-nitrosothiol-modified hard and soft segments.  The resultant NO release was 
influenced by the domain location of the NO donor and the phase miscibility of the hard and soft 
segments. 
Polymer microfibers were prepared and examined as a scaffold to prepare unique 
biomedical materials capable of NO release.  Nitric oxide-releasing small molecules and 
nanoparticles were uniformly dispersed in a polymer solution and electrospun to generate 
microfibers capable of controllably releasing NO.  The influence of polymer composition, 
polymer additive, solution flow rate, spinneret size, and concentration were investigated as a 
means to control fiber size.  The NO release kinetics from the fibrous material were examined as 
a function of fiber diameter and composition.   
To summarize, the specific aims of my research included: 
1) investigating polymer additive hydrophobicity and structure dependence on efficiency 
of the diazeniumdiolation reaction; 
2) synthesizing absorbable polyesters scaffolds with well-defined degradation 
characteristics and NO storage and release capacity; 
3) synthesizing NO-releasing polyurethanes with localized S-nitrosothiol content in both 
hard and soft segment domains; and, 
4) preparing NO-releasing polymer microfibers with well-defined NO release character 
based on polymer composition, size, and polymer additive. 
The goal of this introduction chapter was to provide a brief overview for the need of new 
materials capable of improving material biocompatibility, and recent work with NO-releasing 
polymers.  In Chapter 2, the investigation of the competitive formation of N-diazeniumdiolates 
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and N-nitrosamines on hydrophobic polyamine scaffolds is presented.  Chapter 3 details the 
synthesis, characterization, and in vitro performance of degradable polyester scaffolds 
functionalized to store and release NO.  The synthesis and characterization of NO-releasing 
polyurethanes containing S-nitrosothiol groups in both the hard and soft segment domains is 
presented in Chapter 4.  Chapter 5 details the investigations of NO-releasing polymer microfibers 
with well-defined size and NO release control.  Finally, Chapter 6 summarizes my work and 
provides insight into future studies regarding next generation biomaterials and in vivo testing.  
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Chapter 2: 
Competitive Formation of N-Diazeniumdiolates and N-Nitrosamines via 
Anaerobic Reactions of Polyamines with Nitric Oxide 
 
2.1 Introduction 
The role of nitric oxide (NO) in physiological signaling pathways, vasodilation, 
wound healing, and platelet aggregation has stimulated much research related to the 
molecular storage of NO.1-5  Due to its high reactivity and rapid diffusion, formulations 
of stable scaffolds capable of storing and controllably releasing NO have been developed 
as tools for further elucidating NO’s role in physiology and potential therapeutics.6-8  Of 
the numerous types of these NO donor compounds, diazen-1-ium-1,2-diolates, or N-
diazeniumdiolates, are arguably the most widely researched NO donors to date due to 
their straightforward synthesis, long-term storage capabilities, and ability to 
spontaneously release NO under physiological conditions.  First reported in the 1960s,9, 10 
N-diazeniumdiolates are formed via exposure of primary and secondary amines to high 
pressures of NO gas, resulting in a stable zwitterionic adduct, bearing two molecules of 
NO per amine.  The characteristic proton-initiated decomposition of diazeniumdiolates to 
NO and the parent amine (Scheme 2.1) makes them particularly attractive as potential 
therapeutics.6, 11, 12     
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A number of reports indicate that diazeniumdiolate decomposition and NO release 
rates are directly related to the structure of the parent amine compound (Figure 2.1).11, 13, 
14  For example, competing protonation sites and hydrogen bond stabilization prolong the 
NO-release half lives of diazeniumdiolated polyamines versus monoamine-derived NO 
donors.13  The half life of the hydrogen-bond stabilized diazeniumdiolated derivative of 
diethylenetriamine (DETA/NO) is indicative of this effect, as it is 4 orders of magnitude 
larger than the half life of the sodiated diazeniumdiolate of proline (PROLI/NO) under 
similar solution conditions.12, 15  Since extending NO release duration has therapeutic 
benefits, designing scaffolds for diazeniumdiolate formation containing functional groups 
prone to hydrogen bonding (e.g., amines) has been the focus of recent research.  For 
example, Hrabie and coworkers studied diazeniumdiolate formation on a group of small 
molecule polyamines with NO-release half-lives ranging from a few minutes to over 2 d 
at 22 °C.  The benefits of utilizing diamine compounds as NO donor scaffolds were 
further described by Batchelor et al. in a report detailing the synthesis and biological 
utility of  N,N’-dialkylhexamethylenediamine diazeniumdiolates.  
Toscano and coworkers also studied methods for controlling NO release via 
diazeniumdiolates by preparing sulfonated16 and benzyl substituted diazeniumdiolates 
(Figure 2.2).17-19  These protecting groups may be cleaved photolytically to yield 
diazeniumdiolates capable of characteristic proton-initiated NO release patterns. 
Unfortunately, potentially toxic deprotection byproducts and light dependent deprotection 
complicated potential therapeutic applications.  To address toxicity concerns, 
glycosylated diazeniumdiolates that undergo enzymatic deprotection to form common 
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mammalian metabolites were prepared and shown to controllably release NO 
intracellularly.20, 21  
Harnessing the broad spectrum antimicrobial activity of NO has also been a major 
thrust in the design of more biocompatible implant coatings.  Xerogels,22 polyurethanes23, 
24 and polymethylmethacrylates25, 26 have been synthesized to include NO donor 
functionalities allowing for controlled NO release.  Despite the release of NO for 
extended periods, charge accumulation at the surface of diazeniumdiolate-modified 
polymers still promoted protein adhesion to the surface of the materials potentially 
limiting applicability for many implants.24  Polymeric matrices have also been prepared 
as physical supports for small molecule NO donors such as PROLI/NO,15 N,N'-dimethyl-
hexane-1,6-diamine diazeniumdiolate (MAHMA/NO),27 and N,N’-
dibutylhexamethylenediamine diazeniumdiolate.28  In each of these cases, the polymer 
network slowed water diffusion to the NO donor, extending the duration of NO release.  
However, leaching of hydrophilic NO donors from NO donor/polymer dispersions still 
presents a concern regarding potentially toxic diazeniumdiolate degradation 
byproducts.27, 28  
The design of hydrophobic NO-releasing dopants with enhanced retention in 
polymeric matrices represents an attractive alternative for overcoming the problems 
associated with current methods utilized for surface generated NO release.  However, the 
negative consequences of reaction byproducts during the formation of the NO donors 
remains a question.  Despite the abundance of published research devoted to 
understanding the preparation, characterization, and pharmacological effects of these 
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types of molecules, a great deal remains unknown.  Studies investigating the mechanism 
of diazeniumdiolate formation have yielded two feasible reaction schemes differing only 
in the reactive state of NO.  In the first, NO reacts with an amine to form a nitrosamine 
radical anion that subsequently reacts with another molecule of NO to form the 
diazeniumdiolate.29-31  In contrast, other reports suggest that NO first dimerizes to N2O2 
and then acts electrophilically in coupling with the amine to form the diazeniumdiolate.29  
Although previous work with secondary amines indicates efficient diazeniumdiolate 
formation in situ under high pressures (4–5 atm) of NO and basic conditions,15, 32, 33 the 
rate limiting step of diazeniumdiolate formation is the second addition of NO to the 
intermediate nitrosamine radical anion according to the first mechanism.  As such, low 
NO concentrations and/or slow rate determining steps (Scheme 2.2) may facilitate 
incomplete diazeniumdiolate formation from nitrosamine intermediates, that despite their 
ability to controllably release NO in the presence of light, are widely considered to be 
carcinogenic.7  In this chapter, the synthesis and NO release behavior of 12 different 
dialkyl diamines (Scheme 2.3) with varying alkyl character is described.  The propensity 
for these materials to form both nitrosamines and diazeniumdiolates is evaluated and 
compared with three common monoamine diazeniumdiolates.  Insight into the molecular 
characteristics determining the likelihood of nitrosamine formation over 
diazeniumdiolates is discussed.  
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2.2 Experimental Section 
2.2.1 General 
Butyryl chloride, heptanoyl chloride, lauroyl chloride, palmitoyl chloride, 
ethylenediamine, 1,10-diaminodecane, triethylamine, pyrrolidine, piperidine, proline, and 
borane-tetrahydrofuran complex were purchased from Aldrich Chemical Co. 
(Milwaukee, WI).  Diethylenetriamine, sodium methoxide, and 1,4-diaminobutane were 
purchased from Fluka.  Nitric oxide, argon, and nitrogen gases were purchased from 
National Welders Supply (Durham, NC).  All other common laboratory salts and 
chemicals were purchased from Fisher Scientific and used as received.  All water was 
purified using a Millipore Milli-Q Gradient A-10 purification system (Bedford, MA).  
Absorption spectra were recorded on a Perkin Elmer Lambda 40 UV-Vis 
spectrophotometer (Norwalk , CT).  Nuclear magnetic resonance spectra were obtained in 
CDCl3 using a Bruker 400 MHz AVANCE nuclear magnetic resonance spectrometer.  
Mass spectra were obtained using a Micromass Quattro II triple-quadrupole mass 
spectrometer equipped with a nano-electrospray ionization source operated in positive 
ionization mode.  Nitric oxide release was measured using a Sievers 280i Nitric Oxide 
Analyzer (Boulder, CO).      
2.2.2 Synthesis of N,N’-Dialkyl Diamines  
Primary diamine (4.6 mmol) and triethylamine (10.2 mmol) were added to 60 mL 
of a 2:1 chloroform:methanol mixture at 0 °C.  After stirring for 5 min, an acid chloride 
(10.2 mmol) was added and stirred for an additional 10 min on ice before refluxing for 24 
h.  After 24 h, 5 mL of water was added and the solution stirred for an additional 10 min 
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before cooling to room temperature.  When cool, the solvent was evaporated under 
reduced pressure to yield a white residue.  The residue was re-dissolved in chloroform 
(30 mL) and washed three times with a 1% potassium carbonate (K2CO3) solution.  After 
drying over solid K2CO3, the solvent was evaporated, and the product dried in vacuo 
overnight to yield the diamide precursor.  N-(2-butyrylamino-ethyl)-butyramide (5): 1H 
NMR (CDCl3, δ):  0.96 (t, CH3), 1.66 (m, CH2), 2.18 (t, CH2CONH), 3.41 (m, 
NHCH2CH2NH).  13C NMR (CDCl3, δ): 13.68 (CH3), 19.07 (CH2CH3), 38.59 
(CH2CONH), 40.23 (NHCH2CH2NH), 174.29 (CONH).  MS (ESI) m/z: [M+H+] calcd for 
C10H20N2O2, 201.2; found 201.1.  Heptanoic acid (2-heptanoylamino-ethyl) amide (6): 1H 
NMR (CDCl3, δ):  0.89 (t, CH3), 1.18-1.40 (m, CH2), 1.53-1.68 (t, CH2CH2CO), 2.10-
2.24 (t, CH2CONH), 3.28-3.42 (m, NHCH2CH2NH).  13C NMR (CDCl3, δ): 14.01 (CH3), 
22.50 (CH2CH3), 25.68 (CH2CH2CONH), 28.95 (CH2 CH2CH2CONH), 31.52 (CH2 
CH2CH3), 36.71 (CH2CONH), 40.18 (NHCH2CH2NH), 174.55 (CONH). MS (ESI) m/z: 
[M+H+] calcd for C16H32N2O2, 285.2; found 285.2.  Dodecanoic acid (2-
dodecanoylamino-ethyl) amide (7): 1H NMR (CDCl3, δ): 0.89 (t, CH3), 1.19-1.33 (m, 
CH2), 1.55-1.68 (t, CH2CH2CO), 2.27-2.34 (t, CH2CONH), 3.62-3.67 (m, 
NHCH2CH2NH).  13C NMR (CDCl3, δ): 14.07 (CH3), 22.66 (CH2CH3), 24.96 
(CH2CH2CONH), 29.14-29.57 (CH2), 31.89 (CH2 CH2CH3), 34.11 (CH2CONH), 51.38 
(NHCH2CH2NH), 174.30 (CONH).  MS (ESI) m/z: [M+H+] calcd for C26H52N2O2, 425.4; 
found 425.4.  Hexadecanoic acid (2-hexadecanoylamino-ethyl) amide (8): 1H NMR 
(CDCl3, δ): 0.89 (t, CH3), 1.12-1.34 (m, CH2), 1.61-1.65 (t, CH2CH2CO), 2.30-2.34 (t, 
CH2CONH), 3.62-3.68 (m, NHCH2CH2NH).  13C NMR (CDCl3, δ): 14.10 (CH3), 22.69 
(CH2CH3), 24.97 (CH2CH2CONH), 29.16-29.67 (CH2), 31.92 (CH2 CH2CH3), 34.12 
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(CH2CONH), 51.41 (NHCH2CH2NH), 174.33 (CONH). MS (ESI) m/z: [M+H+] calcd for 
C34H68N2O2, 537.5; found 537.6.  N-(4-butyrylamino-butyl)-butyramide (9): 1H NMR 
(CDCl3, δ):  0.96 (t, CH3), 1.55 (CH2CH3), 1.64-1.70 (m, NHCH2CH2), 2.15-2.18 (t, 
CH2CONH), 3.28-3.31 (m, NHCH2).  13C NMR (CDCl3, δ): 13.75 (CH3), 19.18 
(CH2CH3), 26.98 (CH2CH2CONH), 38.73 (CH2CONH), 38.95 (NHCH2), 173.22 
(CONH).  MS (ESI) m/z: [M+H+] calcd for C12H24N2O2, 228.2; found 228.1.  Heptanoic 
acid (4-heptanoylamino-butyl) amide (10): 1H NMR (CDCl3, δ): 0.89 (t, CH3), 1.18-1.35 
(m, CH2), 1.46-1.53 (CH2CH3), 1.54-1.64 (m, NHCH2CH2), 2.16-2.20 (t, CH2CONH), 
3.27-3.30 (m, NHCH2).  13C NMR (CDCl3, δ):  13.97 (CH3), 22.47 (CH2CH3), 25.74 
(CH2CH2CONH), 26.96-31.52 (CH2), 36.83 (CH2CONH), 38.95 (NHCH2), 173.42 
(CONH).  MS (ESI) m/z: [M+H+] calcd for C18H36N2O2, 312.3; found 312.3.  Dodecanoic 
acid (4-dodecanoylamino-butyl) amide (11): 1H NMR (CDCl3, δ): 0.89 (t, CH3), 1.18-
1.30 (m, CH2), 1.59-1.65 (CH2CH3), 2.30-2.34 (t, CH2CONH), 3.68 (m, NHCH2).  13C 
NMR (CDCl3, δ): 14.07 (CH3), 22.66 (CH2CH3), 24.96 (CH2CH2CONH), 29.15-29.58 
(CH2), 31.89 (CH2CH2CH3), 34.11 (CH2CONH), 51.38 (NHCH2), 174.31 (CONH).  MS 
(ESI) m/z: [M+H+] calcd for C28H56N2O2, 452.4; found 452.5.  Hexadecanoic acid (4-
hexadecanoylamino-butyl) amide (12): 1H NMR (CDCl3, δ): 0.90 (t, CH3), 1.15-1.30 (m, 
CH2), 1.38-1.50 (CH2CH3), 1.62-1.65 (m, NHCH2CH2), 2.30-2.34 (t, CH2CONH), 3.68 
(m, NHCH2).  13C NMR (CDCl3, δ): 14.08 (CH3), 22.67 (CH2CH3), 24.96 
(CH2CH2CONH), 29.10-29.57 (CH2), 31.91 (CH2CH2CH3), 34.12 (CH2CONH), 51.38 
(NHCH2), 174.31 (CONH).  MS (ESI) m/z: [M+H+] calcd for C36H72N2O2, 564.51; found 
564.51.  N-(10-butyrylamino-decyl)-butyramide (13): 1H NMR (CDCl3, δ): 0.96 (t, CH3), 
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1.24-1.34 (m, CH2), 1.46-1.51 (CH2CH3), 1.63-1.70 (m, NHCH2CH2), 2.13-2.19 (t, 
CH2CONH), 3.23-3.28 (m, NHCH2).  13C NMR (CDCl3, δ): 13.74 (CH3), 19.21 
(CH2CH3), 26.79-29.65 (CH2), 38.83 (CH2CONH), 39.44 (NHCH2), 172.85 (CONH).  
MS (ESI) m/z: [M+H+] calcd for C18H36N2O2, 313.3; found 313.3.  Heptanoic acid (10-
heptanoylamino-decyl) amide (14): 1H NMR (CDCl3, δ): 0.89 (t, CH3), 1.21-1.30 (m, 
CH2), 1.46-1.51 (CH2CH3), 1.60-1.65 (m, NHCH2CH2), 2.14-2.18 (t, CH2CONH), 3.22-
3.27 (m, NHCH2).  13C NMR (CDCl3, δ): 14.02 (CH3), 22.51 (CH2CH3), 25.80 
(CH2CH2CONH), 26.81-29.69 (CH2), 31.55 (CH2CH2CH3), 36.95 (CH2CONH), 39.45 
(NHCH2), 173.03 (CONH).  MS (ESI) m/z: [M+H+] calcd for C24H48N2O2, 397.4; found 
397.4.  Dodecanoic acid (10-dodecanoylamino-decyl) amide (15): 1H NMR (CDCl3, δ): 
0.89 (t, CH3), 1.20-1.32 (m, CH2), 1.58-1.63 (m, CH2CH3), 2.28-2.34 (t, CH2CONH), 
3.67 (m, NHCH2).  13C NMR (CDCl3, δ): 14.04 (CH3), 22.64 (CH2CH3), 24.95 
(CH2CH2CONH), 29.13-31.88 (CH2), 34.10 (CH2CONH), 51.34 (NHCH2), 174.26 
(CONH).  MS (ESI) m/z: [M+H+] calcd for C34H68N2O2, 537.5; found 537.6.  
Hexadecanoic acid (10-hexadecanoylamino-decyl) amide (16): 1H NMR (CDCl3, δ):  
0.88 (t, CH3), 1.20-1.31 (m, CH2), 1.59-1.64 (m, CH2CH3), 2.29-2.33 (t, CH2CONH), 
3.67 (m, NHCH2).  13C NMR (CDCl3, δ):  14.07 (CH3), 22.67 (CH2CH3), 24.96 
(CH2CH2CONH), 29.15-31.91 (CH2), 34.11 (CH2CONH), 51.37 (NHCH2), 174.29 
(CONH).  MS (ESI) m/z: [M+H+] calcd for C42H84N2O2, 649.6; found 649.6. 
To form secondary amines, a procedure for amide reduction was adapted from 
that described by Brown and Heim.34  A round bottom flask containing dry diamide was 
attached to a reflux setup where a 2x molar excess of 1M BH3-THF was then added 
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slowly to the reaction flask at 0 °C under N2.  The solution was stirred for 10 min before 
bringing to reflux for 24 h.  After cooling to room temperature, 6M hydrochloric acid (10 
mL) was added slowly.  The residual THF was then evaporated, followed by saturation of 
the resulting aqueous layer with solid sodium hydroxide and extraction 3 times with 20 
mL portions of diethyl ether.  The combined organic phase was dried over K2CO3, 
concentrated under reduced pressure, and dried in vacuo to yield the diamine products.  
N,N’-dibutyl ethylenediamine (17): 1H NMR (CDCl3, δ):  0.95 (t, CH3), 1.37-1.44 (m, 
CH2CH2CH3), 1.54-1.59 (m, CH2CH3), 3.50-3.80 (m, NHCH2).  13C NMR (CDCl3, δ): 
13.82 (CH3), 18.88 (CH2CH3), 34.79 (CH2CH2CH3), 62.79 (CH2NH).  MS (ESI) m/z: 
[M+H+] calcd for C10H24N2, 172.2; found 172.1.  N,N’-diheptyl ethylenediamine (18): 1H 
NMR (CDCl3, δ): 0.87 (t, CH3), 1.18-1.33 (m, CH2), 1.42-1.56 (t, CH2CH2NH) 2.57-2.60 
(t, CH2NH), 2.72 (m, NHCH2CH2NH).  13C NMR (CDCl3, δ): 14.04 (CH3), 22.60 
(CH2CH3), 27.33 (CH2CH2CH2NH), 29.22 (CH2CH2CH2 CH3), 30.17 (CH2CH2NH), 
31.81 (CH2CH2CH3), 49.55 (CH2NH), 50.04 (NHCH2CH2NH). MS (ESI) m/z: [M+H+] 
calcd for C16H36N2, 257.3; found 257.3.  N,N’-dilauryl ethylenediamine (19): 1H NMR 
(CDCl3, δ): 0.90 (t, CH3), 1.12-1.40 (m, CH2), 1.53-1.62 (t, CH2CH2NH), 3.64-3.67 (t, 
CH2NH).  13C NMR (CDCl3, δ): 14.09 (CH3), 22.68 (CH2CH3), 25.74 
(CH2CH2CH2CH3), 29.34 (CH2), 31.91(CH2CH2NH), 32.83 (CH2CH2CH3), 63.12 
(NHCH2CH2NH). MS (ESI) m/z: [M+H+] calcd for C26H56N2, 397.4; found 397.5.  N,N’-
dipalmityl ethylenediamine (20): 1H NMR (CDCl3, δ): 0.89 (t, CH3), 1.15-1.38 (m, CH2), 
1.54-1.59 (t, CH2CH2NH), 3.63-3.66 (t, CH2NH).  13C NMR (CDCl3, δ): 14.08 (CH3), 
22.67 (CH2CH3), 25.75 (CH2CH2CH2CH3), 29.34-29.67 (CH2), 31.91(CH2CH2NH), 
32.83 (CH2CH2CH3), 63.04 (NHCH2CH2NH). MS (ESI) m/z: [M+H+] calcd for 
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C34H72N2, 509.6; found 509.5.  N,N’-dibutyl butylenediamine (21): 1H NMR (CDCl3, δ): 
0.87 (t, CH3),  1.20-1.32 (m, CH2), 1.36-1.42 (CH2CH3), 1.43-1.50 (t, CH2CH2NH), 2.42-
2.60 (NHCH2).  13C NMR (CDCl3, δ): 13.90 (CH3), 20.44 (CH2CH3), 27.80 
(NHCH2CH2CH2CH2NH), 32.00 (CH2CH2CH3), 49.50-49.69 (CH2NH).  MS (ESI) m/z: 
[M+H+] calcd for C12H28N2, 201.2; found 201.2.  N,N’-diheptyl butylenediamine (22): 1H 
NMR (CDCl3, δ):  0.89 (t, CH3), 1.20-1.32 (m, CH2), 1.44-1.54 (CH2CH3), 1.62-1.78 (t, 
CH2CH2NH), 2.57-2.61 (NHCH2).  13C NMR (CDCl3, δ): 14.03 (CH3), 22.59 (CH2CH3), 
27.36-27.98 (NHCH2CH2CH2), 29.23 (CH2), 30.14-30.86 (NHCH2CH2), 31.80 
(CH2CH2CH3), 49.89-50.04 (NHCH2).  MS (ESI) m/z: [M+H+] calcd for C18H40N2, 
285.3; found 285.4.  N,N’-dilauryl butylenediamine (23): 1H NMR (CDCl3, δ): 0.87 (t, 
CH3), 1.15-1.32 (m, CH2), 1.42-1.56 (CH2CH3), 2.50-2.60 (t, CH2CH2NH), 3.50-3.60 
(NHCH2).  13C NMR (CDCl3, δ): 14.03 (CH3), 22.64 (CH2CH3), 25.79 
(CH2CH2CH2CH3), 29.31-29.64 (CH2), 31.89 (NHCH2CH2), 32.81 (CH2CH2CH3), 62.72 
(NHCH2).  MS (ESI) m/z: [M+H+] calcd for C28H60N2, 425.4; found 425.7.  N,N’-
dipalmityl butylenediamine (24): 1H NMR (CDCl3, δ):  0.90 (t, CH3), 1.17-1.35 (m, CH2), 
1.48-1.60 (CH2CH3), 2.59-2.78 (t, CH2CH2NH), 3.64-3.67 (NHCH2).  13C NMR (CDCl3, 
δ):  14.08 (CH3), 22.67 (CH2CH3), 25.75 (CH2CH2CH2CH3), 29.34-30.87 (CH2), 31.91 
(NHCH2CH2), 32.83 (CH2 CH2CH3), 63.06 (NHCH2).  MS (ESI) m/z: [M+H+] calcd for 
C36H76N2, 537.5; found 537.7.  N,N’-dibutyl decylenediamine (25): 1H NMR (CDCl3, δ):  
0.90 (t, CH3), 1.15-1.36 (m, CH2), 1.50-1.64 (CH2CH3), 2.29-2.34 (t, CH2CH2NH), 3.66 
(NHCH2).  13C NMR (CDCl3, δ):  14.09 (CH3), 22.68 (CH2CH3), 24.97 
(CH2CH2CH2CH3), 29.15-29.67 (CH2), 31.92 (NHCH2CH2), 34.12 (CH2 CH2CH3), 51.40 
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(NHCH2).  MS (ESI) m/z: [M+H+] calcd for C18H40N2, 284.3; found 284.4.  N,N’-
diheptyl decylenediamine (26): 1H NMR (CDCl3, δ):  0.88 (t, CH3), 1.20-1.32 (m, CH2), 
1.43-1.52 (CH2CH3), 2.58-2.63 (NHCH2).  13C NMR (CDCl3, δ):  14.04 (CH3), 22.60 
(CH2CH3), 27.31-27.36 (CH2CH2CH2CH3), 29.21-29.91(CH2), 31.81 (NHCH2CH2), 
49.99 (NHCH2).  MS (ESI) m/z: [M+H+] calcd for C24H52N2, 569.4; found 569.5.  N,N’-
dilauryl decylenediamine (27): 1H NMR (CDCl3, δ): 0.91 (t, CH3), 1.15-1.34 (m, CH2), 
1.50-1.62 (CH2CH3), 3.62-3.66 (NHCH2).  13C NMR (CDCl3, δ): 14.07 (CH3), 22.66 
(CH2CH3), 25.76 (CH2CH2CH2CH3), 29.33-29.65 (CH2), 31.90-32.83 (NHCH2CH2), 
62.98 (NHCH2).  MS (ESI) m/z: [M+H+] calcd for C34H72N2, 508.6; found 508.6.  N,N’-
dipalmityl decylenediamine (28): 1H NMR (CDCl3, δ):  0.90 (t, CH3), 1.19-1.40 (m, 
CH2), 1.52-1.62 (CH2CH3), 3.66 (NHCH2).  13C NMR (CDCl3, δ):  14.09 (CH3), 22.68 
(CH2CH3), 25.74 (CH2CH2CH2CH3), 29.35-29.61 (CH2), 31.92-32.83 (NHCH2CH2), 
63.11 (NHCH2).  MS (ESI) m/z: [M+H+] calcd for C42H88N2, 620.7; found 620.6. 
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Scheme 2.1 Proton-initiated decomposition of diazeniumdiolates. 
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Figure 2.1  Common diazeniumdiolate NO donors and their corresponding half lives at 
pH 7.4 and 37 °C.14, 15  
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Figure 2.2  O2-protected diazeniumdiolates: sulfonated16 (A), benzyl-substituted17 (B), 
and glycosylated20 (C). 
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Scheme 2.2 Mechanisms of Diazeniumdiolate Formation: (a) Sequential NO Addition, 
(b) Dimer Addition. 29-31  
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Scheme 2.3 Synthesis of N,N’ dialkyl diamines (where x = 2, 5, 10, 14 and y = 1, 2, 5) 
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Figure 2.3   Amine compounds investigated: (1) proline, (2) pyrrolidine, (3) 
piperidine, (4) diethylenetriamine, (17) N,N’-dibutyl ethylenediamine 
(DBED), (18) N,N’-diheptyl ethylenediamine (DHED), (19) N,N’-dilauryl 
ethylenediamine (DLED), (20) N,N’-dipalmityl ethylenediamine (DPED), 
(21) N,N’-dibutyl-1,4-butylenediamine (DBBD), (22) N,N’-diheptyl-1,4-
butylenediamine (DHBD), (23) N,N’-dilauryl-1,4-butylenediamine 
(DLBD), (24) N,N’-dipalmityl-1,4-butylenediamine (DPBD), (25) N,N’-
dibutyl-1,10-decylenediamine (DBDD), (26) N,N’-diheptyl-1,10-
decylenediamine (DHDD), (27) N,N’-dilauryl-1,10-decylenediamine 
(DLDD), (28) N,N’-dipalmityl-1,10-decylenediamine (DPDD). 
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2.2.3 Nitric Oxide Addition Reactions 
A sample of synthesized diamine was dissolved in methanol (4 mL), followed by 
the addition of a stoichiometric amount of sodium methoxide (1 eq. per 2° amine).  After 
stirring to ensure complete dissolution, the solution was placed in a stainless steel 
reaction chamber where it was flushed with Ar 4 times followed by a series of 4 longer 
Ar exposures (10 min each) and finally charged to a pressure of 5 atm with NO for 3 d 
under constant stirring.  A similar Ar flushing procedure was repeated after 3 d (2 quick 
flushes, 1 long flush).  All samples were then stored at -20 °C until analysis. 
Addition of NO to piperidine, diethylenetriamine, proline, and pyrrolidine were 
undertaken according to procedures described previously in the literature.10, 13, 15, 32 
2.2.4 Nitric oxide release analysis  
 Nitric oxide release analysis was performed at 37 °C in either 0.01 M phosphate 
buffered saline (PBS, pH = 7.4) in the dark or in a 1 M sodium hydroxide (NaOH) 
solution in the presence of direct broad spectrum light (200 W).  The distance of the lamp 
from the reaction flask was positioned to minimize any temperature increase of the water 
bath.  Aliquots of the compounds dissolved in MeOH were added to a reaction flask filled 
with approximately 30 mL of PBS or NaOH under continuous N2 sparging at 70 mL/min.  
Additional N2 flow was supplied to the reaction vessel in order to match the collection 
rate of the instrument at 200 mL/min.  Nitric oxide was monitored via a 
chemiluminescence nitric oxide analyzer calibrated using a zero gas filter (Sievers) and 
NO gas (25.7 PPM, balance N2).  Data was represented as instantaneous NO generation 
(ppb NO gas/mg sample), and total NO released (µmol NO/mg sample vs. time). 
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2.3 Results and Discussion 
2.3.1  Nitric oxide releasing dialkyl diamines   
The fabrication of NO-releasing materials via the physical incorporation of small 
molecule or nanoparticle-based NO donors within polymeric matrices has the potential to 
be a solution to device associated infection caused by the proliferation of opportunistic 
microbes at the site of medical implants.  The dispersion of such NO-releasing species 
within a polymeric matrix will bypass many of the complications (i.e. protein adhesion) 
arising from surface charge accumulation of diazeniumdiolate-modified polymers as the 
location of entrapped dopants will primarily be below the surface of the polymer.  
Additionally, the utilization of different diazeniumdiolate NO donors embedded within a 
variety of biomedical polymers allows for the fine-tuning of NO release characteristics 
based on the nature of the NO donor, NO diffusion through the polymeric matrix,35 and 
polymer properties.  Furthermore, dopant amount may be changed, diversifying the NO-
release characteristics of the material even further.  Despite the potential to generate a 
wide array of NO-releasing materials in this manner, major concerns exists regarding the 
ability of these inherently ionic materials to leach from the host polymer.27, 28  Not only 
does this leaching decrease NO release at the surface of the material, but the diffusion of 
potentially toxic diazeniumdiolate degradation products give rise to additional concerns.  
Furthermore, according to mechanistic insight regarding diazeniumdiolate formation, the 
potential exists for nitrosamine formation in competition with diazeniumdiolates.29-31  In 
order to assess the likelihood of nitrosamine formation, a series of dialkyl diamines with 
varying alkyl content were designed.  In doing so, we sought to identify molecular 
70 
 
characteristics (i.e. hydrogen bonding and hydrophobicity) that may stabilize the 
nitrosamine intermediate, thus decreasing the efficiency of diazeniumdiolate conversion.  
Nitric oxide release from the products was quantified under either standard physiological 
conditions (pH 7.4 PBS, 37 °C) or highly basic conditions (1.0M NaOH) in the presence 
of direct 200 W broad spectrum light.  The degradation of N-diazeniumdiolates to NO 
and the parent amine in phosphate buffered saline,6, 12 and the stability of nitrosamines in 
aqueous solutions at physiological pH7 are well-known.  Similarly, direct light irradiation 
in basic solution was chosen for the detection of nitrosamine-derived NO due to the 
known photodegradation of nitrosamines and the stability of diazeniumdiolates under 
basic conditions.7, 12 
Unexpectedly, more pronounced NO release was observed with light irradiation 
compared to physiological conditions for 9 of the 15 compounds investigated including 
diethylenetriamine (4), and the majority of the synthesized dialkyl diamines.  This 
susceptibility to light irradiation indicates a heterogenous product mixture containing 
both the N-nitroso and the N-diazeniumdiolated species.  Interestingly, N,N’-diheptyl 
ethylenediamine (17) (Figure 2.4),  exhibited over 50-fold greater NO release when 
exposed to light in basic conditions over standard physiological conditions, indicating the 
favorable formation of nitrosamines over diazeniumdiolates.  All analagous compounds 
synthesized from the ethylenediamine core (17-20) also exhibited this trend of 
nitrosamine formation over diazeniumdiolates albeit to a lesser extent, with the average 
nitrosamine/diazeniumdiolate ratio of these compounds approximately 1.00/0.07.  
Despite an increased indicence of diazeniumdiolate formation for compounds synthesized 
from the butanediamine (21-24) and decanediamine cores (25-27) (average 
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nitrosamine/diazeniumdiolate ratios ~1.00/0.75), these compounds also exhibited 
appreciable NO release attributed to the formation of nitrosamines.  However, when the 
monoamine compounds proline (1), pyrrolidine (2), and piperidine (3) were exposed to 
similar conditions, NO release in the presence of light was minimal, indicating 
preferential formation of N-diazeniumdiolates over nitrosamines (Table 2.1).  
Absorption spectroscopy was used to confirm the formation of both N-nitroso and 
N-diazeniumdiolate products on the polyamine precursors (4, 17-28).  Absorbance at 252 
nm, indicative of N-diazeniumdiolates,6 was most intense for monoamine compounds (1–
3), but visible for all species treated with NO except for 18, which exhibited almost 100-
fold greater preference for nitrosamine formation (Table 2.1).  All NO-treated polyamine 
compounds showed supplementary absorbance values between 330–350 nm associated 
with the n→π∗ transition of N-nitroso compounds (Figure 2.5).7  Of note, the molar 
absorptivities of these two functional groups spanned several orders of magnitude, from 
40–90 M-1 cm-1 for the nitrosamine peaks of the synthesized polyamines to 7.2–9.4 x 103 
M-1 cm-1 for diazeniumdiolates.6 
The preference for diazeniumdiolate versus nitrosamine formation seems to be 
influenced by the structure of the amine precursor.  Intramolecular hydrogen bonding is 
possible on the nitrosamine radical anion intermediate formed during diazeniumdiolate 
formation for polyamine compounds, but not monoamines. Specifically, neighboring 
amines may act to stabilize the nitrosamine intermediate in compounds derived from 4 
and 17-20 in the form of N-H···O=N, which has recently been shown to be more stable 
than N-H···N=O.36  These interactions are aided by the proximity of amines for the 
ethylenediamine based conjugates and the bent conformation of the nitrosamine37, 38 
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allowing the formation of a stable 7-membered annular species.  As the amine spacing of 
polyamine compounds was increased from ethylene for 17-20 to butylene for 21-24 (as 
well as ethylene to decylene (25-28)), the calculated nitrosamine:diazeniumdiolate ratio 
decreased (NO-release analysis, Table 1).  Additionally, the UV absorbance due to 
nitrosamines decreased for molecules with 4 carbon spacing between amines (21-24) and 
10 carbon spacing between amines (25-28) relative to those with an ethylene core (17-
20), with a concomitant increase in the diazeniumdiolate absorbance (Figure 2.5). The 
shift from nitrosamine to diazeniumdiolate formation may be attributed to the increased 
strain associated with the formation of larger ring systems (9 and 15 membered for 
butanediamine and decanediamine based conjugates respectively) necessary for the 
intramolecular hydrogen bond stabilitization on the nitrosamine intermediate.  
Additionally, the increased rotational degrees of freedom associated with the longer alkyl 
segments may decrease the likelihood of opportunistic hydrogen bonding by amines due 
to the large increase in the number of conformations available to these molecules in 
solution.  The decreased ability for nitrosamine stabilization may facilitate the second NO 
addition, thus increasing the efficiency of diazeniumdiolate formation.  Additionally, the 
lack of multiple amines on other compounds such as 1–3 do not allow for intramolecular 
hydrogen bond stabilization to the nitrosamine, predicting increased diazeniumdiolate 
formation compared to other investigated compounds.  Representative NO release curves 
for the monoamine 1 after treatment with NO confirm this strong preference of 
diazeniumdiolation, as NO release due to light is insignificant compared to that occurring 
in buffer immersion alone (Figure 2.6).   
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While fully formed diazeniumdiolates and nitrosamines may both experience 
similar hydrogen bond stabilization, interruption of the reaction progression at the 
intermediate stage due to hydrogen bonding impedes the sequential addition of NO and 
thus the complete conversion to the diazeniumdiolate species.  Although, the influence of 
hydrogen bonding is decreased in polar solvents, collapse of the hydrophobic alkyl 
segments of the molecules may further facilitate these stabilizing interactions due to the 
proximity of amines after chain collapse, explaining the presence of nitrosamine 
attributed NO release to compounds 21-27 despite the increased separation of amines due 
to larger alkyl segments than compounds 4 and 17-20.   
To address the incomplete diazeniumdiolate formation, alterations of the NO 
addition reactions were made for all polyamine compounds.  Experiments were 
performed by increasing both the total reaction time of the NO addition from 3 to 5 d and 
the amount of NO available for reaction by increasing the pressure of the NO reactor 
from 4 to 10 atm (maintaining a reaction time of 3 d).  In both instances, the presence of 
nitrosamines was still observed  for the polyamine compounds of interest in similar ratios 
to those observed in Table 2.1.     
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Figure 2.4 Real-time and total (inset) NO release of NO-treated 17 analyzed in the 
presence of 1.0 M NaOH, light (─  ), and PBS, pH 7.4 (─  ).
 
 
 
 
 
74 
 
Table 2.1  NO Release Characteristics of Monoamine and Polyamine Compounds 
Exposed to 4 atm NO for 72 h. 
 
amine 
precursor 
NO initiation 
method 
NO release 
(µmol/mg)a
nitrosamine/ 
diazeniumdiolateb
1 Light 0.04 ± 0.01 1.00/49.75 
 Proton 3.98 ± 0.49  
2 Light 0.06 ± 0.01 1.00/97.09 
 Proton 11.67 ± 0.65  
3 Light 0.06 ± 0.01 1.00/47.85 
 Proton 5.74 ± 0.22  
4 Light 1.14 ± 0.16 1.00/0.38 
 Proton 0.86 ± 0.09  
17 Light 0.42 ± 0.02 1.00/0.15 
 Proton 0.13 ± 0.03  
18 Light 2.16 ± 0.17 1.00/0.01 
 Proton 0.04 ± 0.01  
19 Light 0.91 ± 0.15 1.00/0.04 
 Proton 0.08 ± 0.01  
20 Light 0.37 ± 0.10 1.00/0.09 
 Proton 0.07 ± 0.01  
21 Light 0.06 ± 0.07 1.00/0.08 
 Proton 0.01 ± 0.01  
22 Light 1.58 ± 0.44 1.00/1.44 
 Proton 4.56 ± 0.51  
23 Light 0.18 ± 0.10 1.00/1.25 
 Proton 0.45 ± 0.14  
24 Light 0.38 ± 0.01 1.00/0.29 
 Proton 0.22 ± 0.03  
25 Light 1.47 ± 0.08 1.00/1.43 
 Proton 4.21 ± 0.31  
26 Light 1.23 ± 0.16 1.00/0.07 
 Proton 0.17 ± 0.02  
27 Light 0.58 ± 0.05 1.00/0.70 
 Proton 0.81 ± 0.07  
28 Light c c
 Proton c c
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a Total after 32 min analysis for monoamine compounds and 16 h analysis 
for polyamine compounds based on duration of NO release. b Calculated 
from total NO release assuming one and two molecules of NO for 
nitrosamine and diazeniumdiolates respectively. c Compound instability; not 
analyzed. 
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Figure 2.5 UV/Vis spectra for NO treated 2 (--), 5 (─  ), and 6 (─  ) in MeOH.  [Inset: 
Expanded view of N-nitrosamine absorbance region.] 
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Figure 2.6  Real-time NO release of NO-treated 1 analyzed in 1.0 M NaOH with 
direct light (─  ), and PBS pH 7.4 (─  ).  [Inset: enlarged view of NO flux 
in  1.0 M NaOH with direct light.] 
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2.4 Conclusions 
 Spectroscopic data and NO-release analysis indicate that both diazeniumdiolates 
and nitrosamines form competitively with exposure of polyamines to  high pressures of 
NO.  The inability of monoamine compounds, such as 1–3, to form stabilizing 
intramolecular hydrogen bonds facilitates the conversion of nitrosamine intermediates to 
the intended diazeniumdiolates.  However, molecules capable of forming intramolecular 
hydrogen bonds (i.e. 4, 17–20) or those containing large alkyl segments (21–27) that 
promote chain collapse in polar solvents display an impeded level of diazeniumdiolate 
formation due to the increased stability of the nitrosamine intermediate.  As the effects of 
NO derived from diazeniumdiolate degradation have been shown to be beneficial by 
numerous researchers, the results presented here indicate that the increased incidence of 
nitrosamine formation on polyamine scaffolds may pose concern for some applications of 
these NO donors.  In contrast, the suitability of monoamine species as diazeniumdiolate 
donors is supported by minimal nitrosamine formation.  Overall, the results suggest that 
current synthetic methods may require revision to minimize nitrosamine formation on 
polyamine compounds, or at least stringent characterization to confirm their absence.        
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Chapter 3: 
Degradable Nitric Oxide-Releasing Biomaterials via Post-Polmerization 
Functionalization of Crosslinked Polyesters 
 
3.1 Introduction 
The formulation of diverse biodegradable polymers has become an increasingly 
important aspect in the advancement of biomedical materials.1  Absorption of degradable 
scaffolds by host tissues may overcome long-term biocompatibility problems associated 
with persistent implants, as well as eliminate the high costs and patient morbidity 
associated with follow-up surgeries.2-4 Additionally, these materials may facilitate the 
emergence of unique therapies (e.g., drug delivery) that exploit characteristic degradation 
patterns.1  The development of degradable polymers for use in vascular stents, sutures, 
tissue engineering scaffolds, and joint replacement applications has been widely 
reported.5-9  Despite their promise in addressing specific challenges, the implementation 
of such materials remains limited due to the prevalence of infection associated with 
implantable medical devices in general.10  Indeed, opportunistic microbes at surgical sites 
cause over two million hospital-acquired infections each year in the United States alone.2  
The cost associated with treatment and extended hospitalization for patients with 
nosocomial infections is > $3 billion and expected to increase as the average age of our 
population rises.2  Effective treatments and reducing the incidence of such infections is of 
critical importance to health care. 
Hospital-acquired infections occur due to microbe propagation at the surgical site 
and subsequent formation of a biofilm surrounding the implant.  The biofilm matrix 
protects bacteria, making their eradication particularly challenging without explantation 
of the associated medical device.11  The polymicrobial nature and advanced drug 
resistance mechanisms of biofilms often require the administration of elevated doses of 
antimicrobial agents but with less than adequate results.  Incomplete biofilm elimination 
often leads to the emergence of drug-resistant strains, further complicating treatments.11  
Consequently, prevention of the initial bacterial adherence and colonization at the 
medical device surface is the most ideal strategy for reducing the risk and severity of 
surgical infections.12     
The endogenously produced diatomic free radical nitric oxide (NO) has been 
implicated in a number of physiological roles including vasodilation,13 angiogenesis,14  
wound healing,15  and the elimination of pathogens.16  The effectiveness of NO against 
numerous types of bacteria associated with hospital-acquired infections (e.g. 
Pseudomonas aeruginosa and Staphylococcus aureus) are well documented.17  Since NO 
is highly reactive, the formulation of scaffolds capable of releasing NO in a controlled 
manner are essential to its use as a therapeutic.  As a result, numerous researchers have 
investigated methods aimed at the storage and controlled release of NO.18-20  S-
nitrosothiols and N-diazeniumdiolates represent two of the most well-known NO donor 
molecules.20  While diazeniumdiolates release their NO payload in the presence of a H+ 
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donor,19 S-nitrosothiols liberate their NO in the presence of heat, light, and/or trace 
metals.21  
Due to its short half-life in physiological milieu (~3 s), NO must be generated at 
the site of interest to maximize its efficacy as a therapeutic and minimize potential side 
reactions and toxicity.  Numerous NO-releasing coatings have been designed to minimize 
surface biofouling including the polymers doped with small molecule NO donors (i.e. S-
nitrosoglutathione [GSNO]22 and the diazeniumdiolate form of proline [PROLI/NO]23), 
and those whereby the NO donor is covalently attached to a polymer.  In both cases, NO 
release proved useful in reducing platelet and bacterial adhesion.24-27  However, the fact 
that these polymer coatings are not biodegradable limit their potential uses to short-term 
implants such as catheters or sensors.       
The development of NO-releasing biodegradable polymers will further extend the 
utility of NO release in the biomedical arena.  Herein, we report the synthesis of 
crosslinked polymeric materials capable of both controlled NO release and matrix 
degradation under physiological conditions.  The prepolymer preparation by a melt phase 
reaction and subsequent thermal curing allows for formation of crosslinked products in a 
variety of architectures.  This tunability may be used to tailor the materials for a desired 
application.  Nitric oxide donor functionalization is accomplished via straightforward 
coupling reactions to terminal carboxylic acids present after thermal crosslinking.  A 
range of degradation rates and NO-storage capabilities are achieved by employing 
interchangeable starting materials consisting of polyfunctional alcohols (glycerol and 
pentaerythritol), diacids (glutaric acid and adipic acid), and the NO-donor precursors 
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(cysteamine and penicillamine).  The antibacterial efficacy of these materials against 
Pseudomonas aeruginosa is examined using a static adhesion assay. 
 
3.2 Experimental 
3.2.1 Materials   
Glutaric acid (GA), adipic acid (AA), pentaerythritol, cysteamine, penicillamine, 
and N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC) were 
purchased from the Aldrich Chemical Company (Milwaukee, WI).  Glycerol, N-
hydroxysuccinimide (NHS), and laboratory grade salts and solvents were purchased from 
Fisher Scientific (Fair Lawn, NJ).  Sodium nitrite was purchased from Acros Organics 
(Morris Plains, NJ).  Diethylenetriamine-pentaacetic acid (DTPA) was purchased from 
Fluka (Buchs, Switzerland).  Tryptic soy broth (TSB) and Minimum Essential Media 
(MEM) was purchased from Becton, Dickinson, and Company (Sparks, MD).  Nitric 
oxide calibration gas (25.85 ppm; balance nitrogen) was purchased from National 
Welders Supply Co. (Durham, NC).  Pseudomonas aeruginosa (ATCC #19143) was 
obtained from American Type Culture Collection (Manassas, VA).  Water was purified to 
18.2 ΜΩ⋅cm using a Millipore Milli-Q Gradient A-10 purification system (Bedford, 
MA).       
3.2.2 Characterization   
1H and 13C NMR was performed in methyl sulfoxide-d6 on a Bruker 400 MHz 
AVANCE Nuclear Magnetic Resonance spectrometer.  Gel-permeation chromatography 
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was carried out using a Waters GPC system with a Wyatt Optilab DSP interferometric 
refractometer and a Wyatt Dawn EOS detector with polystyrene standards.  Static water 
contact angle measurements were acquired using a CAM 200 optical angle goniometer.  
Measurements obtained were the average of five frames taken over a period of 5 s 
immediately after administering a drop.  Thermogravimetric analysis was performed 
under a nitrogen atmosphere on a Perkin-Elmer Pyris 1 TGA with a heating rate of 10 
°C/min.  Transition temperatures were measured using a Seiko 220C differential 
scanning calorimeter with heating and cooling rates of 10 °C/min in a nitrogen 
atmosphere.  Nitric oxide release was measured using a Sievers 280i Nitric Oxide 
Analyzer (Boulder, CO) operating at a flow rate of 200 mL min-1.  A two-point 
calibration line was generated using 25.85 ppm NO gas (balance nitrogen) and air passed 
through a Sievers NO zero filter.   
3.2.3 Polyester Synthesis   
Prepolymer melts were formed by heating the desired diacid precursor just above 
its melting temperature for 2 h in either a 1.60:1.00 molar ratio with glycerol, or a 
2.15:1.00 molar ratio with pentaerythritol (Scheme 3.1).  Hybrid polyesters were 
prepared similarly using diacid:glycerol:pentaerythritol molar ratios of 1.00:0.31:0.23.  
After 2 h, the melt was carefully poured into a mold and the prepolymer cured for 24 h at 
elevated temperatures determined to be the minimum temperature required for complete 
curing (75, 120 or 160 °C).  After curing, the solid polyester was removed from the mold 
and cut to produce 1 cm x 1 cm squares of roughly 0.2 cm thickness. 
 
87 
 
3.2.4 Polyester Functionalization   
By controlling the stoichiometry of the prepolymer synthesis, free carboxylic acid 
functionalities remain after curing, permitting conjugation of NO donors using 
straightforward NHS/EDC coupling techniques.  Briefly, a polymer square was added to 
a glass vial containing 10 mL of water.   Exactly 1 mL of 1.56 M NHS (aq). was then 
added to the solution.  After chilling in an ice bath for 5 min, 1 mL of 1.56 M EDC (aq) 
was added, and the vial returned to the ice bath for 10 min.  After allowing the polymer to 
soak at room temperature for 24 h, the square was removed from the NHS/EDC solution, 
rinsed with chilled water and added to another vial containing 10 mL of aqueous 0.25 M 
solutions of either cysteamine or penicillamine (Table 3.1).  To prevent premature 
degradation of the polymer squares, the pH of the solutions was neutralized only 
immediately prior to study.  After soaking for an additional 24 h at room temperature, the 
polymer squares were removed from solution, rinsed thoroughly with chilled water and 
dried in vacuo.  The polymer (thiols) was nitrosated by submerging the squares in 8 mL 
of 10 mg/mL NaNO2 (aq) and adding 8 mL of 0.5 M HCl at 0 °C (ice bath) for 30 min in 
the dark.  The polymer squares were then removed from solution, rinsed with a chilled 
solution of 100 µM DTPA (aq) and dried in vacuo.  Nitrosated squares were stored at -20 
°C until analysis. 
3.2.5 In Vitro Degradation   
Rates of polymer degradation were assessed by placing polymer squares weighing 
approximately 250 mg in 10 mL of PBS at pH 7.4.  After incubation at 37 °C, samples 
were removed, rinsed with water, and dried in vacuo overnight.  The percent mass lost 
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during solution immersion was recorded for each sample with the % degradation 
expressed using the average of three samples for each time point.  Polymer degradation 
was monitored weekly for the initial polymeric materials (PE1, PE2, PE3, PE4) and at 1, 
5, and 10 week intervals for the functionalized squares.  To prevent saturation, incubation 
solutions were changed weekly.   
3.2.6 NO Release Analysis   
Nitric oxide release was measured using a chemiluminescence nitric oxide 
analyzer.  Briefly, a nitrosated polyester square was added to a flask containing 30 mL of 
deoxygenated phosphate buffered saline (PBS) containing 500 µM DTPA as a copper 
chelator at pH 7.4 and 37 °C.  Nitrogen was flowed through the solution at a flow rate of 
70 mL/min, carrying any liberated NO to the analyzer.  Additional nitrogen flow was 
supplied to the flask to match the collection rate of the instrument at 200 mL/min.  The 
analyte solution was shielded from ambient light to ensure that all NO release was 
thermally triggered, unless noted otherwise.       
3.2.7 Bacterial Viability   
P. aeruginosa cultures were grown in TSB to concentrations of 108 colony 
forming units (CFU) mL-1.  Polymer squares were incubated individually in 15 mL 
conical vials containing 4 mL of the bacterial suspension in PBS for 3 h at 37 °C with 
gentle agitation.  The squares were removed from the bacterial suspension, rinsed lightly 
with sterile water, and dried under stream of nitrogen.  The extent of bacterial adhesion 
was measured by phase contrast optical microscopy using a Zeiss Axiovert 200 inverted 
microscope (Chester, VA) coupled with a Zeiss Axiocam digital camera (Chester, VA).  
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Cell adhesion to each surface was quantified by digitally processing each image and 
applying a threshold value to differentiate the background from adhered cells.  Materials 
with rapid degradation rates (PE1 and PE2) were not analyzed in this manner due to the 
onset of surface roughness contributing to localized darkness in the phase contrast optical 
micrographs and decreased optical clarity due to water uptake.  As such, only polyesters 
that remained optically transparent after soaking were selected for comparison (PE3, 
PE4, and PE6).  
3.2.8 In vitro toxicity of polyesters  
 Polyester samples (250 mg) were soaked in PBS for 24 h at 37 °C to remove any 
soluble or degraded materials from the polymers.  L929 mouse fibroblasts were grown in 
MEM supplemented with 10% fetal bovine serum (FBS), and 1% penicillin/streptomycin 
and incubated in 5% CO2 under humidified conditions at 37 °C. Following 80% 
confluency, the cells were trypsinized and seeded onto tissue-culture treated polystyrene 
96-well plates at a density of 3 x 105 cells/ml. Cells were incubated with the polyester 
soak solutions for a period of 24 h. Following the incubation period, the supernatant was 
aspirated and cells were washed with sterile PBS three times. Fresh media (100 µl) was 
added to the cells along with 20 µl of the MTS assay reagent (CellTiter 96 Aqueous Non-
Radioactive Cell Proliferation Assay, Promega, Madison, WI). The mitogenic MTS assay 
for cell viability relies upon the reduction of a yellow MTS compound (3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) as 
a result of mitochondrial respiration. The reduction to a purple formazan derivative 
occurs only in viable cells. The absorbance of this colored solution was quantified at 490
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 Scheme 3.1  Representative synthesis of NO-releasing polyesters derived from glutaric acid and 
glycerol. 
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Table 3.1  Composition of synthesized polyesters. 
         
Polyester Diacid Polyol(s) Thiol Nitrosated (y/n) 
PE1 Glutaric Acid Glycerol - n 
FPE1A Glutaric Acid Glycerol Cysteamine n 
NPE1A Glutaric Acid Glycerol Cysteamine y 
FPE1B Glutaric Acid Glycerol Penicillamine n 
NPE1B Glutaric Acid Glycerol Penicillamine y 
PE2 Adipic Acid Glycerol - n 
FPE2A Adipic Acid Glycerol Cysteamine n 
NPE2A Adipic Acid Glycerol Cysteamine y 
FPE2B Adipic Acid Glycerol Penicillamine n 
NPE2B Adipic Acid Glycerol Penicillamine y 
PE3 Glutaric Acid Pentaerythritol - n 
FPE3A Glutaric Acid Pentaerythritol Cysteamine n 
NPE3A Glutaric Acid Pentaerythritol Cysteamine y 
FPE3B Glutaric Acid Pentaerythritol Penicillamine n 
NPE3B Glutaric Acid Pentaerythritol Penicillamine y 
PE4 Adipic Acid Pentaerythritol - n 
FPE4A Adipic Acid Pentaerythritol Cysteamine n 
NPE4A Adipic Acid Pentaerythritol Cysteamine y 
FPE4B Adipic Acid Pentaerythritol Penicillamine n 
NPE4B Adipic Acid Pentaerythritol Penicillamine y 
PE5 Glutaric Acid Glycerol, 
Pentaerythritol 
- n 
FPE5A Glutaric Acid Glycerol, 
Pentaerythritol 
Cysteamine n 
NPE5A Glutaric Acid Glycerol, 
Pentaerythritol 
Cysteamine y 
PE6 Adipic Acid Glycerol, 
Pentaerythritol 
- n 
FPE6A Adipic Acid Glycerol, 
Pentaerythritol 
Cysteamine n 
NPE6A Adipic Acid Glycerol, 
Pentaerythritol 
Cysteamine y 
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nm using a plate reader (Thermoscientific Multiskan® EX, Waltham, MA). Untreated cells were 
used as controls and results were expressed as % viability with respect to untreated controls.  
Average percent cell viabilities were calculated from at least 8 measurements.  
3.3 Results and Discussion 
3.3.1 Polyester Synthesis and Characterization   
The preparation of crosslinked polyesters via polycondensation reactions allows for the 
synthesis of a wide range of materials.  Initially, four polymer compositions were synthesized 
from their corresponding prepolymers containing a diacid and a polyol.  The first two 
prepolymers were synthesized by the reactions of glycerol with a calculated excess of GA (PE1) 
or AA (PE2).  To alter the crosslink density (and the resulting degradation and thermal 
transitions) of the polyester materials made, glycerol was substituted with the tetrafunctional 
alcohol, pentaerythritol was used in place of glycerol resulting in two additional compositions, 
PE3 and PE4, again containing excess GA or AA, respectively.  Further compositional diversity 
was afforded by incorporating a combination of glycerol and pentaerythritol with each diacid 
yielding PE5 (with GA) and PE6 (with AA).  While 13C NMR confirmed the formation of ester 
linkages (Figure 3.1), GPC analysis indicated prepolymer molecular weights < 1000 g/mol.  
Similarly, accurate estimation of molecular weight could not be determined via end group 
analysis due to the highly branched structure of the prepolymers.  However, the inclusion of 
polyfunctional alcohols allows for sufficient crosslinking even at low prepolymer molecular 
weights.   
As with other crosslinked aliphatic polyesters,28 thermal curing over a wide range of 
temperatures alters the degree of crosslinking and crosslink density, resulting in diverse 
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transition temperatures and degradation properties.  The effects of curing temperatures on the 
properties of compositionally identical polyester formulations is thus not discussed further.  To 
increase throughput, the minimum temperatures required for complete curing after 24 h were 
considered optimal.  As expected, differences in prepolymer melting temperatures and the total 
functionality of the polyol crosslinker resulted in a range of curing temperatures (Table 3.2).  
Higher curing temperatures were necessary for materials containing adipic acid over glutaric acid 
due to the inherently greater melting temperature of adipic acid (151 vs 96 °C for AA and GA, 
respectively).  Additionally, the increase in molecular functionality upon switching the polyol 
precursor from glycerol to pentaerythritol facilitated crosslinking, thereby decreasing the 
necessary curing temperatures compared to materials containing the trifunctional crosslinker.  
As reported by others,28 the curing of crosslinked aliphatic polyesters significantly 
influence the thermal transitions inherent to a material.  Flexible polymers at physiological 
temperatures are often advantageous over more rigid materials due to facilitated surgical 
introductions and improved tissue incorporation.29  As a result, the optimal glass transition 
temperatures (Tg) for the materials synthesized in this study would be below physiological 
temperatures (37 °C).  Likewise, thermal degradation of the polyesters would be minimal under 
normal storage conditions to prolong the lifetime of these materials.  The observed glass 
transition temperatures ranged from -25.5 °C to 3.2 °C for PE3 and PE4, respectively (Table 
3.3).  Additionally, the polyesters synthesized did not exhibit appreciable thermal degradation at 
temperatures below 200 °C.  As expected, AA-based compositions (PE2, PE4) were 
characterized by greater degradation and glass transition temperatures than the corresponding 
GA-based compositions (PE1, PE3).  We attribute this result to the higher degrees of 
crosslinking previously linked to elevated curing temperatures.28  Materials containing both 
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polyols in addition to their respective diacid (PE5, PE6) did not follow this trend.  Rather, the 
GA-based composition (PE5) had both higher glass transition and degradation temperatures than 
the AA-based composition (PE6), attributable to a higher crosslink density caused by the smaller 
diacid constituent and similar curing temperatures. 
3.3.2 In vitro degradation   
As cytotoxicity of degradation products is an important consideration for all degradable 
biomaterials, these materials were designed so that the products of hydrolysis would be 
metabolic intermediates or FDA approved compounds.  Although the compatibility of 
degradation products is essential for such a material, the degradation rate is also an important 
consideration for the application of the material.  Rate of degradation is influenced by material 
composition, water uptake, and degree of crosslinking.30  Due to differences in the composition 
and curing temperatures used in the preparation of the polyesters in this study, a wide variation 
of degradation rates was observed (Figure 3.2).  As expected, the polyesters containing glycerol 
(PE1 and PE2) degraded more rapidly than those containing pentaerythritol (PE3 and PE4) due 
to the decreased crosslink density associated with the trifunctional alcohol.  Additionally, the 
degradation rate data indicated that the GA-based polyesters were more susceptible to hydrolysis 
than their counterparts composed of AA, matching trends identified in previous studies relating 
increased aliphatic chain length to slowed hydrolysis rates.31  The rate of degradation for PE4 
was much slower than anticipated due to the high crosslink density of the material. Through 10 
weeks, no appreciable degradation was observed for PE4.  Even at extended periods (~20 weeks) 
when all other polyesters had degraded appreciably, only 15% mass loss was noted for PE4 
materials.  Polymers containing both glycerol and pentaerythritol (PE5 and PE6) had faster 
degradation rates than PE4, but slower than the other polyesters due to crosslinking effects 
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facilitated by the presence of both polyols and curing. As expected the higher crosslink density 
of PE5 resulted in inhibited hydrolysis and slower degradation compared to PE6.  Overall, 
degradation of all samples except PE4 over the first 10 weeks of analysis was zero-order and 
linear as would be expected for cured, amorphous elastomers (Figure 3.3).7  Complete 
degradation of PE1, PE2, PE3 was observed after 9, 10, and 14 weeks, respectively.  Although 
complete degradation of PE5 and PE6 was not observed over the maximum period investigated 
(15 weeks), extrapolation of the zero-order degradation model based on degradation rates over 
the initial 10 weeks predicts complete degradation after approximately 103 and 45 weeks, 
respectively.  Due to extremely slow degradation rates for PE4, extrapolation of a zero-order 
degradation model was not attempted.   
3.3.3 Polyester Functionalization and Nitrosation   
The availability of free terminal carboxylic acids resulting from the excess GA or AA in 
the prepolymer melt phase permitted the coupling of amine-functionalized molecules via facile 
NHS/EDC techniques.  In this case, coupling of cysteamine and penicillamine to the polymer 
was investigated as a means to store NO.  Due to the hydrolytic instability of ester-based 
materials in acidic or basic solutions, and the pH-dependent reaction kinetics of amide bond 
formation using NHS and EDC, reaction conditions were optimized for control of both polyester 
degradation and aminothiol conjugation.  Upon formation of polymer-bound activated esters via 
exposure of the polyesters to aqueous NHS and EDC, the materials were rinsed with chilled 
water and soaked in solutions containing cysteamine in water (pHs 4–10).  The unadjusted 
alkilinity of cysteamine dissolved in water (pH 10) proved to be excessively harsh for the 
functionalization step as the polyester was observed to degrade extensively.  Less basic solutions 
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(pH 8 and 9) were also not suitable due to decomposition of the polyester matrix after 24 h, 
albeit less pronounced than at pH 10.  While polyesters in slightly acidified solutions (pH 4–6) 
did not degrade appreciably relative to the basic solutions, the subsequent aminothiol coupling 
resulted in decreased  NO release (data not shown).  A neutralized solution of cysteamine 
afforded the optimal pH for functionalization, as determined by minimal mass lost due to 
degradation and maximum NO release capabilities (Figure 3.4).   
S-nitrosothiols are most commonly prepared via reactions of free thiols with solutions of 
acidifed or organic nitrites.21  To prevent uptake of potentially harmful organic nitrites into the 
polyester materials, nitrosothiols were formed via exposure to aqueous solutions of acidified 
nitrite.  Due to the susceptibility of aliphatic polyesters to hydrolysis at acidic pH, the effects of 
solution acidity and reaction duration on polyester stability during nitrosation were investigated.  
As expected, the rate of polymer degradation increased substantially in strongly acidic solutions 
(>1 M HCl) for even short periods of time (i.e, 5–10 min).  With decreasing acid concentration, 
the time necessary to induce noticeable material degradation increased markedly.  The 
nitrosothiol formation observed for functionalized polyesters submerged in solutions of 0.25 M 
HCl containing 10 mg/mL NaNO2 after 30 min combined with minimal mass loss due to 
hydrolysis indicated that the S-nitrosothiol reaction conditions were appropriate for further 
experimentation.  The procedures used for the functionalization and nitrosation of PE1–PE6 did 
not appreciably change the degradation and thermal characteristics of these materials from those 
of the preliminary polyesters (Table 3.4).    
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Figure 3.1  13C NMR spectra of A) glutaric acid, B) glycerol, and C) PE1 prepolymer in methyl 
sulfoxide – d6. 
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Table 3.2  Melt and curing temperatures for polyesters. 
   
Polyester Melt Temperature 
(°C) 
Curing Temperature 
(°C) 
PE1 100 120 
PE2 160 160 
PE3 100 75 
PE4 160 120 
PE5 100 120 
PE6 160 120 
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Table 3.3  Thermal analysis of polyesters PE1– PE6. 
        
Polyester 5% wt loss 
(°C) 
10% wt loss 
(°C) 
Tg  
(°C) 
PE1 242 289 -25.3 
PE2 328 359 -14.0 
PE3 252 412 -25.5 
PE4 419 437 3.2 
PE5 295 368 0.6 
PE6 221 269 -17.0 
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Figure 3.2.  Degradation rates of PE1 – PE6 as mass lost (%) vs. time (■  – PE1, ● – PE2, ▲  – 
PE3,  ▼  - PE4,    - PE5,      – PE6). 
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Figure 3.3  Kinetic fits of polyester degradation for PE1, PE2, PE3, PE5 and PE6. 
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Figure 3.4  Functionalization efficiency of PE1 as % degradation (•) and NO Release (□). 
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 Table 3.4  Thermal analysis for functionalized and nitrosated polyesters.   
 
      
Sample 5% wt loss 
(°C) 
10% wt loss 
(°C) 
FPE1A 265 324 
NPE1A 260 323 
FPE1B 291 332 
NPE1B 301 344 
FPE2A 297 338 
NPE2A 306 339 
FPE2B 262 311 
NPE2B 299 334 
FPE3A 270 340 
NPE3A 236 366 
FPE3B 259 397 
NPE3B 250 389 
FPE4A 407 435 
NPE4A 385 406 
FPE4B 352 404 
NPE4B  381 408  
FPE5A 279 373 
NPE5A 291 369 
FPE6A 292 371 
NPE6A 277 376 
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3.3.4 NO Release Analysis   
The combination of compositional diversity, degradation rates, and thermal transitions 
provide scaffolds with the capacity to store and release variable amounts of NO.  Due to the 
numerous NO release mechanisms inherent to S-nitrosothiols,21 the total NO storage was 
characterized via multiple analyses.  As shown in Figure 3.5, the kinetics of NO release were 
temperature dependent as predicted.  Additionally, NO release was further accelerated upon 
exposure to light, supporting the use of high wattage broad spectrum irradiation to rapidly 
liberate all of the NO from the scaffold and determine NO release (Figure 3.6).  As provided in 
Table 3.5, the total NO storage for the six polyester materials varied by almost two orders of 
magnitude.  Predictably, the total NO release for polyesters containing cysteamine residues was 
larger than their penicillamine counterparts.  The decreased NO storage for penicillamine has 
been attributed to the increased steric crowding of the tertiary thiol functionality compared to 
that of primary thiols (cysteamine).21  Although these steric effects give rise to nitrosothiols with 
increased stabilization compared to primary nitrosothiols, these effects decrease the thiol to 
nitrosothiol conversion efficiency resulting in less NO storage at analogous nitrosation times.  
Extended nitrosation times were not evaluated due to the necessity to limit polymer exposure to 
hydrolytic conditions. The two-component polyesters containing GA also stored more NO than 
those with AA.  This characteristic may be attributed to the temperatures required for thermal 
curing.  As mentioned above, curing temperatures for the polyester prepolymers were selected 
based on the melting temperatures of the diacid precursors.  As a result, AA-containing materials 
were cured at higher temperatures than their GA counterparts giving rise to higher degrees of 
crosslinking.  Increased crosslinking decreases the number of available acid functional groups 
limiting further coupling of cysteamine or penicillamine, and ultimately NO storage capacity.  
105 
 
This trend remained consistent for the three-component polyesters as PE5 was characterized by a 
higher degree of crosslinking than PE6. 
Although the total NO storage of a material is important to assess its utility as a potential 
therapeutic, many of the bioregulatory roles of NO, including vasodilation, bacterial killing, and 
wound healing, are flux dependent.32-36  As such, understanding NO release as a function of time 
is important.  Hetrick et al. previously determined that a 65% reduction of P. aeruginosa 
adhesion to a surface was achievable using NO fluxes of ~21 pmol cm-2 sec -1.35  The maximum 
NO fluxes released from the polyesters prepared herein all exceeded the 21 pmol cm-2 sec -1 
threshold when immersed in PBS solutions at 37 °C (Table 3.5).  The magnitude of NO surface 
fluxes displayed similar trends to the total NO released, with all cysteamine-functionalized 
materials releasing greater amounts of NO than their penicillamine-functionalized counterparts.  
Additionally, both the NO flux and total NO release proved tunable by varying the extent of 
aminothiol coupling to the polyester backbone (Figure 3.7). 
3.3.5 Bacterial Adhesion   
Although NO-releasing materials have been shown to inhibit bacterial adhesion at their 
surfaces in a flux-dependent manner,35 differences in surface chemistry between materials 
undoubtedly influence the extent of adhesion and propagation of bacteria.  As such, the ability of 
the NO-releasing polyesters to inhibit bacterial adhesion was investigated and compared to 
control polyesters.  Indeed, the NO-releasing NPE3A, NPE4A, and NPE6A polyesters 
significantly reduced P. aeruginosa adhesion to the material surface in a dose-dependent manner 
compared to both unmodified and cysteamine-modified controls (Figure 3.8, Table 3.6).  The 
reduction in bacterial adhesion mirrors the total NO release for the three polyesters investigated 
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with NPE3A > NPE6A > NPE4A.  Interestingly, NPE3A caused only a 25% greater reduction in 
P. aeruginosa adhesion compared to NPE4A, despite releasing more NO.  This behavior may be 
attributed to similarities in the maximum NO flux values for these two substrates.  Previous 
studies have indicated that greater concentrations of NO over a short time period prevent 
bacterial adhesion to model substrates more effectively than lower fluxes over extended 
periods.35, 37  Nevertheless, the improved performance of NPE3A over NPE4A is likely due to 
the increased duration of NO release (t1/2 NPE3A: 2.55 ± 0.20 h, t1/2 NPE4A: 0.63 ± 0.18 h).  The 
utilization of slowly degrading polyesters ensures that reduced bacterial adhesion due to 
interfacial degradation of the polyesters over the duration of the experiment is an unlikely source 
of error.  
3.3.6 In vitro toxicity of polyesters  
 The potential cytotoxicity of the polyesters towards healthy mammalian cells warranted 
in vitro toxicity evaluation of the starting materials and their degradable components.  L929 
mouse fibroblasts were employed for these studies due to the prevalence of fibroblasts in both 
the extracellular and wound healing environments.38 As shown in Figure 3.9, PE1 and PE2 
polymers exhibited the greatest cytotoxic response through 24 h with only 34 ± 2 and 53 ± 20% 
viable cells, respectively. Despite this, all other material compositions resulted in at least 65% 
cell viabilities indicating a minimal cytotoxic response.  The rapid degradation of PE1 and PE2 
may result in elevated toxicity due to greater amounts of low-molecular weight degradation 
products in the soak media compared to slower degrading materials (e.g., PE3 and PE4).  Of 
note, the functionalized (e.g., FPE1A and FPE2A) and nitrosated (e.g., NPE1A and NPE2A) 
counterparts of PE1 and PE2 elicited much less cytotoxicity (Figure 3.9, Table 3.7), suggesting 
that appreciable unpolymerized starting materials may also be leaching from PE1 and PE2. The  
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Figure 3.5  Temperature dependence of NO release for NPE1A. 
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Figure 3.6  Nitric oxide release comparison of NPE1A with light trigger (—, 200 W broad 
spectrum) and thermal trigger (---, 37 °C, shielded from light). 
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Table 3.5  Nitric oxide release characteristics for nitrosated polyesters.    
          
Polyester t[NO]a  
(µmol) 
[NO]mb  
(pmol cm-2 sec-1) 
t1/2c  
(h) 
Duration Above 21 pmol 
cm-2 sec-1 (h) 
NPE1A 2.28 ± 0.21 429 ± 93 5.37 ± 0.09 16.31 ± 0.10 
NPE1B 0.80 ± 0.10 210 ± 73 0.97 ± 0.44 0.61 ± 0.10 
NPE2A 1.13 ± 0.02 481 ± 47 1.35 ± 0.23 2.93 ± 0.51 
NPE2B 0.14 ± 0.06 136 ± 62 0.18 ± 0.03 0.43 ± 0.09 
NPE3A 1.86 ± 0.14 384 ± 96 2.55 ± 0.20 4.60 ± 0.74 
NPE3B 0.72 ± 0.29 215 ± 102 3.99 ± 0.98 0.60 ± 0.23 
NPE4A 0.53 ± 0.26 347 ± 87 0.63 ± 0.18  1.09 ± 0.11 
NPE4B 0.04 ± 0.01 53 ± 15 0.11 ± 0.05 0.08 ± 0.01 
NPE5A 0.92 ± 0.16 324 ± 108 0.76 ± 0.14 1.79 ± 0.39 
NPE6A 0.99  ± 0.04 697 ± 46 0.90 ± 0.25 1.16 ± 0.10 
a t[NO] = total NO released 
b [NO]m = maximum NO flux;  
c t1/2 = half life of NO release. 
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Figure 3.7  Total NO release triggered by direct light irradiation for NPE1A as a function of 
cysteamine concentration in functionalization solutions (— 2 mM cysteamine, --- 1 mM 
cysteamine). 
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Figure 3.8  Representative bright field optical micrographs of P. aeruginosa surface coverage on 
polyester substrates. A) PE3, B) FPE3A, C) NPE3A, D) PE4, E) FPE4A, F) NPE4A, G) PE6, H) 
FPE6A, and I) NPE6A.  Dark spots are bacteria.  
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Table 3.6  Reduction of P. aeruginosa adhesion to representative NO-releasing polyester 
substrates.  
                
  
% 
Bacterial 
coverage 
% Bacterial 
coverage of 
unmodified 
controls 
% 
Reduction 
ANOVA 
P-value 
% Bacterial 
coverage of 
cysteamine 
modified 
controls 
% 
Reduction 
ANOVA 
P-value 
NPE3A 
3.98 ± 
2.40 20.04 ± 7.77 80 
3.51 x 
10-20 20.94 ± 5.88 81 
3.51 x 
10-30
NPE4A 
11.19 ± 
6.94 24.89 ± 8.15 55 
1.45 x 
10-9
25.82 ± 
10.61 57 
1.03 x 
10-9
NPE6A 
7.03 ± 
3.07 20.28 ± 8.41 65 
5.92 x 
10-15 27.63 ± 6.03 75 
1.17 x 
10-33
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Figure 3.9  Viability of L929 mouse fibroblasts exposed to polyester leachables and degradation 
products for 24 h. 
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Table 3.7  Statistical analysis of cell viability of L929 mouse fibroblasts exposed to polyester 
degradation products 
  
% Cell 
Viability 
% Cell viability of 
unmodified 
controls 
ANOVA 
P-value 
% Cell viability of 
cysteamine modified 
controls 
ANOVA 
P-value 
NPE1A 
68.17 ± 
11.00 33.79 ± 2.11 3.25 x 10-9 74.17 ± 20.71 0.481 
NPE2A 
87.59 ± 
17.10 52.56 ± 20.21 0.198 65.95 ± 11.10 0.954 
NPE3A 
93.53 ± 
19.96 94.00 ± 27.45 0.637 92.01 ± 1.80 0.664 
NPE4A 
87.27 ± 
16.60 102.09 ± 13.96 0.033 85.11 ± 8.26 0.852 
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soaking of these polyesters in aqueous solutions (required for subsequent functionalization) 
reduces such leaching and subsequent cytotoxicity. 
3.4 Conclusion 
The thermal polycondensation of diacids with polyols was demonstrated as a versatile 
route for the formation of degradable NO-releasing polyesters.  The synthesized polyesters were 
characterized by a wide range of degradation rates and thermal properties based on polymer 
composition and curing conditions.  Facile modification of these substrates was achieved by 
controlling the stoichiometry of the prepolymer melt phase reaction and utilizing straightforward 
aqueous phase coupling reactions with the terminal acid functionalities on the crosslinked 
polyester.  Total incorporation of NO-donating moieties proved dependent on the thermal 
properties of the polymers as materials with lower glass transition temperatures have been shown 
to store and release more NO than materials with higher transition temperatures.  The 
cysteamine- and penicillamine-modified polyesters prepared released between 0.01 – 0.81 µmol 
NO cm-2 for up to 6 days (pH 7.4, 37 °C).  Nitric oxide release from these polyesters reduced 
bacterial adhesion to model substrates by up to 80% compared to controls.  The synthesis of 
absorbable nitric oxide-releasing polyesters represents a significant advancement in the 
development of implantable materials with enhanced antifouling properties.  Future studies are 
planned to evaluate the performance of these polymers in vivo. 
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Chapter 4: 
Synthesis of Nitric Oxide-Releasing Polyurethanes with S-Nitrosothiol-Containing 
Hard and Soft Segments 
 
4.1 Introduction 
 The utility of many biomedical devices is often thwarted by platelet adhesion and 
thrombus formation that occur soon after contact with blood.1-3  For example, biofouling of 
intravascular implants, such as catheters or stents, may lead to the formation of deep vein 
thrombosis and increase the risk of heart attack and stroke.2, 3  In addition to the potential health 
hazards caused by surface thrombosis, the costs associated with extended hospital stays, 
explantations, and re-implantation are rising exponentially.2  Therefore, the design and synthesis 
of implantable materials that exhibit improved thromboresistivity remains an important goal for 
researchers developing blood-contacting medical devices.4-6     
     A wide range of synthetic polymers are currently used as medical implants, including 
polyurethanes, polyesters, and polyacrylates.4, 6  In general, more hydrophilic biomaterials 
possess better blood compatibility due to their low interfacial free energy that reduces plasma 
protein adsorption relative to hydrophobic implants.7  Although polyurethanes are typically 
composed of both hydrophilic soft segments and hydrophobic hard segments, surface segregation 
phenomena and surface restructuring upon contact with water provides polyurethanes with the 
enhanced blood compatibility seen for completely hydrophilic materials.7-10  In addition to 
improved haemocompatibility, the elastomeric and broad mechanical properties provided by the 
microphase separation of the hard and soft segments make polyurethanes attractive candidates 
for use in the design of implants.7  Despite these advantages, protein and platelet adhesion to 
polyurethane surfaces remain problematic in the clinical implementation of devices that use this 
material.2, 3         
     Nitric oxide (NO) assumes many roles in human physiology including neurotransmission,11, 12 
vasodilation,13, 14 wound healing,15 platelet function,16 and the immune response.17, 18  As a result, 
NO has been investigated as a potential solution to the complications associated with implant 
biocompatibility.17-20  Unfortunately, the administration of NO is complicated because of its high 
reactivity and gaseous nature.  Consequently, much research has been directed to the 
development of scaffolds for the storage and controlled release of NO to specific locations.19, 21-23  
A number of molecular platforms may be used to store NO including organic nitrates, N-
diazeniumdiolates, and S-nitrosothiols (RSNOs), the latter being an endogenous NO carrier.  
RSNO NO donors have received much attention recently due to their low toxicity compared to 
other NO donor precursors.  Furthermore, NO release via RSNO decomposition is induced by 
multiple routes including thermal, photolytic and exposure to trace metals.24 
     Previous reports using NO to improve the thromboresistivity of medical implants made use of 
NO donors doped into polymer membranes or the direct modification of polymers to release 
NO.20  While doping of NO scaffolds into polymers allows for tunable NO release, leaching of 
the NO donor and/or degradation products presents toxicity concerns.25  Others have reported the 
incorporation of NO-donors (e.g. N-diazeniumdiolates) onto polyurethane scaffolds at pre- and 
post-polymerization stages.26-28  Unfortunately, the NO release capability is confounded by the 
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presence of protonated surface amines resulting in enhanced protein adhesion.27  Additionally, 
the surface segregation of the NO donor precursors likely prevents significant NO donor 
formation (to diazeniumdiolates) due to their location within the hydrophobic hard segments of 
the polyurethanes. 
     Herein, we report the synthesis of functional polyurethanes capable of NO storage and 
controlled release via S-nitrosothiol NO donors.  The NO donors are formed after incorporation 
of the thiols into the polyurethane structure via exposure to acidified nitrite.  The influence of 
RSNO functionalization in both the hard and soft segments of these polyurethanes provides 
insight into increasing the NO storage capabilities of these materials. 
4.2 Experimental Section 
4.2.1 Materials 
All chemicals were purchased from Sigma-Aldrich (Milwaukee, WI) and used as received unless 
otherwise noted.  Solvents and common laboratory salts were purchased from Fisher Scientific 
(Philadelphia, PA).  Nitric oxide and nitrogen gases were purchased from National Welders 
Supply (Durham, NC).  All water was purified using a Millipore Milli-Q Gradient A-10 
purification system (Bedford, MA).  
4.2.2 Characterization 
All 1H and 13C NMR were performed in CDCl3 on a Bruker 400 MHz AVANCE nuclear 
magnetic resonance spectrometer.  Polymer molecular weights were measured using a Waters 
GPC system with a Wyatt Optilab DSP interferometric refractometer and a Wyatt Dawn EOS as 
the detector with polystyrene standards.  A CAM 200 optical angle goniometer was used to 
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measure static water contact angle.  Thermogravimetric analysis was performed on a Perkin-
Elmer Pyris 1 TGA under an N2 atmosphere using heating rates of 10 °C/min.  Thermal 
transitions were measured using a TA Instruments Q200 differential scanning calorimeter with 
heating rates of 10 °C/min and cooling rates of 5 °C/min.  Nitric oxide release was measured 
using a Sievers 280i nitric oxide analyzer.  
4.2.3 General Procedure for the S-Tritylation of Mercaptoacids   
Equimolar amounts (30 mmol) of an appropriate mercaptoacid and triphenylmethanol 
were dissolved in 60 mL of stirring glacial acetic acid, followed by the dropwise addition of 10 
mL of boron trifluoride diethyl etherate.  After stirring for 4 h at room temperature, the 
yellow/orange solution and precipitate were poured into a mixture of 150 mL of water and 80 
mL of saturated sodium acetate.  The aqueous solution was then extracted with diethyl ether.  
The organic phase was concentrated under reduced pressure and dried in vacuo overnight 
(Scheme 4.1). 1a (94% yield).  1H NMR (CDCl3, δ):  3.04 (s, CH2COOH), 7.23 (t, aromatic), 
7.31 (t, aromatic), 7.43 (t, aromatic) 13C NMR (CDCl3, δ): 34.58 (CH2COOH), 67.27 (SC(Ph)3), 
127.27 (C4), 128.20 (C3), 129.53 (C2), 143.94 (C1), 175.23 (COOH).  Anal. Calcd for C21H18O2S: 
C, 75.4; H, 5.4; S, 9.6.  Found: C, 75.2; H, 5.5; S, 7.4.   2a (81% yield). 1H NMR (CDCl3, δ): 
1.24 (t, CH3), 3.05 (m, CH2), 3.52 (m, CH3CH) 7.20 (t, aromatic), 7.28 (t, aromatic), 7.43 (t, 
aromatic)  13C NMR (CDCl3, δ):  15.21 (CH3), 19.71 (CH), 44.15 (CH2), 68.18 (SC(Ph)3), 
126.94 (C4), 128.10 (C3),  129.46 (C2), 144.25 (C1), 173.39 (COOH), 173.77 (CONH).  Anal. 
Calcd for C24H23NO3S: C, 71.1; H, 5.7; N, 3.5; S, 7.9.  Found: C, 67.8; H, 6.0; N, 3.2; S, 6.7.  3a 
(51% yield) 1H NMR (CDCl3, δ): 1.20-1.45 (CH2), 1.63 (m, SCH2CH2), 2.17 (t, CH2COOH), 
2.38 (t, SCH2), 7.16 (t, aromatic), 7.31 (t, aromatic), 7.44 (t, aromatic).  13C NMR (CDCl3, δ): 
24.71 (CH2CH2COOH), 28.66 - 29.44 (CH2), 32.08 (SCH2), 34.13 (CH2COOH), 66.46 
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(SC(Ph)3), 126.33 (C4), 127.83 (C3), 129.68 (C2), 145.18 (C1), 180.29 (COOH). Anal. Calcd for 
C30H36O2S: C, 78.2; H, 7.9; S, 7.0.  Found: C, 75.4; H, 7.6; S, 6.3.  4a (98% yield).  1H NMR 
((CD3)2SO, δ): 1.95 (t, CH2COOH), 2.07 (SCH2), 7.04 (t, aromatic), 7.12 (t, aromatic), 7.13 (t, 
aromatic)  13C NMR ((CD3)2SO, δ):  26.97 (SCH2), 33.20 (CH2COOH), 66.49 (SC(Ph)3), 126.94 
(C4), 128.23 (C3), 129.37 (C2), 144.62 (C1), 172.93 (COOH).  Anal. Calcd for C22H20O2S: C, 
75.8; H, 5.8; S, 9.2.  Found: C, 75.1; H, 5.8; S, 8.3.   
4.2.4 General Procedure for the Coupling of S-Trityl Mercaptoacids and Diethanolamine   
A slight excess of N-hydroxysuccinimide (NHS, 22 mmol) was added to a round bottom 
flask containing the appropriate protected mercaptoacid (20 mmol, 1a–4a) in 80 mL of stirring 
methylene chloride. After 5 min, the flask was chilled to 0 °C and dicyclohexylcarbodiimide 
(DCC, 22 mmol) was then added to the solution.  The solution was stirred for 10 min on ice 
before the temperature was allowed to rise to room temperature. The solution was stirred for an 
additional 24 h under nitrogen.  The formed precipitate was removed by vacuum filtration, and 
the filtrate returned to a round bottom flask.  Triethylamine (25 mmol) was added to the solution 
in slight excess followed by the addition of diethanolamine (22 mmol) in methylene chloride (10 
mL).  After stirring for 24 h under nitrogen, the solution was washed twice with 60 mL of 
saturated sodium carbonate, and once with 60 mL of saturated sodium bisulfate.  The organic 
phase was then dried over magnesium sulfate, and concentrated under reduced pressure. 1b (95% 
yield).  1H NMR (CDCl3, δ):  3.04 (m, CH2N), 3.45 (m, CH2OH), 3.77 (t, SCH2), 7.24 (t, 
aromatic), 7.31 (t, aromatic), 7.47 (t, aromatic) 13C NMR (CDCl3, δ):  33.78 (CH2S), 51.03 
(CH2N), 60.84 (CH2COOH), 67.08 (SC(Ph)3),  126.91 (C4), 128.01 (C3), 129.50 (C2), 144.07 
(C1), 170.57 (CON). Anal. Calcd for C25H27NO3S: C, 71.2; H, 6.5; N, 3.3; S, 7.6.  Found: C, 
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71.6; H, 7.1; N, 4.6; S, 6.2.  2b (41% yield).  1H NMR (CDCl3, δ): 1.45 (d, CH3), 3.04 (m, 
CH3CH), 3.36 (t, CH2N), 3.52 (t, CH2OH), 3.80 (CH2CON), 7.20 (t, aromatic), 7.28 (t, 
aromatic), 7.45 (t, aromatic).  13C NMR (CDCl3, δ):  19.80 (CH3), 33.82 (SCH), 41.89 
(NHCH2CON), 50.63 (NCH2CH2OH), 60.13 (NCH2CH2OH), 68.15 (SC(Ph)3), 126.84 (C4), 
128.03 (C3), 129.51(C2), 144.23 (C1), 169.25 (SCH(CH3)CONH), 172.80 (CONCH2CH2OH).  
Anal. Calcd for C28H32N2O4S: C, 68.3; H, 6.6; N, 5.7; S, 6.5.  Found: C, 67.4; H, 6.8; N, 5.8; S, 
5.9.  3b (67% yield).  1H NMR (CDCl3, δ): 1.15-1.40 (CH2), 2.15 (m, CH2CON), 2.39 (t, SCH2), 
3.52 (t, CH2N), 3.78 (t, CH2OH), 7.22 (t, aromatic), 7.29 (t, aromatic), 7.42 (t, aromatic).  13C 
NMR CDCl3, δ):  25.59 (CH2CH2COOH), 28.57-29.23 (CH2), 32.05 (SCH2), 33.92 
(CH2COOH), 50.60 (NHCH2CH2OH), 60.85 (NHCH2CH2OH), 66.41 (SC(Ph)3), 126.50 (C4), 
127.78 (C3), 129.63 (C2), 145.07 (C1), 175.46 (CON).  Anal. Calcd for C34H45NO3S: C, 74.6; H, 
8.3; N, 2.6; S, 5.9.  Found: C, 70.0; H, 8.1; N, 3.3; S, 5.4.  4b (88% yield).  1H NMR (CDCl3, δ):  
2.29 (t, CH2CON), 2.57 (t, SCH2), 3.29 (t, CH2N), 3.65 (t, CH2OH), 7.23 (t, aromatic), 7.30 (t, 
aromatic), 7.44 (t, aromatic).  13C NMR (CDCl3, δ): 27.42 (CH2S), 33.80 (CH2CON), 50.70 
(CH2N), 60.81 (CH2OH), 66.90 (SC(Ph)3),  126.70 (C4) 128.02 (C3), 129.60 (C2), 144.83 (C1), 
173.34 (CON).  Anal. Calcd for C26H29NO3S: C, 71.7; H, 6.7; N, 3.2; S, 7.4.  Found: C, 70.9; H, 
6.6; N, 3.2; S, 6.8. 
4.2.5 Polyurethane Synthesis    
A round bottom flask was charged with terathane (1 mol eq.), 4,4’-
methylenebis(cyclohexyl isocyanate) (4 mol eq.) and dibutyltin dilaurate (0.047 mol eq.)  in N,N-
dimethylformamide (DMF, 15 mL).  The reaction mixture was heated at 75 °C for 90 min 
followed by the addition of a chain extender (1b – 4b, 3 mol eq.) in additional DMF.  After a 
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combined reaction time of 24 h at 75 °C, the polyurethane was precipitated in 450 mL water at 4 
°C.  The solid polymer was isolated by vacuum filtration and then dried in vacuo overnight to 
yield the protected polyurethane (Scheme 4.2) (PPU1–PPU4). 
4.2.6 Deprotection of Protected Thiol Polyurethanes   
After dissolving the protected polyurethane (1.0 g) in CH2Cl2 (30 mL), the solution was 
chilled on ice.  A 4:2:1 solution of trifluoroacetic acid:methylene chloride:triisopropysilane (7 
mL) was then added dropwise.  The reaction mixture was stirred for 1 h on ice, concentrated 
under reduced pressure, and dried in vacuo to yield the deprotected polyurethane (TPU1–TPU4).  
To minimize disulfide formation, the solid polymer was stored in an inert atmosphere at -20 °C.   
4.2.7 Polymerization of Epichlorohydrin   
Epichlorohydrin (420 mmol, 38.81 g) was added dropwise to a solution of ethylene 
glycol (20 mmol, 1.23 g) and boron trifluoride diethyl etherate (400µmol, 50 µL) in methylene 
chloride (10 mL) on ice.  After addition of the epichlorohydrin, the solution was allowed to 
slowly rise to room temperature and react for 15 h.  The reaction was quenched by the addition 
of methanol (5 mL).  Subsequent evaporation of the solvent and unreacted starting materials 
yielded polyepichlorohydrin (PECH) as a light yellow viscous oil (Scheme 4.3).        
4.2.8 Polymerization of Polyepichlorohydrin-containing Polyurethane (PU-PECH)   
Dibutyltin dilaurate (0.047 mol eq.)  in DMF (5 mL) was added to a round bottom flask 
containing polyepichlorohydrin (1 mol eq.), 4,4’-methylenebis(cyclohexyl isocyanate) (4 mol 
eq.), and DMF at 70 °C.  The solution was stirred for 90 min before 1,4-butanediol (3 mol eq.) 
was added in additional DMF.  After allowing the reaction to proceed for an additional 22.5 h, 
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the polymer was precipitated by pouring the solution into 450 mL of chilled water.  The product 
was then isolated by vacuum filtration (Scheme 4.4).   
4.2.9 Thiolation of Polyepichlorohydrin-containing Polyurethane   
Sodium hydrosulfide (4.1 g) was slowly added to a solution of PU-PECH (4.0 g) in 
DMF (20 mL) at 95 °C.  After turning bright blue, the solution was stirred for an additional 24 h, 
cooled and diluted by the addition of 75 mL CHCl3.  The solution was then vacuum filtered to 
remove insoluble byproducts and concentrated under reduced pressure to yield a polyurethane  
containing poly(oxiran-2-yl methanethiol) soft segments (PU-POMT).  
4.2.10 Casting and Nitrosation of Thiol-Containing Polyurethane Films   
Deprotected (TPU1–TPU4) or thiolated (PU-POMT) polyurethane films were solution 
cast on glass slides from a 40 mg/mL solution of polymer in CHCl3, then allowed to dry under 
ambient conditions for 30 min.  Cast films were stored at -20 °C to minimize any further 
disulfide formation.  S-nitrosothiols functionalized films were prepared by submerging the 
polymer-coated glass slide in 2 mL of a 50 mg/mL solution of NaNO2 in water, and slowly 
adding 5 mL of 5 M HCl.  The films were soaked on ice shielded from light for 2 h, rinsed 
copiously with a chilled solution of 100 µM diethylenetriamine pentaacetic acid (DTPA) in 
water, and dried in vacuo.  Films were stored at -20 °C prior to experimentation.  
4.2.11 Nitric Oxide Release Characterization   
Nitric oxide release from the polyurethanes was measured using a Sievers model 280i 
chemiluminescence nitric oxide analyzer (Boulder, CO).  The instrument was calibrated using a 
26.39 ppm NO gas (balance N2) and air passed through a Sievers NO zero filter.  Analysis was 
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performed by placing a polyurethane film in a reaction flask held at 37 °C filled with 30 mL of 
deoxygenated phosphate buffered saline (PBS) containing 500 µM DTPA and sparged with N2 at 
a flow rate of approximately 70 mL min-1.  Additional N2 flow was supplied via a side-arm to 
match the collection rate of the instrument at 200 mL min-1.  The reaction flask was shielded 
from light to prevent undesirable photo-triggered release of NO. 
 
4.3 Results and Discussion 
4.3.1 Synthesis and Characterization of Hard Segment-Modified Polyurethanes   
The design and synthesis of polyurethanes containing S-nitrosothiol-modified chain 
extenders or soft segments represents a new class of NO-release scaffold that allows for the 
evaluation of NO donor spatial effects as a function of thiol position along the backbone.  The 
evaluation of RSNO chain extended polyurethanes first required the synthesis of chain extenders 
capable of presenting free thiols post-polymerization.  To maximize thiol availability following 
polyurethane synthesis, thiol group protection is essential to prevent thiocarbamate formation 
upon reaction of thiols-containing chain extenders and isocyanates.  As a result, we evaluated the 
synthesis of four protected thiol-containing chain extenders.  The utilization of mercaptoacid 
starting materials (1–4) provided a facile approach in generating S-trityl mercaptoacids (1a–4a) 
and subsequent attachment to amine-containing diol species, such as diethanolamine, to generate 
a group of diverse chain extenders (1b–4b) (Scheme 4.1). 
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Scheme 4.1  Protected mercaptoacid (1a-4a) and chain extender (1b-4b) synthesis. 
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Scheme 4.2  Representative polymerization, deprotection, and nitrosation of TPU polymers 
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Scheme 4.3 Epichlorohydrin polymerization 
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Scheme 4.4 Polymerization, substitution, and nitrosation of PU-PECH. 
 
 
 
132 
 
Polyurethane preparation was initiated first by the formation of isocyanate end-capped 
terathane polyether glycol prepolymers followed by chain extension using the protected thiol 
chain extenders (1b–4b).  Isolated polymers were observed to have similar molar ratios of 
components compared to the reaction mixture based on NMR analysis. Molecular weight, 
polydispersity, and thermal characteristics for the resulting protected-thiol polyurethanes 
(PPU1–PPU4) are shown in Table 4.1.  The molecular weights of the protected thiol 
polyurethanes ranged from 1.0 x 104 to 1.9 x 104 with polydispersities from 1.4 to 1.9, as 
expected from step-growth kinetics (PDI ~ 2.0).  The observed glass transition temperature range 
for the protected polymers (-78 to -64 °C) was similar to values obtained for Terathane alone (-
77 °C) as predicted by previous studies indicating that polyurethane thermal transitions closely 
resemble those of their prepolymer derivatives.29  As shown by comparing PPU3 and PPU4 to 
PPU1, higher glass transition temperatures were observed for polymers containing longer 
alkanethiol grafts from the chain extenders (-64 and -71 to -78 °C).  We attribute this result to the 
decreased crystallization tendencies of the polyurethanes chains caused by interferences of the 
chain extender grafts.  As the length of these grafts increase, the ability of polymer domains to 
crystallize is diminished due to spatial interferences of the grafts.  As a result, glass transition 
temperatures increase.  Despite these increases, the glass transitions observed indicate that the 
polyurethanes will maintain their flexibility at physiological temperatures making them suitable 
candidates for biomaterial applications.     
Polyurethanes are desirable biomedical materials due to their unique surface and bulk 
behavior.  For examples, the reduced adhesion of blood proteins and platelets is aided by a 
unique surface reorganization property that occurs in the presence of water.7   In solution, the 
low surface energy soft segments are oriented at the surface while the hydrophobic hard 
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segments remain in the bulk material to minimize the overall surface free energy at the 
interface.8  As shown in Figure 4.1, PPU1 – PPU4 exhibited a surface restructuring phenomena 
as evidenced by steadily decreasing water contact angles upon exposure to water droplets.  After 
20 min of water exposure, the contact angle measurements all decreased from ~80° at t = 0 by 
approximately 1° min-1.  Based on this linear trend, the contact agnles should all approach that of 
the polyether glycol alone (44°) after exposure for ~30 min.  Due to surface restructuring and a 
significant concentration of soft segments, the chain extender composition did not have an 
appreciable effect on the wetting properties of the films. 
Introducing NO-release ability to PPU1 – PPU4 required free thiol groups capable of S-
nitrosothiol modification.  As a result, the polyurethanes were deprotected by exposure to a 
solution of TFA:CH2Cl2:TIPS for 1 h on ice.  Almost immediately, a bright yellow color resulted 
indicating the formation of the triphenylmethyl cation.  Scavenging of this trityl cation by TIPS 
resulted in a steady decrease in the intensity of the solution’s color until it became colorless 
indicating complete deprotection.  Due to the rapid oxidation of thiols to disulfides in the 
presence of oxygen, special care was taken to minimize oxygen exposure of the isolated thiol-
containing polyurethanes (TPU1 – TPU4).  Still, extremely rapid disulfide formation was 
observed for TPU3, rendering it insoluble in all organic solvents tested.  As the other thiol-
containing polyurethanes were not as reactive, the onset of disulfide formation is attributed to 
increased chain extender graft mobility (rotational degrees of freedom) about the length of the 
carbon chain for TPU3 over other TPU compositions.  Exposure of the other TPU compositions 
to ambient oxygen for 1–2 days ultimately resulted in disulfide formation and organic solvent 
insolubility.  The rapid disulfide formation of all TPU conjugates upon exposure to 
tetrahydrofuran prevented molecular weight determination post-deprotection via GPC.  
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Deprotection of the polyurethanes resulted in substantial decreases in degradation 
temperatures relative to their protected analogs. Thermogravimetric analysis indicated 10% 
degradation for all TPUs investigated at temperatures at least 67 °C lower than their 
corresponding protected polyurethane.  However, the effect of deprotection on the glass 
transition temperatures was minimal, with all TPU glass transition temperatures ranging from -
68 to -84 °C.  These values correspond well with the transition temperature for the polyether 
glycol soft segment alone making these polymers appropriately flexible materials at 
physiological temperatures.  
Due to decreases in the segmental motion of polymers caused by crosslinking, the 
influence of spontaneous disulfide formation of TPUs on surface reorganization was a concern.  
Static water contact angle goniometry was used to characterize the surfaces of thin TPU films 
exposed to an oxygen atmosphere for at least 5 d.  Similar to the PPU family of polyurethanes, 
all TPU compositions analyzed exhibited static water contact angles that decreased with time 
indicating that low free energy constituents were able to reorient at the surface of the material.  
Interestingly, the instantaneous static water contact angles for TPU1 and TPU2 were greater 
after deprotection than before, indicating an increased presence of hard segment domains at the 
surface of the material after deprotection.  The presence of free thiols in the chain extenders 
likely act to promote miscibility of the distinct polymer domains resulting in diminished 
microphase separation and more uniform hard segment distribution.  Differences in the optical 
clarity of these materials support this observation as the TPU films appeared visibly more 
opaque than their PPU counterparts that were completely transparent.  The static water contact 
angles vs. time for TPU4 mimicked those of PPU4 more closely than the other polymer analogs 
did with their deprotected counterparts. The similarity in surface energy is attributed to 
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maintained phase separation as a result of the longer chain extender graft and the phase demixing 
that remains.  Increased optical clarity of TPU4 compared to TPU1 and TPU2 further support 
this hypothesis.  Overall, the continued presence of domain restructuring at the material:water 
interface after deprotection for TPU1, TPU2, and TPU4 further ensure biocompatible material 
characteristics for implant coating materials. 
4.3.2 Synthesis and Characterization of Soft Segment Modified Polyurethane   
Successful modification of a polyurethane soft segment requires the use of an appropriate 
polymer with reactive functional groups along the backbone.   Isocyanate-alcohol coupling to 
generate urethane linkages must be retained, necessitating that subsequent functionalization steps 
not alter or consume the reactive chain termini.  The reactivity of functional groups capable of 
storing NO (e.g., thiols and amines) with isocyanates prevent their incorporation in the backbone 
prior to polymerization without appropriate protecting groups (similar to PPU1–PPU4) due to 
the high occurrence of undesirable side reactions and cross-linking.  To enable derivitization 
with NO donor functionalities, polyepichlorohydrin (PECH) was chosen as an appropriate soft 
segment for further modification.  Epichlorohydrin may be polymerized cationically in the 
presence of low molecular weight diols resulting in the formation of dihydroxytelechelic PECH 
with molecular weights up to approximately 2.5 x 103 g mol-1.30-33  Despite low molecular weight 
products, molar masses appropriate for polyurethane soft segments and the telechelic nature of 
the resulting polymers make this synthetic mechanism ideal.  The polymerization of 
epichlorohydrin using boron trifluoride diethyl etherate in the presence of ethylene glycol led to 
PECH as a viscous transparent oil.  The number average molecular weight of this product was 
approximately 1.2 x 103 g mol-1 based on gel permeation chromatography with a polydispersity 
index of 1.1 (Table 4.1).  Nuclear magnetic resonance was used to confirm the presence of 
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alcohol termini (Figure 4.2).  Subsequent end group analysis indicated molecular weights of 
approximately 1.6 x 103.  The GPC-determined molecular weights likely deviated from those 
determined using end group analysis due to signal overlap of end group protons by those from 
the polymer main chain. 
 Incorporation of the dihydroxytelechelic PECH as a polyurethane soft segment was 
accomplished by forming the isocyanate end-capped PECH via reaction in DMF in the presence 
of dibutyltin dilaurate.  The resulting prepolymers were then chain extended using 1,4-butanediol 
giving rise to PU-PECH with a resulting molecular weight of 4.4 x 103 with a PDI of 1.6 (Table 
1), and consistent molar ratios of starting materials compared to the reaction solution.   The glass 
transition temperature for PU-PECH (6 °C) was substantially greater than its corresponding soft 
segment PECH (-60 °C).  This deviation is attributed to halogen substitution along the soft 
segment backbone, a phenomenon previously shown to increase glass transition temperatures.34 
 The surface properties of PU-PECH follow the trends observed with the chain extender-
modified polyurethanes (Figure 4.1).  Upon exposure to a water droplet for 20 min, the contact 
angle steadily decreased from 80°, where the hard segment domains were accessible at the 
surface, to 55°, where the soft segment domains are preferentially oriented at the surface.  
Similar to the PPUs, the transparency of the films indicated an appreciable degree of microphase 
separation. 
 Substitution of the chlorine atoms with thiol functionalities along the polymer soft 
segment allows for straightforward nitrosation and NO storage.  Modification of the soft segment 
of this polyurethane would also give insight into spatial considerations governing the ability to 
nitrosate thiols within hard vs. soft segment domains.  Thiolation of PU-PECH resulted in a 
137 
 
polyurethane, PU-POMT, with similar properties to its parent chain.  As expected for a polymer 
with decreasing chlorine content, the glass transition decreased slightly from 6 °C to -9 °C upon 
thiolation.34  Similar to the TPU polymers, the onset of degradation for PU-POMT was also 
decreased compared to its parent polyurethane.   
 As a result of the surface segregation phenomenon, incorporation of thiol functionalities 
along the soft segment domain of polyurethanes should increase the extent of nitrosothiol 
formation due to increases in the solution accessibility of the thiol containing domain and 
subsequent nitrosation, which occurs in aqueous solution.8  Additionally, the absence of polar 
thiol functionalities in the hard segments should prevent mixing of hard and soft segments 
resulting in elastic materials with a high degree of optical clarity.9  Static water contact angle 
measurements indicated that thiolation of the polyurethane affected neither the instantaneous 
surface energy nor the surface reorientation exhibited by most polyurethanes.  Furthermore, the 
resulting films had a high degree of optical clarity compared to the TPU family of polyurethanes.   
4.3.3 Nitrosation and NO Release Characterization   
Enhancing the antifouling behavior of polyurethanes via NO release represents a 
significant step toward the development of biocompatible implant coatings.  However, the 
existence of microphase separated domains and surface segregation inherent to polyurethanes 
makes polymer design a crucial step in the development of a material with appropriate attributes.  
The design of materials capable of chemically storing NO in both the hard and soft segments of 
the polyurethane chain should provide insight into spatial considerations necessary for optimal 
NO donor placement and impact on the material characteristics on the resulting polymer.  
Nitrosation of TPUs and PU-POMT was achieved by immersing cast films in a solution of 
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acidified nitrite on ice for 2 h (as films of TPU3 could not be cast due to disulfide formation, 
NTPU3 was not investigated).  S-nitrosothiol formation was confirmed by monitoring the 
characteristic absorbance using UV-visible spectroscopy24 (Figure 4.3).  
In accordance with other NO-releasing polymers, the total NO release as well as 
maximum instantaneous NO fluxes were found to be highly dependent on the polymer structure 
(Table 4.2).  After nitrosation, all polymers investigated were observed to release NO both in the 
presence of light (characteristic of S-nitrosothiols) and under physiological conditions (pH 7.4, 
37 °C) with NO totals ranging from comparable (NTPU4) to almost 1 order of magnitude larger 
(NTPU1 and NPU-POMT) than diazeniumdiolated polyurethanes.  The levels of total NO 
release and instantaneous flux followed the same trend for all polymers investigated (NPU-
POMT > NTPU1 > NTPU2 > NTPU4).  The NO release levels were greatest for NPU-POMT 
due to the readily accessible thiols along the low surface energy soft segment of the 
polyurethane, that reoriented outward in solution.  The presence of thiols at this interface both 
facilitated nitrosation by making the functionalities more accessible to solution interactions, and 
allowed for more rapid NO release by minimizing the need for NO diffusion through the 
polymer matrix.35   
As all of NO’s physiological functions are concentration dependent, the duration over 
which these polymers are capable of releasing NO is an important characteristic.17, 36  Fluxes 
>0.4 pmol cm-2 s-1 have been shown to be sufficient for significantly reducing platelet adhesion, 
and represent an ideal threshold for determining the therapeutic efficacy of blood contacting 
materials.36  Although, the majority of NO release from all S-nitrosothiol-modified polyurethanes 
synthesized occurs during an initial bolus release of NO over the first 10-15 minutes, the films 
continue releasing measurable amounts of NO for almost 3 d (NTPU1), with both NTPU1 and 
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NPU-POMT releasing NO above the antithrombotic threshold for over 30 h (Figure 4.4).  
Despite releasing measurable amounts of NO, NTPU2 and NTPU4 do not maintain 
antithrombotic NO release levels beyond 1 h.        
Despite all NTPU materials possessing thiol-containing hard segments, both the NO 
release totals and kinetics differed drastically.  The increased presence of hard segment domains 
at the solution interface for TPU1 and TPU2 (due to more efficient domain mixing) allowed for 
more complete nitrosation due to the solution accessibility of free thiols.  The slight NO release 
disparity between NTPU1 and NTPU2 is likely the result of hard/soft segment miscibility 
differences between the two polymer systems and the resulting solution accessibility of the hard 
segments.  Indeed, the efficient microphase separation of NTPU4 resulted in a material that 
released the smallest amount of NO compared to the other polymer systems investigated.  The 
decreased solution accessibility of the hard segments thus limited both thiol to nitrosothiol 
conversion and NO diffusion through the polymer matrix upon nitrosothiol decomposition.   
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Table 4.1 Modified chain extender and soft segment polyurethane properties. 
Sample Mn x 103  
(g mol-1) 
PDI 5% wt loss 
(°C) 
10% wt loss 
(°C) 
Tg  
(°C) 
Terathane 1.2 2.1 278 310 -77 
PPU1 12.1 1.9 238 252 -78 
PPU2 19.2 1.5 225 241 -75 
PPU3 10.0 1.7 182 241 -64 
PPU4 12.8 1.4 216 239 -71 
TPU1 - - 142 185 -84 
TPU2 - - 112 145 -72 
TPU3 - - 88 104 -81 
TPU4 - - 131 155 -68 
PECH 1.2 1.1 279 298 -60 
PU-PECH 4.4 1.6 171 227 6 
PU-POMT - - 129 192 -9 
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Figure 4.1.  Contact angles of polyurethane samples (  – PPU1, ● – PPU2,      -PPU3,     –PPU4,                       
–    PU-PECH, □ – TPU1,○   – TPU2,     – TPU4, ◊ – PU-POMT).  
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Figure 4.2. 1H NMR spectra of epichlorohydrin (---) and PECH (—). 
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Figure 4.3.  UV/Vis spectra of TPU1 (—) and NTPU1 (---). 
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Table 4.2.  Nitric oxide-release properties of nitrosated polyurethanes. 
Sample  [NO]T  
(μmol mg‐1) 
[NO]T  
(μmol cm‐2) 
[NO]max  
(pmol cm‐2 sec‐1) 
NTPU1  0.11 ± 0.01  0.16 ± 0.02  532 ± 196 
NTPU2  0.08 ± 0.03  0.11 ± 0.03  241 ± 166 
NTPU4  0.03 ± 0.01  0.05 ± 0.01  53 ± 4 
NPU‐POMT  0.14 ± 0.02  0.20 ± 0.03  605 ± 253  
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Figure 4.4  Instantaneous NO flux for NTPU1 (—) in PBS at pH 7.4 and 37 °C compared to 
antithrombotic threshold values (---). 
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4.4 Conclusion   
 Surface restructuring and microphase separation are important characteristics of 
polyurethanes that dictate the behavior of these polymers as implant materials and coatings.  It is 
important to understand that any functionalization of polyurethanes to enhance biocompatibility 
or performance should not interfere with these properties.  S-nitrosothiol functionalization at 
hard and soft segment domains of polyurethanes was undertaken to supplement the antifouling 
behavior of polyurethanes via NO release and better understand the effects of such modifications 
on polyurethane properties.  Herein, we observed that free thiol incorporation into hard segments 
alters polyurethane properties based on the resulting phase miscibility of hard and soft segment 
domains.  Additionally, the NO release properties of S-nitrosothiol-modified polyurethanes are 
related to this domain miscibility with highly miscible domains yielding materials with greater 
NO storage and release.  Soft segment-thiol modification proved to be most promising avenue 
for NO donor incorporation due to the retention of surface restructuring and microphase 
separation, and high thiol to nitrosothiol conversion efficiencies related to the solution 
accessibility of the thiols.  Additionally, this system should provide tunable NO release based on 
soft segment molecular weight and PECH:chain extender ratios, which will dictate total RSNO 
content.  Despite this, the impact of soft segment modifications on the stability and mechanical 
properties of resulting polyurethanes is unknown and currently being investigated.  Although 
many works have shown the antiplatelet properties of NO-releasing polymers, future work is 
aimed at characterizing the antifouling properties of these materials.   
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Chapter 5: 
Nitric Oxide-Releasing Electrospun Polymer Microfibers  
 
5.1 Introduction 
Nitric oxide (NO) is an endogenously produced free radical essential to numerous 
physiological functions including wound healing,1 vasodilation,2 and angiogenesis.3  As such, the 
therapeutic potential of administering exogenous NO as a treatment for certain disease states is a 
popular area of research.4-6  However, harnessing the therapeutic potential of this free radical has 
proven challenging due to concentration dependent effects and NO’s high reactivity.4, 5  
Although, low molecular weight or small molecule nitric oxide donors, such as N-
diazeniumdiolates and S-nitrosothiols, have been shown to be efficient scaffolds for storing and 
delivering NO to physiological loci, well-tuned control of long-term NO release has remained 
elusive.4, 7    
The incorporation of NO donor functionalities into macromolecular scaffolds by physical 
immobilization is a promising method to prolong durations of NO release based on diffusion-
mediated control of NO release from the material.  However, more precise control over temporal 
NO release often require chemical modifications.8-10  The development of therapeutic materials 
with well-defined ranges of NO release often necessitates the use of extensive synthetic 
processes and the preparation of numerous chemical compounds.11, 12  It is thus desirable to 
prepare materials with well-defined structural features that are able to control both the rates of 
water uptake and NO diffusion out of the material.   
Electrospinning is a popular method for the preparation of well-defined micro- and 
nanomaterials.13, 14  In this process, an electric field is applied to a liquid droplet at the tip of a 
capillary.  As the surface tension of the liquid is overcome by electrostatic repulsion due to 
charge accumulation, the deformed liquid droplet erupts at a critical point to form a viscoelastic 
jet, that accelerates toward a grounded target with its path determined by both the evaporation of 
solvent and electrostatic repulsion within the fiber.13, 14  A range of material morphologies (i.e., 
fibers, spheres, and rings) and dimensions may be achieved by fine-tuning a number of 
parameters, including solution concentration, conductivity, flow rate, viscosity, applied voltage, 
and target distance.13-15  Additionally, nonwoven mats, aligned fibers and twisted yarns may all 
be fabricated by altering the collection method of the fibers.13  
 High surface areas, facile functionalization, and tunable mechanical characteristics make 
electrospun materials attractive for several applications including those for medical purposes.16  
Electropsun fibers have been investigated as template for tissue engineering,16-19 drug delivery,16, 
20 wound dressings,16, 21, 22 and enzyme immobilization.16  By combining the already attractive 
characteristics of these materials with NO release, the ability to fabricate a library of therapeutic 
materials may emerge.  Well-tuned, diffusion-mediated NO release may be achieved by simply 
controlling fiber size and polymer composition, without chemical modification to the 
incorporated NO donor. 
Herein, we report the preparation of NO-releasing microfibers prepared by 
electrospinning polymer solutions of Tecoflex polyurethane, Tecophilic polyurethane, and 
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poly(vinyl chloride) containing disodium 1-[2-(carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-
diolate (PROLI/NO), a well characterized small molecule NO donor with fast NO release 
kinetics.23  Fiber diameter and NO release are examined as a function of polymer type and 
solution concentration, and dopant amount.  Potential medical applications for the fabricated 
materials are discussed. 
 
5.2 Experimental Section 
5.2.1 Materials   
High molecular weight poly(vinyl chloride) was obtained from Fluka (Buchs, 
Switzerland).  Poly(methyl methacrylate) (typical Mw 120,000), proline, and sodium methoxide 
were purchased from Aldrich Chemical Co. (Milwaukee, WI). Tecoflex SG-85A polyurethane  
and Tecophilic HP-93A-100 polyurethane were gifts from Thermedics (Woburn, MA).  All 
laboratory grade salts and solvents were purchased from Fisher Scientific.  Water was purified 
using a Millipore Milli-Q Gradient A-10 purification system (Bedford, MA).  Nitrogen, argon, 
and nitric oxide gases were purchased from National Welders Supply (Durham, NC). 
5.2.2 Characterization   
Electrospun fibers were sputter-coated with 2.5 nm Au/Pd and imaged using a Hitachi S-
4700 Scanning Electron Microscope.  Fiber diameters were averaged from at least 75 
measurements.  Solution conductivities were measured using a Malvern Nano Series Zetasizer 
operated in zeta potential mode using an average of 5 measurements.   
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5.2.3 Synthesis of PROLI/NO   
PROLI/NO was prepared following procedures described previously in the literature.23  
Briefly, 2.05 g of proline was dissolved in a solution consisting of 25 mL of methanol and 2.00 g 
sodium methoxide.  The solution was then placed in a stainless steel reaction vessel where it was 
flushed with Ar a total of eight times over 45 min and charged with NO to a pressure of 5 atm for 
3 d with constant stirring.  A series of three additional Ar purges were performed after 3 d, 
before the solution was precipitated by the addition of 150 mL of diethyl ether and stored at -20 
°C for 4 h to aid in precipitation.  The precipitate was isolated by vacuum filtration and dried in 
vacuo to yield PROLI/NO as a white solid.  The isolated PROLI/NO was stored at -20  °C.        
5.2.4 Fiber Formation 
Electrospun fibers were fabricated using a custom electrospinning apparatus consisting of 
a Series 205B High Voltage Power Supply from Bertan Associates, Inc. and a Kent Scientific 
Genie Plus syringe pump.   Voltage was applied to standard stainless steel blunt-tip needles 
(Jensen Global, Santa Barbara, CA) attached to solution-filled syringes positioned atop the 
syringe pump.  A grounded circular steel disk covered in aluminum foil was mounted 
perpendicular to the direction of the syringe at a distance of 15 cm.  Polymer samples were 
dissolved in 2 mL of a 3:1:1 mixture of tetrahydrofuran:N,N’ dimethylformamide: methanol.  For 
samples containing dopant, the polymer was first dissolved in 1.6 mL of a 3:1 mixture of 
THF:DMF, followed by the addition of dopant dissolved in 400 μL of MeOH.  Fibers were 
electrospun at applied voltages ranging from 10 – 20 kV, flow rates of 15 – 100 μL min-1, and 
spinneret diameters of 0.152 – 0.965 mm ID (30 gauge – 18 gauge blunt tip needles) with 
variable polymer and dopant concentrations.    
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5.2.5 Nitric Oxide Release Analysis   
Nitric oxide release from the electrospun materials was investigated using a Sievers 
chemiluminescence Nitric Oxide Analyzer Model 280i.  Electrospun samples were removed 
from their aluminum foil substrate and placed in a solution of deoxygenated phosphate buffered 
saline (PBS, pH 7.4) held at 37 °C.  The reaction flask was connected to the analyzer and 
sparged with N2 gas at 70 mL min-1 with additional N2 flow supplied via a vessel sidearm to 
match the instrument collection rate of 200 mL min-1.  Nitric oxide release from the samples was 
measured in real time at 1 s intervals. A calibration line was constructed using 26.39 ppm NO 
gas (balance N2) and air passed through a Sievers NO zero filter.        
       
5.3 Results and Discussion 
5.3.1 Fiber Formation   
Electrospinning is an extremely complex technique that is highly dependent on several 
parameters including conductivity, concentration, solution composition, and additives.24, 25  As a 
result, optimization of methods to fabricate fibers of well-defined diameters was required before 
investigating the effects of NO donor incorporation on fiber formation and NO release 
characteristics.  Although an essential component of the electrospinning process, the significance 
in the variation of applied voltage on fiber diameter and morphology has been debated.24, 25   
Increasing the applied voltage has been shown to decrease the diameter of the charged liquid jet 
up to a threshold value beyond which diameters increase as the increasing electric field draws 
more material out of the syringe.24  Other studies have shown minimal impact of applied voltage 
variation on fiber diameters.25   The influence of applied voltage on Tecoflex fibers spun from 
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solution was thus investigated by varying the magnitude of applied voltage from 10–25 kV.  As 
shown in Figure 5.1, the dependence of applied voltage on the diameter of fibers electrospun 
from 12 and 16% Tecoflex solutions was minimal.  Although local maxima of fiber diameters 
was noted with increasing voltage for each polymer concentration, high fiber diameter 
polydispersities at each voltage resulted in insignificant statistical differences.  
 During the electrospinning process, the flight of the charged polymer jet is primarily 
dictated by the electrostatic charge buildup required to overcome the surface tension of the 
spinning solution.  However, altering the amount of solution exposed to the applied electric field 
may influence fiber formation.24, 25  The effect of solution flow rate through the electrified 
capillary on fiber formation was thus also investigated (Table 5.1).  Similar to previously 
published reports,24, 25 variation of the flow rate from 15–100 μL min-1 did not significantly 
influence fiber diameters at low polymer solution concentrations (8 wt%).  In contrast, 
significant changes in average fiber diameters were observed for the higher polymer solution 
concentrations (12 and 16 wt%).  The average fiber diameters from 16 wt% solutions of 
Tecoflex, Tecophilic, and PVC increased by 66, 40, and 37%, respectively, when solution flow 
rates were increased from 50 to 100 μL min-1.  Substantial increases in fiber diameters were also 
observed for 12 wt% solutions of Tecophilic and PVC upon doubling the solution flow rate from 
50 to 100 μL min-1 (32 and 97%, respectively).  Despite these changes, increasing the flow rate 
of lower concentration polymer solutions did not result in any significant increase in resultant 
fiber diameter.  This behavior is likely only seen at higher polymer concentrations due to 
contributions from the higher solution viscosity and increased polymer chain entanglement as 
polymer wt% increases.   
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Important morphological changes were also observed as solution flow rates were altered 
for 8 wt% Tecoflex solutions.  As shown in Figure 5.2, 8 wt% solutions electrospun at 15 μL 
min-1 resulted in the formation of beaded fibers, indicating a threshold concentration for 
electrospinning.  Under these conditions, electrospray and electrospinning contributions may 
result from insufficient solution cohesion and the expulsion of charged droplets from the Taylor 
cone.15, 26  Upon increasing the solution flow rate to 50 and 100 μL min-1, the electrospun 
materials were free of beading indicating that electrospray contributions were overcome by the 
increased solution volume in the electric field.  By forcing additional polymer through the 
electric field, charge accumulation is mediated via additional volume over which the 
accumulated charge may be spread.  In turn, charge buildup necessary for the expulsion of 
charged droplets is avoided.24   
 The Taylor cone is a deformed liquid droplet created at the tip of a capillary in the 
presence of an applied voltage.27, 28  It is from this feature that charged jets and droplets are 
expelled during electrospinning and electrospraying, respectively.14  As such, alterations in the 
structure of the Taylor cone may influence the electrospinning process and resulting fiber size 
and/or morphology.  As the size of the Taylor cone is a function of the capillary diameter, the 
effect of capillary size on electrospinning was investigated for the three polymers.  Similar to 
flow rate, changing the capillary diameter did not influence fiber size independently of other 
variables (Table 5.2).  No trend in fiber size was observed by varying capillary diameter during 
electrospinning experiments for Tecoflex solutions.  Furthermore, needle gauge variation did not 
inhibit beaded fiber formation for 8 wt% Tecoflex solutions.  Varying the capillary diameter of 
Tecophilic solutions resulted in the greatest spread in fiber diameter with the largest diameter 
needle (18 gauge) producing the largest diameter fibers for 8, 12, and 16 wt% polymer solutions 
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compared to fibers spun from 22 and 30 gauge needles.  An increase in polymer concentration 
was coupled with an increase in average fiber diameters when switching from 30 to 18 gauge 
needles as fiber diameters from 8, 12, and 16 wt% Tecophilic increased by 13, 50, and 83%, 
respectively. Although diameters of fibers electrospun from 8, 12, and 16 wt% PVC solutions 
did not change appreciably with increasing capillary diameter, 16 wt% PVC did not result in 
fiber formation using a 30 gauge needle due to substantial clogging.   
   The alteration of electrospinning parameters to influence fiber diameter is a difficult task 
because of the multiple variables that are important to the development of well-defined micro- 
and nano-fibers.  Indeed, the fine interplay between specific parameters minimizes the influence 
that one variables will have on ensuing fiber diameter and morphology.  As such, it is expected 
that the variation of one electrospinning parameter may exhibit inconsistent effects when using 
different polymer compositions and/or solution concentrations.  Although a small degree of 
product control is achievable by varying applied voltage, capillary diameter, and flow rate, the 
most easily controlled and influential electrospinning parameter for tuning fiber size and 
morphology remains solution concentration (Figure 5.3).  In general, our results indicate that 
increasing polymer concentrations in solution will produce fibers with larger average diameters 
than those spun from lower concentration solutions.     
5.3.2 Dopant Effects on Fiber Formation   
The incorporation of additives into electrospun scaffolds is a popular method for 
imparting specific functions to these materials.16, 29, 30  However, the addition of even small 
amounts of dopant may influence the formation of electrospun materials due to alterations in 
solution behavior (e.g., viscosity, surface tension, etc.), which has been shown to dictate
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Figure 5.1  Fiber diameter as a function of applied voltage and needle gauge for A) 12 wt% and 
B) 16 wt% Tecoflex. 
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Table 5.1  Flow rate dependence on electrospun fiber diameter. 
Polymer Weight Percent 
(%) 
Flow Rate 
(μL min-1) 
Diameter 
(nm) 
Tecoflex Polyurethane 8 15 b 
 8 50 454 ± 188 
 8 100 392 ± 147 
 12 15 1103 ± 601 
 12 50 947 ± 283 
 12 100 1006 ± 512 
 16 15 2025 ± 527 
 16 50 1788 ± 676 
 16 100 2974 ± 1032 
Tecophilic Polyurethane 8 15 334 ± 77 
 8 50 347 ± 104 
 8 100 384 ± 143 
 12 15 621 ± 185 
 12 50 626 ± 182 
 12 100 827 ± 196 
 16 15 719 ± 168 
 16 50 1244 ± 180 
 16 100 1745 ± 296 
Poly(vinyl chloride) 8 15 125 ± 47 
 8 50 164 ± 75 
 8 100 210 ± 109 
 12 15 418 ± 210 
 12 50 596 ± 337 
 12 100 1174 ± 626 
 16 15 524 ± 174 
 16 50 531 ± 160 
  16 100 726 ± 281 
b-electrospinning resulted in the formation of beaded fibers. 
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Figure 5.2  SEM images of Tecoflex polyurethane fibers electrospun from 8 wt% solutions with 
flow rates of A) 15 μL min-1, B) 50 μL min-1, and C) 100 μL min-1. 
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Table 5.2  Influence of needle gauge on electrospun fiber diameters. 
Polymer Weight Percent 
(%) 
Needle Gauge Flow Rate 
(μL min-1) 
Diameter 
(nm) 
Tecoflex Polyurethane 8 18 15 b 
 8 22 15 b 
 8 30 15 b 
 12 18 15 1307 ± 635 
 12 22 15 1103 ± 601 
 12 30 15 1283 ± 275 
 16 18 15 1544 ± 698 
 16 22 15 2025 ± 527 
 16 30 15 1472 ± 727 
Tecophilic Polyurethane 8 18 15 446 ± 139 
 8 22 15 334 ± 77 
 8 30 15 396 ± 81 
 12 18 15 667 ± 179 
 12 22 15 621 ± 185 
 12 30 15 445 ± 122 
 16 18 15 1334 ± 180 
 16 22 15 719 ± 168 
 16 30 15 730 ± 79 
Poly(vinyl chloride) 8 18 15 185 ± 73 
 8 22 15 125 ± 47 
 8 30 15 178 ± 65 
 12 18 15 357 ± 128 
 12 22 15 418 ± 210 
 12 30 15 394 ± 144 
 16 18 15 561 ± 166 
 16 22 15 524 ± 174 
  16 30 15 c 
b-electrospinning resulted in the formation of beaded fibers. 
c- resulted in capillary clogging, no fiber formation. 
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Figure 5.3  SEM images of Tecoflex fibers electrospun from A) 8, B) 12, and C) 16 wt% 
solutions at 15 kV with flow rates of 15 μL min-1 using a 22 gauge needle. 
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 electrospinning capabilities.29, 30  Therefore, understanding the influence of specific dopants on 
electrospinning behavior is an essential parameter to investigate.  Physical incorporation of 
PROLI/NO and proline (control) in Tecoflex resulted in smaller fiber diameters than undoped 
fibers, with the highest additive content generally resulting in the smallest fibers (Table 5.3).  
Significant additive concentrations paired with elevated polymer concentrations, however, 
resulted in increased fiber diameters (687 ± 173 nm for 12% Tecoflex, 2.4% prolino, 50 μL min-
1) and in some cases capillary clogging preventing electrospinning altogether (16% Tecoflex, 
3.2% proline or PROLI/NO).  Unlike undoped fibers, the inclusion of proline and PROLI/NO in 
8 wt% Tecoflex solutions electrospun at 15 μL min-1 led to the formation of non-beaded fibers 
confirming that the presence of additives also influences fiber morphology (Figure 4).  
Nevertheless, beading reappeared as the proline content in solution was increased to 1.6 wt%, 
suggesting high concentrations of dopant influenced the cohesiveness of the liquid jet.  Fibers 
containing PROLI/NO exhibited slightly smaller fiber diameters than fibers containing the same 
concentration of proline, confirming that an additive’s influence on fiber diameter is contingent 
upon both structure and concentration.  Solution conductivity measurements indicated that this 
decrease in fiber diameter upon PROLI/NO inclusion was an artifact of the solutions containing 
the ionic diazeniumdiolates versus uncharged proline (Table 5.4).  Others have reported 
extensively on the influence of solution conductivitiy on electrospinning.13, 24, 25, 29  Of note, 
greater polymer concentrations did not show the same trends with PROLI/NO inclusion resulting 
in slightly larger diameters than their proline-containing counterparts.  The degree of fiber 
branching also increased upon addition of higher concentrations of additives.  
Although Tecoflex and Tecophilic are synthesized from similar components, the influence of 
additives on fibers electrospun from these polyurethanes was vastly different.  In general, the 
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 size of doped Tecophilic fibers was less than that observed using Tecoflex (Table 5.3).  Proline-
containing Tecoflex fibers electrospun from low polymer concentration solutions (8 wt%) 
exhibited higher average fiber diameters than their undoped counterparts.  The addition of 
PROLI/NO to low concentration Tecophilic solutions resulted in fiber diameters similar to those 
of undoped Tecophilic fibers electrospun from the same concentration solution.  As the 
Tecophilic concentration was increased, the incorporation of either proline or PROLI/NO 
resulted in increased fiber diameters relative to undopedfibers, in contrast to the behavior of 
Tecoflex.  Despite higher conductivities for solutions containing PROLI/NO, the increased size 
of fibers containing additives was actually smaller in magnitude for fibers containing proline 
versus PROLI/NO.  This trend remained consistent at both 12 and 16 wt% polymer.  
Furthermore, the incidence of fiber branching, which was prevalent for doped Tecoflex fibers, 
was greatly diminished for doped Tecophilic polyurethane fibers.   
 Doping of additives also altered diameters of polymeric microfibers composed of PVC.  
Low concentration PVC solutions containing proline formed slightly larger fibers compared to 
undoped counterparts (125 ± 47 nm vs. 195 ± 69 for undoped and 0.4 wt% proline solutions of 
8% PVC).  However, PROLI/NO inclusion did not appreciably change the size of the fibers 
(Table 3).  As polymer concentration was increased to 12 wt%, the fiber diameter increased 
slightly for compositions containing proline, while significant decreases were observed for 
PROLI/NO-doped materials.  High concentrations (16 wt%) of PVC resulted in substantial 
capillary clogging with dopant concentrations ≥ 0.8 wt%.  Of note, 16 wt% PVC solutions 
containing 0.8 wt% proline resulted in smaller diameter fibers compared to those prepared with 
PROLI/NO.  Contrary to what was observed for the Tecoflex and Tecophilic polyurethanes, the 
incorporation of PROLI/NO did not alter fiber size relative to undoped materials.  
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 Table 5.3  Influence of dopant type and concentrations on fiber diameter. 
   
Polymer Weight Percent
(%) 
Rate 
(μL min-1)
Dopant Diameter 
(nm) 
Tecoflex 8 15 - b 
 8 15 0.4% proline 548 ± 237 
 8 15 0.8% proline 399 ± 125 
 8 15 1.6% proline b 
 8 15 0.4% PROLI/NO 308 ± 85 
 8 15 0.8% PROLI/NO 313 ± 103 
 8 15 1.6% PROLI/NO 353 ± 140 
 12 50 - 947 ± 283 
 12 50 0.6% proline 769 ± 235 
 12 50 1.2% proline 742 ± 246 
 12 50 2.4% proline 687 ± 173 
 12 50 0.6% PROLI/NO 549 ± 124 
 12 50 1.2% PROLI/NO 453 ± 170 
 12 50 2.4% PROLI/NO 790 ± 296 
 16 15 - 2025 ± 527 
 16 15 0.8% proline 818 ± 197 
 16 15 1.6% proline 924 ± 241 
 16 15 3.2% proline c 
 16 15 0.8% PROLI/NO 1047 ± 188 
 16 15 1.6% PROLI/NO 938 ± 232 
  16 15 3.2% PROLI/NO c 
Tecophilic 8 15 - 334 ± 77 
 8 15 0.4% proline 416 ± 135 
 8 15 0.8% proline 503 ± 180 
 8 15 1.6% proline 558 ± 132 
 8 15 0.4% PROLI/NO 330 ± 103 
 8 15 0.8% PROLI/NO 373 ± 104 
 8 15 1.6% PROLI/NO 308 ± 81 
 12 15 - 621 ± 185 
 12 15 0.6% proline 804 ± 223 
 12 15 1.2% proline 743 ± 246 
 12 15 2.4% proline 795 ± 220 
 12 15 0.6% PROLI/NO 972 ± 200 
 12 15 1.2% PROLI/NO 870 ± 214 
 12 15 2.4% PROLI/NO 754 ± 197 
 16 15 - 719 ± 168 
 16 15 0.8% proline 1408 ± 243 
 16 15 1.6% proline c 
 16 15 3.2% proline c 
 16 15 0.8% PROLI/NO 1857 ± 524 
 16 15 1.6% PROLI/NO c 
  16 15 3.2% PROLI/NO c 
Poly(vinyl 8 15 - 125 ± 47 
 8 15 0.4% proline 195 ± 69 
 8 15 0.8% proline 226 ± 75 
 8 15 1.6% proline 192 ± 84 
166 
 
  8 15 0.4% PROLI/NO 128 ± 67 
 8 15 0.8% PROLI/NO 135 ± 51 
 8 15 1.6% PROLI/NO 144 ± 64 
 12 15 - 418 ± 210 
 12 15 0.6% proline 432 ± 202 
 12 15 1.2% proline 500 ± 256 
 12 15 2.4% proline 576 ± 214 
 12 15 0.6% PROLI/NO 302 ± 134 
 12 15 1.2% PROLI/NO 254 ± 136 
 12 15 2.4% PROLI/NO 232 ± 115 
 16 15 - 524 ± 174 
 16 15 0.8% proline 226 ± 98 
 16 15 1.6% proline c 
 16 15 3.2% proline c 
 16 15 0.8% PROLI/NO 565 ± 242 
 16 15 1.6% PROLI/NO c 
  16 15 3.2% PROLI/NO c 
   b-electrospinning resulted in the formation of beaded fibers. 
c- resulted in capillary clogging, no fiber formation. 
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Figure 5.4  SEM images of Tecoflex fibers electrospun from 8 wt% polymer solutions at 15 kV, 
using a 22 gauge needle, at flow rates of 15 μL min-1containing A) no additives B) 0.4 wt% 
proline, and C) 0.4 wt% PROLI/NO. 
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 5.3.3 Nitric Oxide Release   
The preparation of scaffolds capable of prolonging NO release from low molecular 
weight NO donors is an important aspect for the development of NO-based therapeutics. 
Additionally, the ability to control NO release is also essential.  Several strategies may be 
employed to generate well-defined structural features that control water uptake by a material, 
allowing for exploitation of the proton-induced dissociation mechanism of diazeniumdiolates.  
The ability to easily control fiber diameter makes electrospinning a useful technique for 
preparing materials with well-defined structural features for controlling NO release.   
 We thus investigated the NO release properties of electrospun polymers 
containing PROLI/NO as a function of polymer composition and fiber size.  PROLI/NO-doped 
Tecophilic fibers (the most hydrophilic polymer investigated) were characterized with NO 
release half lives approximately double that of PROLI/NO alone (Table 5.5).  Surprisingly, the 
NO-release kinetics were not altered as a function of fiber diameter with NO release half life 
ranging from 75–85 s regardless of fiber size.  However, total NO release was tunable based on 
the incorporation of different wt% NO donor in the electrospinning solution.  The inability to 
regulate the NO release kinetics with Tecophilic fibers is attributed to the high rates of water 
uptake associated with the hydrophilic fibers. Although fibers composed of Tecoflex 
polyurethane exhibited similar fiber diameter ranges as the Tecophilic materials, more tunable 
NO release was expected based on the differences in hydrophilicty.  For instance, the reduced 
water uptake for Tecoflex fibers should prolong NO release half lives compared to Tecophilic 
fibers.   The NO-release half-lives of PROLI/NO-doped Tecoflex fibers were more than twice as 
long as fibers composed of the more hydrophilic Tecophilic (Table 5.5). Greater NO release 
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 durations were also observed with increasing NO donor concentrations.  Tecoflex fibers 
containing 10 wt% PROLI/NO showed similar half lives to those containing 5 wt% PROLI/NO. 
However, fibers generated from 12 and 16 wt% polymer solutions showed increased NO-release 
half lives (e.g., 30 to 500 s) upon additional PROLI/NO incorporation, attributed to larger fibers.  
As PROLI/NO concentrations were increased further to 20 wt%, the NO-release half lives 
decreased from that observed at lower NO donor concentrations.  Such behavior may be 
attributed to concomitant decreases in the relative polymer wt%, thus reducing the water uptake-
mediated effects on diazeniumdiolate decomposition.   
As PVC was the most hydrophobic polymer investigated, we expected that PROLI/NO-doped 
PVC fibers would possess the longest NO-release half lives.  Indeed, electrospun PVC fibers 
containing 5 wt% PROLI/NO exhibited half lives that were significantly longer than any of the 
polyurethane compositions (Table 5.5).  Of note, fibers electrospun from more dilute PVC 
solutions (i.e., 8 and 12 wt%) had less than theoretical NO release.  This disparity may be 
attributed to decreased water uptake by the hydrophobic PVC fibers compared to the 
polyurethane compositions resulting in incomplete diazeniumdiolate decomposition.  As the 
viscosity of 16 wt% polymer solutions inhibited efficient mixing of PROLI/NO within the 
solution, the resulting fibers lacked homogenous PROLI/NO distribution.  Water uptake was thus 
concentrated around the more hydrophilic PROLI/NO-containing domains, resulting in more 
efficient diazeniumdiolate breakdown.  
By increasing the NO donor concentration to 10 wt% (in fibers), theoretical NO release 
was achieved for fibers formed from both 8 and 12 wt% PVC solutions. Such NO release may be 
attributed to the increased water uptake associated with more hydrophilic NO donor in the fibers.   
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Table 5.4  Influence of dopant type on conductivity of electrospinning solutions. 
 
Polymer solution Dopant Solution Conductivity 
(μS cm-1) 
8% Tecoflex - 2.3 ± 0.4 
8% Tecoflex 0.4% proline 2.4 ± 0.3 
8% Tecoflex 0.8% proline 1.9 ± 0.2 
8% Tecoflex 1.6% proline 1.7 ± 0.2 
8% Tecoflex 0.4% PROLI/NO 146.2 ± 13.1 
8% Tecoflex 0.8% PROLI/NO 124.1 ± 20.4 
8% Tecoflex 1.6% PROLI/NO 159.4 ± 1.8 
12% Tecoflex - 1.4 ± 0.1 
12% Tecoflex 0.6% proline 6.8 ± 0.7 
12% Tecoflex 1.2% proline 7.7 ± 0.3 
12% Tecoflex 2.4% proline 17.1 ± 4.3 
12% Tecoflex 0.6% PROLI/NO 136.8 ± 3.1 
12% Tecoflex 1.2% PROLI/NO 102.0 ± 1.6 
12% Tecoflex 2.4% PROLI/NO 157.2 ± 2.4 
16% Tecoflex - 2.5 ± 0.4 
16% Tecoflex 0.8% proline 3.5 ± 0.5 
16% Tecoflex 1.6% proline 3.4 ± 0.6 
16% Tecoflex 3.2% proline 12.3 ± 3.9 
16% Tecoflex 0.8% PROLI/NO 102.7 ± 10.9 
16% Tecoflex 1.6% PROLI/NO 45.1 ± 3.1 
16% Tecoflex 3.2% PROLI/NO 112.8 ± 3.5 
8% Tecophilic - 5.4 ± 0.1 
8% Tecophilic 0.4% proline 3.6 ± 0.4 
8% Tecophilic 0.8% proline 4.1 ± 0.5 
8% Tecophilic 1.6% proline 2.6 ± 0.3 
8% Tecophilic 0.4% PROLI/NO 176.0 ± 2.9 
8% Tecophilic 0.8% PROLI/NO 128.0 ± 3.2 
8% Tecophilic 1.6% PROLI/NO 156.6 ± 3.6 
12% Tecophilic - 4.9 ± 0.2 
12% Tecophilic 0.6% proline 13.2 ± 3.1 
12% Tecophilic 1.2% proline 5.7 ± 0.9 
12% Tecophilic 2.4% proline 4.6 ± 0.6 
12% Tecophilic 0.6% PROLI/NO 238.8 ± 30.4 
12% Tecophilic 1.2% PROLI/NO 170.4 ± 10.5 
12% Tecophilic 2.4% PROLI/NO 131.0 ± 6.3 
16% Tecophilic - 5.3 ± 0.2 
16% Tecophilic 0.8% proline 15.7 ± 2.9 
 16% Tecophilic 1.6% proline 5.5 ± 0.1 
16% Tecophilic 3.2% proline a 
16% Tecophilic 0.8% PROLI/NO 306.2 ± 44.1 
16% Tecophilic 1.6% PROLI/NO 172.2 ± 9.0 
16% Tecophilic 3.2% PROLI/NO a  
8% PVC - 5.1 ± 0.1 
8% PVC 0.4% proline 6.9 ± 1.1 
8% PVC 0.8% proline 4.4 ± 0.3 
8% PVC 1.6% proline 28.9 ± 9.0 
8% PVC 0.4% PROLI/NO 168.6 ± 14.6 
8% PVC 0.8% PROLI/NO 203.0 ± 8.0 
8% PVC 1.6% PROLI/NO 239.6 ± 8.6 
12% PVC - 13.7 ± 2.6 
12% PVC 0.6% proline 5.0 ± 0.2 
12% PVC 1.2% proline 4.2 ± 0.2 
12% PVC 2.4% proline 7.8 ± 2.1 
12% PVC 0.6% PROLI/NO 153.2 ± 8.1 
12% PVC 1.2% PROLI/NO 190.8 ± 3.6 
12% PVC 2.4% PROLI/NO 201.8 ± 3.1 
16% PVC - 10.7 ± 1.9 
16% PVC 0.8% proline 5.4 ± 0.2 
16% PVC 1.6% proline 4.6 ± 0.4 
16% PVC 3.2% proline a 
16% PVC 0.8% PROLI/NO 144.4 ± 7.3 
16% PVC 1.6% PROLI/NO 171.2 ± 4.8 
16% PVC 3.2% PROLI/NO  a 
Spinning Solution - 3.0 ± 0.1 
a – homogeneous suspensions could not be formed. 
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Table 5.5  Nitric oxide-release characteristics of PROLI/NO-doped electrospun polymer 
microfibers. 
Polymer Weight 
Percent 
Dopant (NO Donor) 
(wt% in solution) 
Fiber Diameter 
(nm) 
t[NO] 
(μmol mg-1) 
[NO]m 
(ppb mg-1) 
t1/2
(s) 
Tecophilic 8 0.4 330 ± 103 0.16 ± 0.03 11800 ± 3800 81 ± 8 
 8 0.8 373 ± 104 0.42 ± 0.05 29100 ± 3600 85 ± 9 
 8 1.6 308 ± 81 0.85 ± 0.06 67000 ± 10500 75 ± 5 
 12 0.6 972 ± 200 0.23 ± 0.03 19000 ± 5600 77 ± 12 
 12 1.2 870 ± 214 0.44 ± 0.04 31500 ± 4000 85 ± 15 
 12 2.4 754 ± 197 0.99 ± 0.14 83700 ± 5300 75 ± 13 
 16 0.8 c - - - 
 16 1.6 c - - - 
  16 3.2 c - - - 
Tecoflex 8 0.4 308 ± 85 0.20 ± 0.01 7600 ±  4100 173 ± 79 
 8 0.8 313 ± 103 0.42 ± 0.06 11000 ± 3000 168 ± 52 
 8 1.6 353 ± 140 0.79 ± 0.15 44100 ± 800 105 ± 25 
 12 0.6 549 ± 124 0.18 ± 0.06 4000 ± 2600 229 ± 77 
 12 1.2 453 ± 170 0.50 ± 0.02 11700 ± 3800 260 ± 126 
 12 2.4 790 ± 296 0.95 ± 0.03 39400 ± 4900 143 ± 27 
 16 0.8 1047 ± 188 0.24 ± 0.06 7100 ± 3100 275 ± 152 
 16 1.6 938 ± 232 0.49 ± 0.04 6800 ± 2800 734 ± 329 
  16 3.2 c - - - 
Poly(vinyl 8 0.4 128 ± 67 0.09 ± 0.01 1500 ± 200 1288 ± 110 
 8 0.8 135 ± 51 0.35 ± 0.13 3800 ± 2500 2600 ± 3700
 8 1.6 144 ± 64 0.78 ± 0.07 25500 ± 10600 209 ± 73 
 12 0.6 302 ± 134 0.15 ± 0.05 900 ± 300 5241 ± 3271
 12 1.2 254 ± 136 0.38 ± 0.10 2200 ± 900 5055 ± 1078
 12 2.4 232 ± 115 0.77 ± 0.11 28500 ± 3500 198 ± 110 
 16 0.8 565 ± 242 0.20 ± 0.02 1200 ± 500 5613 ± 4568
 16 1.6 c - - - 
  16 3.2 c - - - 
 c- resulted in capillary clogging, no fiber formation. 
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 Unfortunately, additional NO donor (3.2 wt% in solution, 20 wt% in fibers) circumvented the 
electrospinning of fibers from 16 wt% solutions.  Similar to Tecoflex fibers, PVC fibers 
electrospun with 20 wt% PROLI/NO resulted in fibers with reduced NO-release half lives 
compared to fibers containing lower NO donor concentrations.    
5.4 Conclusions 
  The physiological role of NO in numerous signaling pathways supports its investigation 
as a potential therapeutic for a wide range of ailments.  However, NO’s ubiquitous nature and 
concentration dependent effects require its generation close to the intended site of action.  Herein 
we describe the preparation of electrospun polymer microfibers containing a low molecular 
weight NO donor (PROLI/NO) as platforms capable of controlled NO release.  Polymer 
composition, fiber diameter, and NO donor concentration each mediate fiber size and NO 
release, but to varying extents.  The ability to tune NO release kinetics by varying 
electrospinning parameters and the attractive features of fibers support further investigation into 
their use as biomedical scaffolds.  Future studies aim to investigate the antibacterial and 
antithrombotic capabilities of these materials as potential medical device coatings. 
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Chapter 6: 
Summary and Future Research Directions 
 
6.1 Summary and Future Research Directions 
The design and synthesis of NO-releasing polymeric materials via both covalent 
modification and dispersion of NO-releasing additives were investigated.  In Chapter 2 I 
described the synthesis of lipophilic polyamine compounds designed as N-diazeniumdiolate NO 
donors with enhanced retention in polymeric matrices.  The competitive formation of potentially 
carcinogenic N-nitrosamines was shown to occur during the diazeniumdiolation reaction for 
polyamine compounds where hydrogen-bonding stabilized the nitrosamine anion intermediate.  
Stabilization of this intermediate prevented the second NO addition required for N-
diazeniumdiolate formation.1, 2  Amine spacing within the compounds was shown to have a 
significant effect on the ability to form diazeniumdiolates, as compounds with intramolecular 
hydrogen bonds exhibited greater nitrosamine formation than those without.  Chain collapse of 
polyamine compounds with substantial alkyl content facilitated this hydrogen bonding by 
increasing the proximity of amines.  As evidenced by UV/Vis spectroscopy and NO release 
analysis, monoamine compounds reacted in a similar fashion preferentially formed 
diazeniumdiolate NO donors in high yield, due to their inability to stabilize the nitrosamine 
anion intermediate.  To investigate the incomplete diazeniumdiolate formation in polyamines, 
reaction times and pressures were varied systematically.  However, the presence of nitrosamines 
was still observed for all polyamine compounds regardless of these reaction parameters.  As 
diazeniumdiolates are one of the most commonly investigated NO donors, the competitive 
formation of carcinogenic byproducts during typical diazeniumdiolate syntheses will have 
profound implications for the future preparation of diazeniumdiolated therapeutics and will force 
the development of alternative synthetic methods. 
Future work in this area should focus on systematic studies aimed at understanding the 
mechanisms of diazeniumdiolation and optimizing reaction conditions to minimize nitrosamine 
formation.  The mechanism of diazeniumdiolate formation has long been debated, with 
arguments supporting two distinct hypotheses.1-3  One mechanism identifies a sequential addition 
of two molecules of NO to an amine with a discrete nitrosamine radical anion intermediate.1, 2  
The other mechanism proposes that NO first dimerizes to N2O2, which then acts electrophilically 
to couple with the amine.2, 3  While the first mechanism has received the greatest support, a few 
researchers have proposed a hypothesis in which the favored mechanism of diazeniumdiolation 
is dependent on the concentration of NO.3  At low NO concentrations NO reacts stepwise with 
an amine to form a diazeniumdiolate.  Alternatively, as the concentration of NO is increased, the 
NO dimer preferentially adds to the amine to form a diazeniumdiolate.  If this reaction proceeds 
in such a manner, nitrosamine byproduct formation may be reduced by conducting the reaction at 
higher pressures of NO, thereby forcing the reaction to proceed through the NO dimer.  Although 
preliminary investigations of this were reported in Chapter 2, a much wider range of NO 
concentrations and pressures should be examined.  Face-to-face donor-acceptor complexes, 
which have been proposed to facilitate the formation of the NO dimer through charge-transfer 
complexation and electrostatic interactions, should also be investigated as a means to force 
diazeniumdiolation to occur via the NO dimer.4 Greater diazeniumdiolate reaction efficiency 
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should allow hydrophobic diazeniumdiolated polymer additives to be synthesized with enhanced 
retention in polymeric matrices. 
The synthesis of degradable S-nitrosothiol-modified polyesters was described in Chapter 
3.  The thermal polycondensation of polyols (e.g., glycerol and pentaerythritol) with diacids 
(e.g., glutaric acid and adipic acid) was shown to generate highly crosslinked materials with 
tunable degradation rates and glass transition temperatures dependent on the composition of the 
material and curing temperatures.  Precise control over the reaction stoichiometry resulted in the 
formation of crosslinked polyesters with carboxylic acid end groups that could be utilized for 
material functionalization.  The coupling of thiol-containing compounds to these polyesters 
resulted in thiol-modified polyesters, that upon exposure to dilute nitrous acid allowed for S-
nitrosothiol functionalities capable of NO release.   These NO-releasing polyesters were shown 
to release up to 0.81 µmol NO cm-2 for up to 6 d under physiological conditions with 
antibacterial properties.  Indeed, adhesion of P. aeruginosa to NO-releasing substrates was 
dependent on the NO dose delivered and cold be reduced by up to 80% compared to non-NO-
releasing controls.  The use of metabolic intermediates and FDA approved compounds as 
polyester precursors resulted in materials without appreciable cytotoxicity to native cells.  These 
results represent the first reports of completely degradable S-nitrosothiol-modified polyesters and 
may facilitate further research in the development of degradable NO-releasing materials. 
Future studies relating to these materials should first focus on identifying important 
mechanical characteristics of these materials, including the storage modulus, Young’s modulus, 
and ultimate strain in order to match materials possessing certain characteristics to appropriate 
applications.5  To increase the diversity of NO-releasing materials, degradable NO-releasing 
polyesters with well-defined pore structures should also be synthesized.6  Well-defined pores, 
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such as those formed via the salt leaching method,7 should provide additional surface area, 
thereby maximizing thiol functionalization and increasing related NO storage capacity in 
addition to extending the usefulness of these materials to new therapeutic applications, such as 
tissue engineering.  Furthermore, the microstructure should enhance resistance to the foreign 
body response by preventing FBGC formation as detailed in the literature.6, 8, 9  The influence of 
these microstructures on material characteristics such as degradation rates, storage moduli, and 
ultimate elasticity should be evaluated.10  Recent reports of the synergistic behavior of NO with 
other types of antimicrobial agents (i.e., silver) highlight the advantage of combination therapies 
arising from one unique scaffold(Susan BJ paper).  As such, the dispersion of other antimicrobial 
agents within the degradable NO-releasing scaffold should be investigated.  The antimicrobial 
efficacy of the resulting materials should benefit by adding long term antimicrobial release 
triggered by the bulk degradation of the polymer.11, 12  Finally, the in vivo performance of these 
materials should be evaluated in order to assess their ability to improve device compatibility in a 
dynamic system.13 
In Chapter 4, the synthesis of S-nitrosothiol-modified polyurethanes capable of releasing 
NO was described.  Unlike previous reports, this work incorporated NO donors into both 
polyurethane hard and soft segments by incorporating thiol groups within both of these domains 
of the polyurethanes.  The incorporation of NO-releasing functionalities within the soft segment 
domain of the polyurethanes resulted in materials with more substantial NO storage capacity 
than their hard segment-modified counterparts due to increased thiol content and restructuring of 
the soft segment at the material’s surface.  The lowest amount of NO was stored on modified 
hard segments having minimal phase miscibility with the polyether glycol soft segments due to 
lower water uptake (into the hydrophobic hard segment domains) and minimal surface 
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restructuring.  The structure of the modified chain extenders was also shown to have a 
pronounced effect on NO loading of the polyurethanes.  Chain extenders with greater polarity 
resulted in pronounced hard and soft segment miscibilities and greater NO release capacities than 
materials with less polar hard segments and lowered phase immiscibility.  Overall, the retention 
of microphase separation and increased NO loading make soft segment NO donor modifications 
the more promising strategy for synthesizing NO-releasing polyurethanes. 
As many important mechanical characteristics of polyurethanes arise from the 
microphase separation of hard and soft segments, other chain extender modifications should be 
examined to identify systems that retain the useful polyurethane properties while maximizing 
NO release.  Detailed mechanical analyses should be performed to identify the effects of hard 
and soft segment domain miscibility on specific polyurethane properties such as storage modulus 
and elasticity.14  If the intended applications of these materials are as sensor coatings, then 
analyte permeability, stability, and performance against physiological responses should also be 
assessed and compared with other common sensor coating materials, such as unmodified 
polyurethanes and xerogel materials. 
The fabrication of NO-releasing electrospun polymeric microfibers was described in 
Chapter 5.  As expected, the proton-initiated decomposition mechanism of N-diazeniumdiolates 
made the control of NO release rates from these fibers highly diffusion dependent.15, 16  Indeed, 
the NO release kinetics were dependent on the NO donor, rate of water uptake, fiber diameter, 
and rate of NO diffusion out of the polymer matrix.  Furthermore, the preparation of microfibers 
with a wide range of NO release rates and durations could be prepared by varying polymer 
composition and other electrospinning parameters.  As electrospinning allows for the formation 
of well-defined micro and nanomaterials, the combination of NO release with this material 
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fabrication technique has the potential to generate diverse materials capable of improving 
essential properties of existing material biomaterials, such as wound dressings, while extending 
the therapeutic efficacy of NO to new and emerging therapies. 
The architecture of electrospun fibers makes them unique candidates for a number of 
biomedical applications including wound dressings,17, 18 medical device coatings,17 and tissue 
engineering scaffolds.19, 20  The impact of NO release kinetics on wound healing, bacterial 
adhesion, and thrombosis should be investigated by preparing fibers of variable polymer 
composition, NO donor type and amount, and thickness.  Following such investigations, the 
efficiency of these non-woven mats in various in vivo models should be examined.  In a new 
direction, the potential of electrospun microfibers as electrochemical sensor membranes should 
be evaluated.  Analytical performance characteristics of such sensors could be tailored by tuning 
fiber size to control analyte permeability while improving biocompatibility via NO release.  The 
larger surface areas associated with electrospun materials may enhance the sensitivity of 
enzymatic biosensors by providing additional enzymatic reaction sites at the sensor surface.21  
Additionally, the critical roles of NO in the bone remodeling cycle should be investigated using 
degradable electrospun NO releasing fibers.  Absorbable polymers such as PLA, PCL, or PLGA 
have traditionally been used as tissue engineering scaffolds.  Using these polymers the 
fabrication of fibers with controlled NO release may facilitate new bone growth by promoting 
osteoblast differentiation.17, 19, 20, 22  Nitric oxide storage capacity, NO release kinetics, and fiber 
degradation rates each will likely influence the performance of such scaffolds and should be 
investigated thoroughly.   
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6.2 Conclusions 
In total, my work has demonstrated the diversity of synthetic NO-releasing materials that 
may be pursued as strategies for enhancing the biocompatibility of materials used to construct 
medical devices.  As more information becomes available regarding the effects of NO 
administration from exogenous sources, the demand for unique materials capable of releasing 
NO should rise.  The techniques, materials, and observations described in the preceding chapters 
for preparing such materials may prove useful for synthesizing the next generation of polymers 
that address more than one fouling mechanisms of medical implants.  The ubiquitous effects of 
NO release on multiple physiological signaling pathways will likely influence methods aimed at 
designing materials capable of resisting medical implant fouling, and may represent the 
prototype for designing new therapeutics. 
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H NMR spectra for compound 27. 
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13
C NMR spectra for compound 27. 
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1
H NMR spectra for compound 28. 
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13
C NMR spectra for compound 28. 
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1
H NMR spectra of PE1 prepolymer in DMSO – d6.  
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13
C NMR spectra of PE1 prepolymer in DMSO – d6. 
 
 
 
 
 
 
 
239 
 
 
 
 
 
 
1
H NMR spectra of PE2 prepolymer in DMSO – d6.  
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13
C NMR spectra of PE2 prepolymer in DMSO – d6. 
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1
H NMR spectra of PE3 prepolymer in DMSO – d6.  
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13
C NMR spectra of PE3 prepolymer in DMSO – d6. 
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1
H NMR spectra of PE4 prepolymer in DMSO – d6.  
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13
C NMR spectra of PE4 prepolymer in DMSO – d6. 
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1
H NMR spectra of PE5 prepolymer in DMSO – d6.  
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13
C NMR spectra of PE5 prepolymer in DMSO – d6. 
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1
H NMR spectra of PE6 prepolymer in DMSO – d6.  
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13
C NMR spectra of PE6 prepolymer in DMSO – d6. 
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1
H NMR spectra of compound 1a. 
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13
C NMR spectra of compound 1a. 
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1
H NMR spectra of compound 2a. 
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13
C NMR spectra of compound 2a. 
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1
H NMR spectra of compound 3a. 
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13
C NMR spectra of compound 3a. 
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1
H NMR spectra of compound 4a. 
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13
C NMR spectra of compound 4a. 
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1
H NMR spectra of compound 1b. 
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13
C NMR spectra of compound 1b. 
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1
H NMR spectra of compound 2b. 
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13
C NMR spectra of compound 2b. 
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1
H NMR spectra of compound 3b. 
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13
C NMR spectra of compound 3b. 
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1
H NMR spectra of compound 4b. 
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13
C NMR spectra of compound 4b. 
 
 
 
